10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 26, 2023

or 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                     to                     

Commission file number 0-12933 

___________________________________________________________

LAM RESEARCH CORPORATION

(Exact name of registrant as specified in its charter)

___________________________________________________________

Delaware	94-2634797
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

4650 Cushing Parkway, Fremont, California 94538

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (510) 572-0200

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, Par Value $0.001 Per Share	LRCX	The Nasdaq Stock Market
		(Nasdaq Global Select Market)

__________________________________________________

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

As of April 20, 2023, the Registrant had 134,340,474 shares of Common Stock outstanding.

LAM RESEARCH CORPORATION

TABLE OF CONTENTS

		Page No.
	PART I. Financial Information
Item 1.	Financial Statements (Unaudited):
	Condensed Consolidated Statements of Operations for the three and nine months ended March 26, 2023 and March 27, 2022	3
	Condensed Consolidated Statements of Comprehensive Income for the three and nine months ended March 26, 2023 and March 27, 2022	4
	Condensed Consolidated Balance Sheets as of March 26, 2023, and June 26, 2022	5
	Condensed Consolidated Statements of Cash Flows for the nine months ended March 26, 2023 and March 27, 2022	6
	Condensed Consolidated Statements of Stockholders’ Equity for the three and nine months ended March 26, 2023 and March 27, 2022	7
	Notes to Condensed Consolidated Financial Statements	9
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	28
Item 4.	Controls and Procedures	28
	PART II. Other Information
Item 1.	Legal Proceedings	30
Item 1A.	Risk Factors	30
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	43
Item 3.	Defaults Upon Senior Securities	43
Item 4.	Mine Safety Disclosures	43
Item 5.	Other Information	43
Item 6.	Exhibits	44
Signatures		45

PART I. FINANCIAL INFORMATION

ITEM 1.    Financial Statements

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
Revenue	$	3,869,569	$	4,060,416	$	14,221,259	$	12,591,485
Cost of goods sold	2,197,237		2,243,791		7,835,743		6,820,190
Restructuring charges, net - cost of goods sold	66,720		—		66,720		—
Total cost of goods sold	2,263,957		2,243,791		7,902,463		6,820,190
Gross margin	1,605,612		1,816,625		6,318,796		5,771,295
Research and development	429,451		407,120		1,325,211		1,193,091
Selling, general, and administrative	193,500		217,408		632,922		675,735
Restructuring charges, net - operating expenses	40,408		—		40,408		—
Total operating expenses	663,359		624,528		1,998,541		1,868,826
Operating income	942,253		1,192,097		4,320,255		3,902,469
Other income (expense), net	(3,331)		(57,402)		(74,660)		(68,260)
Income before income taxes	938,922		1,134,695		4,245,595		3,834,209
Income tax expense	(124,914)		(112,917)		(537,201)		(437,857)
Net income	$	814,008	$	1,021,778	$	3,708,394	$	3,396,352
Net income per share:
Basic	$	6.03	$	7.34	$	27.28	$	24.17
Diluted	$	6.01	$	7.30	$	27.20	$	24.02
Number of shares used in per share calculations:
Basic	134,924		139,229		135,945		140,534
Diluted	135,395		140,057		136,314		141,400

See Notes to Condensed Consolidated Financial Statements

Lam Research Corporation 2023 Q3 10-Q 3

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in thousands)

(unaudited)

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
Net income	$	814,008	$	1,021,778	$	3,708,394	$	3,396,352
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	3,727		(14,958)		11,588		(28,810)
Cash flow hedges:
Net unrealized (losses) gains during the period	(3,320)		12,506		(3,135)		16,293
Net losses (gains) reclassified into net income	2,546		(5,759)		(5,478)		(17,205)
	(774)		6,747		(8,613)		(912)
Available-for-sale investments:
Net unrealized gains (losses) during the period	652		(1,333)		1,222		(4,523)
Net (gains) losses reclassified into net income	(105)		(34)		(158)		1,456
	547		(1,367)		1,064		(3,067)
Defined benefit plans, net change in unrealized component	276		58		848		(749)
Other comprehensive income (loss), net of tax	3,776		(9,520)		4,887		(33,538)
Comprehensive income	$	817,784	$	1,012,258	$	3,713,281	$	3,362,814

See Notes to Condensed Consolidated Financial Statements

Lam Research Corporation 2023 Q3 10-Q 4

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except per share data)

	March 26, 2023		June 26, 2022
	(unaudited)		(1)
ASSETS
Cash and cash equivalents	$	5,305,648	$	3,522,001
Investments	63,849		135,731
Accounts receivable, less allowance of $5,359 as of March 26, 2023, and $5,606 as of June 26, 2022	3,262,140		4,313,818
Inventories	4,881,935		3,966,294
Prepaid expenses and other current assets	216,455		347,391
Total current assets	13,730,027		12,285,235
Property and equipment, net	1,855,117		1,647,587
Restricted cash and investments	250,688		251,534
Goodwill	1,622,172		1,515,113
Intangible assets, net	179,647		101,850
Other assets	1,605,710		1,394,313
Total assets	$	19,243,361	$	17,195,632
LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade accounts payable	$	601,930	$	1,011,208
Accrued expenses and other current liabilities	1,990,147		1,974,272
Deferred profit	1,840,795		1,571,898
Current portion of long-term debt and finance lease obligations	8,457		7,381
Total current liabilities	4,441,329		4,564,759
Long-term debt and finance lease obligations, less current portion	4,996,920		4,998,449
Income taxes payable	885,348		931,117
Other long-term liabilities	512,376		422,941
Total liabilities	10,835,973		10,917,266
Commitments and contingencies
Stockholders’ equity:
Preferred stock, at par value of $0.001 per share; authorized, 5,000 shares, none outstanding	—		—
Common stock, at par value of $0.001 per share; authorized, 400,000 shares as of March 26, 2023 and June 26, 2022; issued and outstanding, 134,692 shares as of March 26, 2023, and 136,975 shares as of June 26, 2022	135		137
Additional paid-in capital	7,680,059		7,414,916
Treasury stock, at cost; 159,940 shares as of March 26, 2023, and 157,087 shares as of June 26, 2022	(20,627,829)		(19,481,429)
Accumulated other comprehensive loss	(105,095)		(109,982)
Retained earnings	21,460,118		18,454,724
Total stockholders’ equity	8,407,388		6,278,366
Total liabilities and stockholders’ equity	$	19,243,361	$	17,195,632

(1)Derived from audited financial statements

See Notes to Condensed Consolidated Financial Statements

Lam Research Corporation 2023 Q3 10-Q 5

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands) (unaudited)

	Nine Months Ended
	March 26, 2023		March 27, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$	3,708,394	$	3,396,352
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	252,828		245,807
Deferred income taxes	(133,101)		(83,451)
Equity-based compensation expense	218,105		189,476
Other, net	11,537		(78,325)
Changes in operating assets and liabilities	(1,550)		(1,014,119)
Net cash provided by operating activities	4,056,213		2,655,740
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets	(422,898)		(420,288)
Business acquisitions, net of cash acquired	(119,955)		—
Purchases of available-for-sale securities	—		(567,819)
Proceeds from maturities of available-for-sales securities	65,015		167,123
Proceeds from sales of available-for-sale securities	6,837		1,543,094
Other, net	(8,381)		(33,898)
Net cash (used for) provided by investing activities	(479,382)		688,212
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt	(21,145)		(9,857)
Treasury stock purchases	(1,147,998)		(2,989,574)
Dividends paid	(675,572)		(607,234)
Reissuance of treasury stock related to employee stock purchase plan	44,996		46,380
Proceeds from issuance of common stock	7,673		4,685
Other, net	(635)		197
Net cash used for financing activities	(1,792,681)		(3,555,403)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(1,349)		(13,544)
Net increase (decrease) in cash, cash equivalents, and restricted cash	1,782,801		(224,995)
Cash, cash equivalents, and restricted cash at beginning of period	3,773,535		4,670,750
Cash, cash equivalents, and restricted cash at end of period	$	5,556,336	$	4,445,755
Schedule of non-cash transactions:
Accrued payables for stock repurchases	$	4,081	$	4,624
Accrued payables for capital expenditures	38,225		57,930
Dividends payable	233,043		208,057
Transfers of finished goods inventory to property and equipment	64,932		62,116
Reconciliation of cash, cash equivalents, and restricted cash	March 26, 2023		March 27, 2022
Cash and cash equivalents	$	5,305,648	$	4,194,719
Restricted cash and cash equivalents	250,688		251,036
Total cash, cash equivalents, and restricted cash	$	5,556,336	$	4,445,755

See Notes to Condensed Consolidated Financial Statements

Lam Research Corporation 2023 Q3 10-Q 6

LAM RESEARCH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands)

(unaudited)

	Three Months Ended
	March 26, 2023
	Common Stock Shares	Common Stock		Additional Paid-in Capital		Treasury Stock		Accumulated Other Comprehensive Loss		Retained Earnings		Total
Balance at December 25, 2022	135,403	$	135	$	7,606,149	$	(20,071,931)	$	(108,871)	$	20,879,153	$	8,304,635
Issuance of common stock	454	1		(1)		—		—		—		—
Purchase of treasury stock	(1,165)	(1)		—		(555,898)		—		—		(555,899)
Equity-based compensation expense	—	—		73,911		—		—		—		73,911
Net income	—	—		—		—		—		814,008		814,008
Other comprehensive income	—	—		—		—		3,776		—		3,776
Cash dividends declared ($1.725 per common share)	—	—		—		—		—		(233,043)		(233,043)
Balance at March 26, 2023	134,692	$	135	$	7,680,059	$	(20,627,829)	$	(105,095)	$	21,460,118	$	8,407,388
	Nine Months Ended
	March 26, 2023
	Common Stock Shares	Common Stock		Additional Paid-in Capital		Treasury Stock		Accumulated Other Comprehensive Loss		Retained Earnings		Total
Balance at June 26, 2022	136,975	$	137	$	7,414,916	$	(19,481,429)	$	(109,982)	$	18,454,724	$	6,278,366
Issuance of common stock	570	1		7,672		—		—		—		7,673
Purchase of treasury stock	(2,984)	(3)		—		(1,152,030)		—		—		(1,152,033)
Reissuance of treasury stock	131	—		39,366		5,630		—		—		44,996
Equity-based compensation expense	—	—		218,105		—		—		—		218,105
Net income	—	—		—		—		—		3,708,394		3,708,394
Other comprehensive income	—	—		—		—		4,887		—		4,887
Cash dividends declared ($5.175 per common share)	—	—		—		—		—		(703,000)		(703,000)
Balance at March 26, 2023	134,692	$	135	$	7,680,059	$	(20,627,829)	$	(105,095)	$	21,460,118	$	8,407,388
See Notes to Condensed Consolidated Financial Statements

Lam Research Corporation 2023 Q3 10-Q 7

	Three Months Ended
	March 27, 2022
	Common Stock Shares	Common Stock		Additional Paid-in Capital		Treasury Stock		Accumulated Other Comprehensive Loss		Retained Earnings		Total
Balance at December 26, 2021	140,275	$	140	$	7,220,359	$	(17,294,255)	$	(88,146)	$	16,637,683	$	6,475,781
Issuance of common stock	664	1		491		—		—		—		492
Purchase of treasury stock	(2,232)	(2)		—		(1,322,525)		—		—		(1,322,527)
Equity-based compensation expense	—	—		68,543		—		—		—		68,543
Net income	—	—		—		—		—		1,021,778		1,021,778
Other comprehensive loss	—	—		—		—		(9,520)		—		(9,520)
Cash dividends declared ($1.50 per common share)	—	—		—		—		—		(208,057)		(208,057)
Balance at March 27, 2022	138,707	$	139	$	7,289,393	$	(18,616,780)	$	(97,666)	$	17,451,404	$	6,026,490
	Nine Months Ended
	March 27, 2022
	Common Stock Shares	Common Stock		Additional Paid-in Capital		Treasury Stock		Accumulated Other Comprehensive Loss		Retained Earnings		Total
Balance at June 27, 2021	142,501	$	143	$	7,052,962	$	(15,646,701)	$	(64,128)	$	14,684,912	$	6,027,188
Issuance of common stock	763	1		4,684		—		—		—		4,685
Purchase of treasury stock	(4,654)	(5)		—		(2,974,188)		—		—		(2,974,193)
Reissuance of treasury stock	97	—		42,271		4,109		—		—		46,380
Equity-based compensation expense	—	—		189,476		—		—		—		189,476
Net income	—	—		—		—		—		3,396,352		3,396,352
Other comprehensive loss	—	—		—		—		(33,538)		—		(33,538)
Cash dividends declared ($4.50 per common share)	—	—		—		—		—		(629,860)		(629,860)
Balance at March 27, 2022	138,707	$	139	$	7,289,393	$	(18,616,780)	$	(97,666)	$	17,451,404	$	6,026,490

See Notes to Condensed Consolidated Financial Statements

Lam Research Corporation 2023 Q3 10-Q 8

LAM RESEARCH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 26, 2023

(Unaudited)

NOTE 1 — BASIS OF PRESENTATION

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of Lam Research Corporation (“Lam Research” or the “Company”) for the fiscal year ended June 26, 2022, which are included in the Company’s Annual Report on Form 10-K as of and for the year ended June 26, 2022 (the “2022 Form 10-K”). The Company’s reports on Form 10-K, Form 10-Q and Form 8-K are available online at the Securities and Exchange Commission website on the Internet. The address of that site is www.sec.gov. The Company also posts its reports on Form 10-K, Form 10-Q and Form 8-K on its corporate website at https://investor.lamresearch.com. The content on any website referred to in this Form 10-Q is not a part of or incorporated by reference in this Form 10-Q unless expressly noted.

The condensed consolidated financial statements include the accounts of Lam Research and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 25, 2023 and includes 52 weeks. The quarters ended March 26, 2023 (the “March 2023 quarter”) and March 27, 2022 included 13 weeks.

NOTE 2 — RECENT ACCOUNTING PRONOUNCEMENTS

Recently Adopted or Effective

In March 2020, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides temporary optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued. In January 2021, the FASB issued ASU 2021-01, “Reference Rate Reform (Topic 848),” which permits entities to apply optional expedients in Topic 848 to derivative instruments modified because of discounting transition resulting from reference rate reform. In December 2022, the FASB issued ASU 2022-06, “Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848,” extending the relief offered in this series of ASUs through December 31, 2024.

In December 2022, the Company executed Amendment No. 1 To Second Amended and Restated Credit Agreement, the primary purpose of which was to change the reference rate for borrowings under the Credit Agreement by replacing LIBOR with the Secured Overnight Financing Rate (“SOFR”). The Company applied practical expedients provided in Topic 848 allowing for the changes in contractual terms to be accounted for prospectively. These modifications had no significant impact on our financial statements. Refer to Note 12 - Long-term debt and other borrowings for further information regarding the terms of the Credit Agreement.

In October 2021, the FASB issued ASU No. 2021-08, “Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,” which requires contract assets and contract liabilities (e.g., deferred revenue) acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, “Revenue from Contracts with Customers” as if the acquirer had originated the contracts. The guidance is applied prospectively to acquisitions occurring on or after the effective date. The Company early adopted ASU No. 2021-08 during the quarter ended December 25, 2022. The adoption of the new standard did not have a material impact on the Company’s Condensed Consolidated financial statements.

Updates Not Yet Effective

There are no new accounting pronouncements not yet adopted or effective that are expected to have a material impact on the Company’s Condensed Consolidated Financial Statements.

Lam Research Corporation 2023 Q3 10-Q 9

NOTE 3 — REVENUE

Deferred Revenue

Revenue of $149.1 million and $1,881.8 million included in deferred profit at June 26, 2022 was recognized during the three and nine months ended March 26, 2023, respectively.

The following table summarizes the transaction price for contracts that have not yet been recognized as revenue as of March 26, 2023 and when the Company expects to recognize the amounts as revenue:

	Less than 1 Year		1-3 Years			More than 3 Years			Total
	(In thousands)
Deferred revenue	$	1,731,567	$	243,733	(1)	$	27,444	(1)	$	2,002,744

(1)This amount is reported in Deferred profit on the Company's Condensed Consolidated Balance Sheets as the customers can demand the liability to be performed at any time.

Disaggregation of Revenue

The Company operates in one reportable business segment: manufacturing and servicing of wafer processing semiconductor manufacturing equipment. The Company’s material operating segments qualify for aggregation due to their customer base and similarities in economic characteristics, nature of products and services, and processes for procurement, manufacturing, and distribution.

The Company operates in seven geographic regions: United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. For geographical reporting, revenue is attributed to the geographic location in which the customers’ facilities are located. The Company serves three primary markets: memory, foundry, and logic/integrated device manufacturing.

The following table presents the Company’s revenues disaggregated between system and its customer support-related revenue:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(In thousands)
System revenue	$	2,256,033	$	2,650,842	$	8,985,538	$	8,315,898
Customer support-related revenue and other	1,613,536		1,409,574		5,235,721		4,275,587
	$	3,869,569	$	4,060,416	$	14,221,259	$	12,591,485

System revenue includes sales of new leading-edge equipment in deposition, etch and clean markets.

Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from the Company’s Reliant product line.

The following table presents the Company’s revenues disaggregated by geographic region:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(In thousands)
Korea	$	847,728	$	961,300	$	2,780,158	$	2,947,657
China	839,710		1,277,502		3,633,692		3,966,185
Taiwan	713,708		663,494		2,825,827		2,074,681
United States	594,426		309,161		1,402,641		782,170
Japan	406,219		342,329		1,440,857		1,324,996
Europe	311,843		128,149		912,249		387,685
Southeast Asia	155,935		378,481		1,225,835		1,108,111
	$	3,869,569	$	4,060,416	$	14,221,259	$	12,591,485

Lam Research Corporation 2023 Q3 10-Q 10

The following table presents the percentages of leading- and non-leading-edge equipment and upgrade revenue to each of the primary markets the Company serves:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
Memory	32	%	66	%	46	%	62	%
Foundry	46	%	21	%	18	%	26	%
Logic/integrated device manufacturing	22	%	13	%	36	%	12	%

NOTE 4 — EQUITY-BASED COMPENSATION PLANS

The Lam Research Corporation 2015 Stock Incentive Plan, as amended, provides for the grant of non-qualified equity-based awards of the Company’s Common Stock to eligible employees and non-employee directors, including stock options, restricted stock units (“RSUs”), and market-based performance RSUs (“market-based PRSUs”). An option is a right to purchase Common Stock at a set price. An RSU award is an agreement to issue a set number of shares of Common Stock at the time of vesting. The Company’s market-based PRSUs contain both a market condition and a service condition. The Company’s option, RSU, and market-based PRSU awards typically vest over a period of three years. The Company also has an employee stock purchase plan that allows employees to purchase its Common Stock at a discount through payroll deductions.

The Company recognized the following equity-based compensation expense (including expense related to the employee stock purchase plan) and related income tax benefit in the Condensed Consolidated Statements of Operations:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(in thousands)
Equity-based compensation expense	$	73,911	$	68,543	$	218,105	$	189,476
Income tax benefit recognized related to equity-based compensation expense	$	12,045	$	23,933	$	32,249	$	41,155

NOTE 5 — OTHER INCOME (EXPENSE), NET

The significant components of other income (expense), net, are as follows:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(in thousands)
Interest income	$	41,974	$	1,938	$	83,155	$	8,988
Interest expense	(47,217)		(46,710)		(139,930)		(138,531)
Gains (losses) on deferred compensation plan-related assets, net	5,443		(13,118)		3,588		(5,737)
Foreign exchange (losses) gains, net	(5,519)		943		(8,812)		1,657
Other, net	1,988		(455)		(12,661)		65,363
	$	(3,331)	$	(57,402)	$	(74,660)	$	(68,260)

Other, net includes an unrealized gain totaling $63.6 million associated with an equity investee that became publicly traded during the nine months ended March 27, 2022. Refer to Note 8 - Financial Instruments for additional information regarding the Company’s investments.

Lam Research Corporation 2023 Q3 10-Q 11

NOTE 6 — INCOME TAX EXPENSE

The Company’s provision for income taxes and effective tax rate are as follows:

	Three Months Ended						Nine Months Ended
	March 26, 2023			March 27, 2022			March 26, 2023			March 27, 2022
	(in thousands, except percentages)
Income tax expense	$	124,914		$	112,917		$	537,201		$	437,857
Effective tax rate	13.3		%	10.0		%	12.7		%	11.4		%

The difference between the U.S. federal statutory tax rate of 21% and the Company’s effective tax rate for the three and nine months ended March 26, 2023 and March 27, 2022 was primarily due to income in lower tax jurisdictions.

The Internal Revenue Service (“IRS”) has examined the Company’s U.S. federal income tax return for the fiscal year ended June 24, 2018. As of September 25, 2022, the IRS has proposed adjustments resulting in a tax liability increase of approximately $50.0 million, which was previously reserved. The Company has agreed to pay the amount and has made a partial cash settlement in the September quarter with the remaining settlement expected to be paid based on the IRS requirements.

The IRS is examining the Company’s U.S. federal income tax returns for the fiscal years ended June 30, 2019, and June 28, 2020. As of March 26, 2023, no adjustments have been proposed by the IRS. The Company is unable to make a reasonable estimate as to when cash settlements, if any, with the IRS will occur.

The Company is in various stages of examinations in connection with all of its tax audits worldwide, and it is difficult to determine when these examinations will be settled. It is reasonably possible that over the next 12-month period the Company may experience an increase or decrease in its uncertain tax positions as a result of tax examinations or lapses of statutes of limitation. The change in uncertain tax positions as a result of lapses of statutes of limitation may range up to $18.3 million.

NOTE 7 — NET INCOME PER SHARE

Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the treasury stock method, for dilutive stock options, restricted stock units, and convertible notes. The following table reconciles the inputs to the basic and diluted computations for net income per share. 

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(in thousands, except per share data)
Numerator:
Net income	$	814,008	$	1,021,778	$	3,708,394	$	3,396,352
Denominator:
Basic average shares outstanding	134,924		139,229		135,945		140,534
Effect of potential dilutive securities:
Employee stock plans	471		828		369		866
Diluted average shares outstanding	135,395		140,057		136,314		141,400
Net income per share - basic	$	6.03	$	7.34	$	27.28	$	24.17
Net income per share - diluted	$	6.01	$	7.30	$	27.20	$	24.02

For purposes of computing diluted net income per share, weighted-average common shares do not include potentially dilutive securities that are anti-dilutive under the treasury stock method. The impact from potentially dilutive securities, including options and RSUs, was not material for the three and nine months ended March 26, 2023 and March 27, 2022.

Lam Research Corporation 2023 Q3 10-Q 12

NOTE 8 — FINANCIAL INSTRUMENTS

The Company maintains an investment portfolio of various holdings, types, and maturities. The Company’s mutual funds, which are related to the Company’s obligations under the deferred compensation plan, are classified as trading securities. Investments classified as trading securities are recorded at fair value based upon quoted market prices. Differences between the cost and fair value of trading securities are recognized as other income (expense), net in the Condensed Consolidated Statements of Operations. All of the Company’s debt securities are classified as available-for-sale and consequently are recorded in the Condensed Consolidated Balance Sheets at fair value with unrealized gains or losses associated with market valuation changes, unrelated to credit losses, reported as a separate component of accumulated other comprehensive income (loss), net of tax; and credit losses, if any, recognized as other income (expense), net in the Condensed Consolidated Statements of Operations.

The Company periodically invests in equity securities. For equity investments that do not have a readily determinable fair value, the Company records them using either 1) the measurement alternative which measures the equity investments at cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes; or 2) the equity method whereby the Company recognizes its proportional share of the income or loss from the equity method investment on a one-quarter lag. The equity method is utilized when the Company does not have the ability to control the investee but is deemed to have the ability to exercise significant influence over the investee’s operating or financial policies. For equity investments that have a readily determinable fair value, the Company records them at fair market value on a recurring basis based upon quoted market prices. Realized and unrealized gains and losses resulting from application of the measurement alternative, the impact of the application of the equity method to the Company’s equity investments, and recognition of changes in fair market value, as applicable, are recognized as other income (expense), net in the Condensed Consolidated Statements of Operations.

Fair Value

The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability.

A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. The level of an asset or liability in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:

Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities with sufficient volume and frequency of transactions.

Level 2: Valuations based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active for identical assets or liabilities, or model-derived valuations techniques for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3: Valuations based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities and based on non-binding, broker-provided price quotes and may not have been corroborated by observable market data.

The Company engages with pricing vendors to provide fair values for a majority of its Level 1 and Level 2 investments. The vendors provide either a quoted market price or use observable inputs without applying significant adjustments in their pricing. Significant observable inputs include interest rates and yield curves observable at commonly quoted intervals, volatility and credit risks. The fair value of derivative contracts is determined using observable market inputs such as the foreign currency rates, forward rate curves, currency volatility and interest rates and considers nonperformance risk of the Company and its counterparties.

The Company’s primary financial instruments include its cash, cash equivalents, investments, restricted cash and investments, long-term investments, accounts receivable, accounts payable, long-term debt and leases, and foreign currency related derivative instruments. The estimated fair value of cash, time deposits, accounts receivable, and accounts payable approximates their carrying value due to the short period of time to their maturities. The estimated fair values of lease obligations approximate their carrying value as the majority of these obligations have interest rates that adjust to market rates on a periodic basis. The fair value of the Company’s senior notes is based on the quoted price (level 2); the fair value of the Company's senior notes have not changed materially to that disclosed in Note 14, “Long Term Debt and Other Borrowings,” to the Company’s Consolidated Financial Statements in Part II, Item 8 of our 2022 Form 10-K.

Equity Investments measured at fair value on a non-recurring basis

As of March 26, 2023, and June 26, 2022, equity investments of $128.9 million and $125.2 million, respectively, were reported in other assets in the Condensed Consolidated Balance Sheets.

Lam Research Corporation 2023 Q3 10-Q 13

With the exception of one equity investee that became publicly traded during the nine months ended March 27, 2022, net gains resulting from the application of the measurement alternative to the Company’s equity investments were immaterial for the three and nine months ended March 26, 2023, and March 27, 2022. Refer to Note 5 - Other Income (Expense), net for additional information regarding the gain associated with an equity investee that became publicly traded in the nine months ended March 27, 2022.

Debt and Equity Investments measured at fair value on a recurring basis

The following tables set forth the Company’s cash, cash equivalents, investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of March 26, 2023, and June 26, 2022:

	March 26, 2023
									(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)		Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Level 1:
Money market funds	$	2,534,717	$	—	$	—	$	2,534,717	$	2,534,717	$	—	$	—	$	—
Mutual funds	87,004		9,710		(2,234)		94,480		—		—		—		94,480
Level 1 Total	2,621,721		9,710		(2,234)		2,629,197		2,534,717		—		—		94,480
Level 2:
Corporate notes and bonds	64,593		—		(744)		63,849		—		63,849		—		—
Level 2 Total	64,593		—		(744)		63,849		—		63,849		—		—
Total subject to fair value hierarchy	$	2,686,314	$	9,710	$	(2,978)	$	2,693,046
Cash							$	1,414,563	$	1,411,064	$	—	$	661	$	2,838
Time deposits							1,609,894		1,359,867		—		250,027		—
Total							$	5,717,503	$	5,305,648	$	63,849	$	250,688	$	97,318

	June 26, 2022
									(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)		Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Level 1:
Money market funds	$	712,076	$	—	$	—	$	712,076	$	712,076	$	—	$	—	$	—
Mutual funds	84,851		12,027		(1,659)		95,219		—		—		—		95,219
Level 1 Total	796,927		12,027		(1,659)		807,295		712,076		—		—		95,219
Level 2:
Corporate notes and bonds	137,859		—		(2,128)		135,731		—		135,731		—		—
Level 2 Total	137,859		—		(2,128)		135,731		—		135,731		—		—
Total subject to fair value hierarchy	$	934,786	$	12,027	$	(3,787)	$	943,026
Cash							$	1,017,253	$	1,015,747	$	—	$	1,506	$	—
Time deposits							2,044,206		1,794,178		—		250,028		—
Total							$	4,004,485	$	3,522,001	$	135,731	$	251,534	$	95,219

The Company accounts for its investment portfolio at fair value. Realized gains (losses) for investment sales are specifically identified. Management assesses the fair value of investments in debt securities that are not actively traded through consideration of interest rates and their impact on the present value of the cash flows to be received from the investments.

The Company evaluates its investments with fair value less than amortized cost by first considering whether the Company has the intent to sell the security or whether it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. In either such situation, the difference between fair value and amortized cost is recognized as a loss in the income statement. Where such sales are not likely to occur, the Company considers whether a portion of the loss is the result of a credit loss. To the extent such losses are the result of credit losses, those amounts are recognized in the income statement. All other differences between fair value and amortized cost are recognized in other comprehensive income. No such losses were recognized through the income statement during the three and nine months ended March 26, 2023 and March 27, 2022.

Lam Research Corporation 2023 Q3 10-Q 14

Gross realized gains/(losses) from sales of investments were insignificant in the three and nine months ended March 26, 2023 and March 27, 2022.

The following is an analysis of the Company’s investments in unrealized loss positions:

	March 26, 2023
	Unrealized Losses Less than 12 Months				Unrealized Losses 12 Months or Greater				Total
	Fair Value		Gross Unrealized Loss		Fair Value		Gross Unrealized Loss		Fair Value		Gross Unrealized Loss
	(in thousands)
Mutual funds	$	11,634	$	(922)	$	15,332	$	(1,312)	$	26,966	$	(2,234)
Corporate notes and bonds	16,838		(88)		46,560		(656)		63,398		(744)
	$	28,472	$	(1,010)	$	61,892	$	(1,968)	$	90,364	$	(2,978)

The amortized cost and fair value of cash equivalents, investments, and restricted investments with contractual maturities are as follows as of March 26, 2023:

	Cost		Fair Value
	(in thousands)
Due in one year or less	$	4,200,733	$	4,200,066
Due after one year through five years	8,471		8,394
	$	4,209,204	$	4,208,460

The Company has the ability, if necessary, to liquidate its investments in order to meet the Company’s liquidity needs in the next 12 months. Accordingly, those investments with contractual maturities greater than 12 months from the date of purchase nonetheless are classified as short-term on the accompanying Condensed Consolidated Balance Sheets.

Derivative Instruments and Hedging

The Company’s hedging strategies and policies are unchanged from those disclosed in Note 9, “Financial Instruments,” to our Consolidated Financial Statements in Part II, Item 8 of our 2022 Form 10-K. The financial statement impacts from derivative instruments and hedging activities were not material as of and for the three and nine months ended March 26, 2023 and March 27, 2022.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, investments, restricted cash and investments, trade accounts receivable, and derivative financial instruments used in hedging activities. Cash is placed on deposit at large, global financial institutions. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company’s cash are creditworthy and, accordingly, minimal credit risk exists with respect to these balances.

The Company’s overall portfolio of available-for-sale securities must maintain an average minimum rating of “AA-” or “Aa3” as rated by Standard and Poor’s, Fitch Ratings, or Moody’s Investor Services. To ensure diversification and minimize concentration, the Company’s policy limits the amount of credit exposure with any one financial institution or commercial issuer.

The Company is exposed to credit losses in the event of nonperformance by counterparties on foreign currency and interest rate hedge contracts that are used to mitigate the effect of exchange rate and interest rate fluctuations, and on contracts related to structured share repurchase arrangements. These counterparties are large global financial institutions, and, to date, no such counterparty has failed to meet its financial obligations to the Company.

Credit risk evaluations, including trade references, bank references, and Dun & Bradstreet ratings, are performed on all new customers and the Company monitors its customers’ financial condition and payment performance. In general, the Company does not require collateral on sales.

Lam Research Corporation 2023 Q3 10-Q 15

NOTE 9 — INVENTORIES

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. System shipments to customers in Japan, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers. Inventories consist of the following:

	March 26, 2023		June 26, 2022
	(in thousands)
Raw materials	$	3,219,721	$	2,401,490
Work-in-process	396,415		471,348
Finished goods	1,265,799		1,093,456
	$	4,881,935	$	3,966,294

NOTE 10 — GOODWILL AND INTANGIBLE ASSETS

Goodwill

The balance of goodwill is approximately $1.6 billion and $1.5 billion as of March 26, 2023 and June 26, 2022, respectively. As of March 26, 2023 and June 26, 2022, $62.0 million of the goodwill balance is tax deductible and the remaining balance is not tax deductible due to purchase accounting and applicable foreign law. Refer to Note 17 - Business Combinations for additional information regarding the Company’s goodwill balance.

Intangible Assets

The following table provides the Company’s intangible assets, other than goodwill:

	March 26, 2023						June 26, 2022
	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
	(in thousands)
Customer relationships	$	644,083	$	(630,262)	$	13,821	$	633,252	$	(627,376)	$	5,876
Existing technology	717,210		(671,335)		45,875		676,924		(664,278)		12,646
Patents and other intangible assets	197,612		(107,742)		89,870		167,821		(84,493)		83,328
Intangible assets subject to amortization	1,558,905		(1,409,339)		149,566		1,477,997		(1,376,147)		101,850
In process research and development	30,081		—		30,081		—		—		—
Total intangible assets	$	1,588,986	$	(1,409,339)	$	179,647	$	1,477,997	$	(1,376,147)	$	101,850

The Company recognized $13.8 million and $20.4 million in intangible asset amortization expense during the three months ended March 26, 2023 and March 27, 2022, respectively. The Company recognized $37.4 million and $58.9 million in intangible asset amortization expense during the nine months ended March 26, 2023 and March 27, 2022, respectively.

The estimated future amortization expense of intangible assets as of March 26, 2023, is reflected in the table below. The table excludes $20.7 million of capitalized costs for internal-use software, included in Patents and other intangible assets in the table above, that have not been placed into service.

Fiscal Year	Amount
	(in thousands)
2023 (remaining 3 months)	$	13,014
2024	40,799
2025	26,696
2026	16,575
2027	12,262
Thereafter	19,570
	$	128,916

Refer to Note 17 - Business Combinations for additional information regarding the Company’s intangible assets.

Lam Research Corporation 2023 Q3 10-Q 16

NOTE 11 — ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consist of the following:

	March 26, 2023		June 26, 2022
	(in thousands)
Accrued compensation	$	433,643	$	481,070
Warranty reserves	277,183		232,248
Income and other taxes payable	383,610		465,601
Dividend payable	233,043		205,615
Restructuring	75,257		—
Other	587,411		589,738
	$	1,990,147	$	1,974,272

NOTE 12 — LONG-TERM DEBT AND OTHER BORROWINGS

Revolving Credit Facility

On March 12, 2014, the Company established an unsecured Credit Agreement. This agreement was amended on November 10, 2015 (the “Amended and Restated Credit Agreement”), October 13, 2017 (the “2nd Amendment”), February 25, 2019 (the “3rd Amendment”), June 17, 2021 (the “Second Amended and Restated Credit Agreement”), and December 7, 2022 (“Amendment No.1 to Second Amended and Restated Credit Agreement”). The Amendment No.1 To Second Amended and Restated Credit Agreement replaces the benchmark reference rate, LIBOR, with term SOFR equal to the term rate determined by the CME term SOFR administrator plus 0.10% (“adjusted term SOFR”), with no change to the amount or timing of contractual cash flows.

Interest on amounts borrowed under the credit facility is, at the Company’s option, based on (1) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus 0.5%, or (c) adjusted term SOFR plus 1.0%, plus a spread of 0.00% to 0.30%, or (2) adjusted term SOFR, plus a spread of 0.805% to 1.30%, in each case plus a facility fee, with such spread and facility fee determined based on the rating of the Company’s non-credit enhanced, senior unsecured long-term debt. Such spreads and such facility fees are further subject to sustainability adjustments as described in the Amendment No.1 To Second Amended and Restated Credit Agreement, in each case based on the Company’s performance of certain energy savings and health and safety standards metrics. As of March 26, 2023, the Company had no borrowings outstanding under the credit facility and was in compliance with all financial covenants.

NOTE 13 — LEASES

The Company leases certain office spaces, manufacturing and warehouse spaces, equipment, and vehicles. While the majority of the Company’s lease arrangements are operating leases, the Company has certain leases that qualify as finance leases.

Selected Leases and Related Guarantees

The Company leases the majority of its administrative, research and development and manufacturing facilities, regional sales/service offices, and certain equipment under non-cancelable leases. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters, Tualatin, Oregon campus, and certain other facility leases provide the Company with options to extend the leases for additional periods or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based on the general rate of inflation.

The Company has finance leases for certain improved properties in Fremont and Livermore, California (the “California Facility Leases”). The Company is required to maintain cash collateral in an aggregate of approximately $250.0 million in separate interest-bearing accounts as security for the Company’s obligations. These amounts are recorded with other restricted cash and investments in the Company’s Condensed Consolidated Balance Sheet as of March 26, 2023.

During the seven-year term of the California Facility Leases and when the terms of the California Facility Leases expire, the property subject to the California Facility Leases may be re-marketed. The Company has guaranteed to the lessor that each property will have a certain minimum residual value. The aggregate maximum guarantee made by the Company under the California Facility Leases is $298.4 million.

NOTE 14 — COMMITMENTS AND CONTINGENCIES

Refer to Note 13 - Leases for details regarding guarantees surrounding selected leases.

Lam Research Corporation 2023 Q3 10-Q 17

Other Guarantees

The Company has issued certain indemnifications to its lessors for taxes and general liability under some of its agreements. The Company has entered into insurance contracts that are intended to limit its exposure to such indemnifications. As of March 26, 2023, the Company had not recorded any liability on its Condensed Consolidated Financial Statements in connection with these indemnifications, as it does not believe that it is probable that any material amounts will be paid under these guarantees.

Generally, the Company indemnifies, under pre-determined conditions and limitations, its customers for infringement of third-party intellectual property rights by the Company’s products or services. The Company seeks to limit its liability for such indemnity to an amount not to exceed the sales price of the products or services subject to its indemnification obligations. The Company does not believe that it is probable that any material amounts will be paid under these guarantees.

The Company provides guarantees and standby letters of credit to certain parties as required for certain transactions initiated during the ordinary course of business. As of March 26, 2023, the maximum potential amount of future payments that the Company could be required to make under these arrangements and letters of credit was $99.6 million. The Company does not believe, based on historical experience and information currently available, that it is probable that any material amounts will be required to be paid.

In addition, the Company has entered into indemnification agreements with its directors, officers, and certain other employees, consistent with its Bylaws and Certificate of Incorporation; and under local law, the Company may be required to provide indemnification to its employees for actions within the scope of their employment. Although the Company maintains insurance contracts that cover some of the potential liability associated with these indemnification agreements, there is no guarantee that all such liabilities will be covered. The Company does not believe, based on historical experience and information currently available, that it is probable that any material amounts will be required to be paid under such indemnification agreements or statutory obligations.

Warranties

The Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements. As of March 26, 2023, warranty reserves totaling $35.6 million were recognized in other long-term liabilities, the remainder were included in accrued expenses and other current liabilities in the Company’s Condensed Consolidated Balance Sheets.

Changes in the Company’s product warranty reserves were as follows:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(in thousands)
Balance at beginning of period	$	318,969	$	228,388	$	256,258	$	191,758
Warranties issued during the period	54,158		71,707		225,735		213,816
Settlements made during the period	(60,440)		(71,957)		(187,174)		(200,375)
Changes in liability for warranties issued during the period	(942)		—		999		—
Changes in liability for pre-existing warranties	1,087		12,190		17,014		35,129
Balance at end of period	$	312,832	$	240,328	$	312,832	$	240,328

Legal Proceedings

While the Company is not currently a party to any legal proceedings that it believes material, the Company is either a defendant or plaintiff in various actions that have arisen from time to time in the normal course of business, including intellectual property claims. The Company accrues for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. Based on current information, the Company does not believe that a material loss from known matters is probable and therefore has not recorded an accrual of any material amount for litigation or other contingencies related to existing legal proceedings.

Lam Research Corporation 2023 Q3 10-Q 18

NOTE 15 — STOCK REPURCHASE PROGRAM

In May 2022, the Board of Directors authorized the Company to repurchase up to an additional $5.0 billion of Common Stock; this authorization supplements the remaining balances from any prior authorizations. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. This repurchase program has no termination date and may be suspended or discontinued at any time.

Repurchases under the repurchase program were as follows during the periods indicated:

Period	Total Number of Shares Repurchased		Total Cost of Repurchase			Average Price Paid Per  Share (1)			Amount Available Under Repurchase Program (3)
	(in thousands, except per share data)
Available balance as of June 26, 2022									$	5,514,636
Quarter ended September 25, 2022	675	(2)	$	104,982		$	432.74		$	5,409,654
Quarter ended December 25, 2022	1,125		$	483,226		$	429.42		$	4,926,428
Quarter ended March 26, 2023	1,017		$	483,418	(3)	$	475.18	(3)	$	4,443,010

(1)    Average price paid per share excludes the effect of accelerated share repurchase activities. See additional disclosure below regarding the Company’s accelerated share repurchase activity during the nine months ended March 26, 2023.

(2)    Includes shares received at final settlement of accelerated share repurchase agreements; see additional disclosures below regarding the Company’s accelerated share repurchase activity during the nine months ended March 26, 2023.

(3)    As of January 1, 2023, the Company’s net share repurchases are subject to a 1% excise tax under the Inflation Reduction Act. Excise tax incurred reduces the amount available under the repurchase program, as applicable, and is included in the cost of share repurchased in the Condensed Consolidated Statement of Stockholders’ Equity.

In addition to the shares repurchased under the Board-authorized repurchase program shown above, during the three and nine months ended March 26, 2023, the Company acquired 148 thousand shares at a total cost of $72.5 million and 167 thousand shares at a total cost of $80.4 million, respectively, which the Company withheld through net settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under the Company’s equity compensation plans. The shares retained by the Company through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under the Company’s equity compensation plan.

Accelerated Share Repurchase Agreements

On June 2, 2022, the Company entered into an accelerated share repurchase agreement (the "June 2022 ASR") with two financial institutions to repurchase a total of $500 million of Common Stock. The Company took an initial delivery of approximately 717 thousand shares, which represented 75% of the prepayment amount divided by our closing stock price on June 2, 2022. The total number of shares received under the June 2022 ASR was based upon the average daily volume weighted average price of the Company’s Common Stock during the repurchase period, less an agreed upon discount. Final settlement of the June 2022 ASR occurred in September 2022, resulting in the receipt of approximately 433 thousand additional shares, which yielded a weighted-average share price of $435.20 for the transaction period.

Lam Research Corporation 2023 Q3 10-Q 19

NOTE 16 — ACCUMULATED OTHER COMPREHENSIVE LOSS

The components of accumulated other comprehensive loss, net of tax at March 26, 2023, as well as the activity for the nine months ending March 26, 2023, were as follows:

	Accumulated Foreign Currency Translation Adjustment		Accumulated Unrealized  Gain or Loss on Cash flow hedges		Accumulated Unrealized  Holding Gain or Loss on Available-For-Sale Investments		Accumulated Unrealized  Components of Defined  Benefit Plans		Total
	(in thousands)
Balance at June 26, 2022	$	(81,755)	$	(12,330)	$	(1,637)	$	(14,260)	$	(109,982)
Other comprehensive income (loss) before reclassifications	11,588		(3,135)		1,222		848		10,523
Gains reclassified from accumulated other comprehensive loss to net income (1)	—		(5,478)		(158)		—		(5,636)
Net current-period other comprehensive income (loss)	11,588		(8,613)		1,064		848		4,887
Balance at March 26, 2023	$	(70,167)	$	(20,943)	$	(573)	$	(13,412)	$	(105,095)

(1)    Amount of after-tax gains reclassified from AOCI into net income is not material in the aggregate, or to any individual location in our Condensed Consolidated Statements of Operations.

NOTE 17 — BUSINESS COMBINATIONS

In November 2022, the Company completed two business combination transactions acquiring the outstanding shares of two separate private companies in cash transactions valued at $153.8 million as of the respective purchase dates. The Company’s preliminary assessment of acquisition date fair value of the assets acquired and liabilities assumed resulted in the recognition of $102.2 million of goodwill and $81.2 million of intangible assets; all other assets acquired and all liabilities assumed were immaterial. The preliminary fair value of net tangible liabilities assumed and intangible assets acquired was based on preliminary valuations, estimates, and assumptions which are subject to change within the measurement period (up to one year from the acquisition date). The Company expensed all associated costs, as incurred, in selling, general, and administrative expense in the Condensed Consolidated Statement of Operations for the three and nine months ended March 26, 2023.

The following table is a summary of the preliminary fair value estimates of the identifiable intangible assets and their useful lives:

	Weighted-Average Useful Life	Estimated Purchase Date Fair Value
		(in thousands)
Existing technology	7 years	$	40,294
Customer relationships	8 years	10,835
In process research and development	Indefinite	30,081
		$	81,210

NOTE 18 — RESTRUCTURING CHARGES, NET

The Company records employee severance and separation costs that meet the requirements for recognition in accordance with the relevant guidance of ASC 420, Exit or Disposal Cost Obligations, or ASC 712, Compensation - Non-retirement Post-employment Benefits, as applicable. For involuntary termination benefits that are not provided under the terms of an ongoing benefit arrangement, the liability for the current fair value of expected future costs associated with a management-approved restructuring plan is recognized in the period in which the plan is communicated to the employees and the plan is not expected to change significantly. For ongoing benefit arrangements, inclusive of statutory requirements, employee termination costs are accrued when the existing situation or set of circumstances indicates that an obligation has been incurred, it is probable the benefits will be paid, and the amount can be reasonably estimated. Termination benefits associated with employees that elected to voluntarily terminate as part of the restructuring plan are recorded when the employee irrevocably accepts the offer and the amount can be reasonably estimated. If applicable, the Company records such costs into operating expense over the terminated employees’ future service period beyond any minimum or legally required retention period. The majority of restructuring charges that have been incurred but not yet paid are recorded in Accrued expenses and other current liabilities in the Condensed Consolidated Balance Sheets.

Lam Research Corporation 2023 Q3 10-Q 20

In the three and nine months ended March 26, 2023, the Company initiated a restructuring plan designed to better align the Company’s cost structure with its outlook for the economic environment and business opportunities. Under the plan the Company terminated approximately 1,400 employees, incurring expenses related to employee severance and separation costs. Employee severance and separation costs primarily relate to severance, non-cash severance, including equity award compensation expense, pension and other termination benefits. Additionally, the Company made a strategic decision to relocate certain manufacturing activities to pre-existing facilities.

During the three and nine months ended March 26, 2023, net restructuring costs of $66.7 million and $40.4 million were recorded in restructuring charges, net - cost of goods sold, and restructuring charges, net - operating expenses, respectively in the Condensed Consolidated Statements of Operations.

The Company anticipates the restructuring plan to be substantially complete by December 24, 2023, and estimates that incremental restructuring charges totaling approximately $40 million will be incurred through the fiscal quarter ending December 24, 2023.

The following table is a summary of the activity related to the restructuring plan:

	Severance and Benefits		Other		Total
	(in thousands)
Restructuring expense	$	98,508	$	8,620	$	107,128
Cash payments	(20,658)		(2,967)		(23,625)
Non-cash activities	(2,269)		(794)		(3,063)
Restructuring liability as of March 26, 2023	$	75,581	$	4,859	$	80,440

Lam Research Corporation 2023 Q3 10-Q 21

ITEM 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

With the exception of historical facts, the statements contained in this discussion are forward-looking statements, which are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Certain, but not all, of the forward-looking statements in this report are specifically identified as forward-looking, by use of phrases and words such as “believe,” “estimated,” “anticipate,” “expect,” “probable,” “intend,” “plan,” “aim,” “may,” “should,” “could,” “would,” “will,” “continue,” and other future-oriented terms. The identification of certain statements as “forward-looking” does not mean that other statements not specifically identified are not forward-looking. Forward-looking statements include but are not limited to statements that relate to: trends and opportunities in the global economic environment; trends and opportunities in the semiconductor industry, including in the end markets and applications for semiconductors, and in device complexity; growth or decline in the industry and the market for, and spending on, wafer fabrication equipment; the anticipated levels of, and rates of change in, margins, market share, served addressable market, capital expenditures, research and development expenditures, international sales, revenue (actual and/or deferred), operating expenses and earnings generally; management’s plans and objectives for our current and future operations and business focus; restructuring activities; volatility in our quarterly results; the makeup of our customer base; customer and end user requirements and our ability to satisfy those requirements; customer spending and demand for our products and services, and the reliability of indicators of change in customer spending and demand; the effect of variability in our customers’ business plans or demand for our products and services; our competition, and our ability to defend our market share and to gain new market share; the success of joint development and collaboration relationships with customers, suppliers, or others; outsourced activities; our supply chain and the role of suppliers in our business, including the impacts of supply chain constraints and material costs; our leadership and competency, and our ability to facilitate innovation; our research and development programs; our ability to create sustainable differentiation; technology inflections in the industry and our ability to identify those inflections and to invest in research and development programs to meet them; our ability to deliver multi-product solutions; the resources invested to comply with evolving standards and the impact of such efforts; changes in state, federal and international tax laws, our estimated annual tax rate and the factors that affect our tax rates; legal and regulatory compliance; the estimates we make, and the accruals we record, in order to implement our critical accounting policies (including but not limited to the adequacy of prior tax payments, future tax benefits or liabilities, and the adequacy of our accruals relating to them); hedging transactions; debt or financing arrangements; our investment portfolio; our access to capital markets; uses of, payments of, and impact of interest rate fluctuations on, our debt; our intention to pay quarterly dividends and the amounts thereof, if any; our ability and intention to repurchase our shares; credit risks; controls and procedures; recognition or amortization of expenses; our ability to manage and grow our cash position; our strategic relevance with our customers; our ability to scale our operations to respond to changes in our business; the value of our patents; the materiality of potential losses arising from legal proceedings; the probability of making payments under our guarantees; the impact of the COVID-19 pandemic; and the sufficiency of our financial resources or liquidity to support future business activities (including but not limited to operations, investments, debt service requirements, dividends, and capital expenditures). Such statements are based on current expectations and are subject to risks, uncertainties, and changes in condition, significance, value, and effect, including without limitation those discussed below under the heading “Risk Factors” within Part II Item 1A and elsewhere in this report and other documents we file from time to time with the Securities and Exchange Commission (“SEC”), such as our annual report on Form 10-K for the year ended June 26, 2022 (our “2022 Form 10-K”), our quarterly reports on Form 10-Q for the fiscal quarters ended September 25, 2022 and December 25, 2022, and our current reports on Form 8-K. Such risks, uncertainties, and changes in condition, significance, value, and effect could cause our actual results to differ materially from those expressed in this report and in ways not readily foreseeable. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on information currently and reasonably known to us. We do not undertake any obligation to release the results of any revisions to these forward-looking statements, which may be made to reflect events or circumstances that occur after the date of this report or to reflect the occurrence or effect of anticipated or unanticipated events.

Documents To Review In Connection With Management’s Discussion and Analysis Of Financial Condition and Results Of Operations

For a full understanding of our financial position and results of operations for the three and nine months ended March 26, 2023, and the related Management’s Discussion and Analysis of Financial Condition and Results of Operations below, you should also read the Condensed Consolidated Financial Statements and notes presented in this Form 10-Q and the financial statements and notes in our 2022 Form 10-K.

Lam Research Corporation 2023 Q3 10-Q 22

EXECUTIVE SUMMARY

Lam Research Corporation is a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry. We have built a strong global presence with core competencies in areas like nanoscale applications enablement, chemistry, plasma and fluidics, advanced systems engineering and a broad range of operational disciplines. Our products and services are designed to help our customers build smaller and better performing devices that are used in a variety of electronic products, including mobile phones, personal computers, servers, wearables, automotive vehicles, and data storage devices.

Our customer base includes leading semiconductor memory, foundry, and integrated device manufacturers that make products such as non-volatile memory, dynamic random-access memory, and logic devices. Their continued success is part of our commitment to driving semiconductor breakthroughs that define the next generation. Our core technical competency is integrating hardware, process, materials, software, and process control, enabling results on the wafer.

Semiconductor manufacturing, our customers’ business, involves the complete fabrication of multiple dies or integrated circuits on a wafer. This involves the repetition of a set of core processes and can require hundreds of individual steps. Fabricating these devices requires highly sophisticated process technologies to integrate an increasing array of new materials with precise control at the atomic scale. Along with meeting technical requirements, wafer processing equipment must deliver high productivity and be cost-effective.

Demand from cloud computing, 5G, the Internet of Things, and other markets is driving the need for increasingly powerful and cost-efficient semiconductors. At the same time, there are growing technical challenges with traditional two-dimensional scaling. These trends are driving significant inflections in semiconductor manufacturing, such as the increasing importance of vertical scaling strategies like three-dimensional architecture as well as multiple patterning to enable shrinks.

We believe we are in a strong position with our leadership and expertise in deposition, etch, and clean to facilitate some of the most significant innovations in semiconductor device manufacturing. Our Customer Support Business Group provides products and services to maximize installed equipment performance, predictability, and operational efficiency. Several factors create opportunity for sustainable differentiation for us: (i) our focus on research and development, with several on-going programs relating to sustaining engineering, product and process development, and concept and feasibility; (ii) our ability to effectively leverage cycles of learning from our broad installed base; (iii) our collaborative focus with semi-ecosystem partners; (iv) our ability to identify and invest in the breadth of our product portfolio to meet technology inflections; and (v) our focus on delivering our multi-product solutions with a goal to enhance the value of Lam’s solutions to our customers.

In the quarter-ended March 26, 2023, customer demand weakened due to wafer fabrication equipment spending reductions resulting primarily from incremental demand weakness in memory. We did, however, continue to see improvement in supply chain constraints and were able to fulfill shipments of nearly all our outstanding back order systems. As a result of expected reduced business levels we initiated a restructuring plan in the March 2023 quarter designed to better align the Company’s cost structure with its outlook. We incurred a charge for the workforce actions associated with the restructuring plan in the March quarter of approximately $98.5 million. Over the course of calendar year 2023, we are projecting expenditures in the range of $250 million associated with various business process improvements and initiatives, inclusive of the March 2023 quarter restructuring activity. Risks and uncertainties related to the COVID-19 pandemic, supply chain challenges, and inflationary pressures may continue to negatively impact our revenue and gross margin. Over the longer term, we believe that secular demand for semiconductors combined with technology inflections in our industry, including 3D device scaling, multiple patterning, process flow, and advanced packaging chip integration, will drive sustainable growth and lead to an increase in the served addressable market for our products and services in the deposition, etch, and clean businesses.

Lam Research Corporation 2023 Q3 10-Q 23

The following table summarizes certain key financial information for the periods indicated below:

	Three Months Ended
	March 26, 2023			December 25, 2022
	(in thousands, except per share data and percentages)
Revenue	$	3,869,569		$	5,277,569
Gross margin	$	1,605,612		$	2,376,349
Gross margin as a percent of total revenue	41.5		%	45.0		%
Total operating expenses	$	663,359		$	696,187
Net income	$	814,008		$	1,468,507
Diluted net income per share	$	6.01		$	10.77

In the March 2023 quarter, revenue decreased 27% compared to the December 2022 quarter, driven by a decrease in both systems and customer-support related revenue as a result of the weakening demand environment, compounded by regulatory trade restrictions imposed on shipments of wafer fabrication equipment and related parts and service to certain customers in China. The deferred revenue balance was $2,002.7 million at the end of the March 2023 quarter, consistent with the balance at the end of the December 2022 quarter of $1,984.0 million. Advanced deposit additions from newer customers increased during the March 2023 quarter, offsetting the decline in deferred balances related to shipments we completed of tools that had critical parts outstanding. We aim to balance the requirements of our customers with the availability of resources, as well as performance to our operational and financial objectives. As a result, from time to time, we exercise discretion and judgment as to the timing and prioritization of manufacturing and deliveries of products, which has impacted, including in the current fiscal year, and may in the future impact, the timing of revenue recognition with respect to such products.

The decrease in gross margin as a percentage of revenue in the March 2023 quarter compared to the December 2022 quarter was primarily a result of costs associated with restructuring related activities and product rationalization charges, as well as unfavorable absorption costs due to lower business volumes and customer and product mix. The decrease in operating expenses in the March 2023 quarter compared to the December 2022 quarter was primarily driven by decreases in outside service spending and supplies expense, partially offset by an increase in restructuring related charges, employee-related expenses from seasonality, product rationalization costs and transformational costs.

Our cash and cash equivalents, investments, and restricted cash and investments balances increased to $5.6 billion at the end of the March 2023 quarter compared to $4.8 billion at the end of the December 2022 quarter. This increase was primarily the result of $1,726.4 million of cash generated from operating activities, partially offset by $581.9 million of share repurchases, including net share settlement of employee stock-based compensation, $234.0 million of dividends paid to stockholders; and $119.5 million of capital expenditures. Employee headcount as of March 26, 2023 was approximately 18,700. We expect the employee headcount balance to decrease further in the June 2023 quarter as many of the employees impacted by our restructuring activity have termination dates in early April.

RESULTS OF OPERATIONS

Revenue

	Three Months Ended						Nine Months Ended
	March 26, 2023			December 25, 2022			March 26, 2023			March 27, 2022
Revenue (in millions)	$	3,870		$	5,278		$	14,221		$	12,591
Korea	22		%	20		%	20		%	23		%
China	22		%	24		%	26		%	32		%
Taiwan	18		%	19		%	20		%	16		%
United States	16		%	10		%	9		%	6		%
Japan	10		%	11		%	10		%	11		%
Europe	8		%	6		%	6		%	3		%
Southeast Asia	4		%	10		%	9		%	9		%

Revenue for the March 2023 quarter decreased 27% from the December 2022 quarter primarily from reductions in wafer fabrication equipment spending as well as from regulatory trade restrictions imposed on shipments of wafer fabrication equipment and related parts and services to China.

Lam Research Corporation 2023 Q3 10-Q 24

The following table presents our revenue disaggregated between system and customer support-related revenue:

	Three Months Ended				Nine Months Ended
	March 26, 2023		December 25, 2022		March 26, 2023		March 27, 2022
	(In thousands)
System revenue	$	2,256,033	$	3,547,518	$	8,985,538	$	8,315,898
Customer support-related revenue and other	1,613,536		1,730,051		5,235,721		4,275,587
	$	3,869,569	$	5,277,569	$	14,221,259	$	12,591,485

Please refer to Note 3, “Revenue,” to the Condensed Consolidated Financial Statements of this Form 10-Q for additional information regarding the composition of the two categories into which revenue has been disaggregated.

The following table presents the percentages of leading- and non-leading-edge equipment and upgrade revenue to each of the primary markets we serve:

	Three Months Ended				Nine Months Ended
	March 26, 2023		December 25, 2022		March 26, 2023		March 27, 2022
Memory	32	%	50	%	46	%	62	%
Foundry	46	%	31	%	18	%	26	%
Logic/integrated device manufacturing	22	%	19	%	36	%	12	%

The decrease in the memory market for the nine months ended March 26, 2023 as compared to the same period in 2022, is primarily due to decreases in NAND investments by our customers during this time period.

Gross Margin

	Three Months Ended						Nine Months Ended
	March 26, 2023			December 25, 2022			March 26, 2023			March 27, 2022
	(in thousands, except percentages)
Gross margin	$	1,605,612		$	2,376,349		$	6,318,796		$	5,771,295
Percent of revenue	41.5		%	45.0		%	44.4		%	45.8		%

Gross margin as a percentage of revenue was lower in the March 2023 quarter compared to the December 2022 quarter primarily due to $66.7 million in restructuring-related charges and $26.8 million in costs associated with product rationalization, as well as unfavorable customer and product mix.

The decrease in gross margin as a percentage of revenue in the nine months ended March 26, 2023 compared to the same period in the prior year was primarily driven by costs associated with restructuring related activities, product rationalization, as well as higher levels of manufacturing-related spending as a result of increased inflationary pressures, partially offset by favorable customer and product mix.

Research and Development

	Three Months Ended						Nine Months Ended
	March 26, 2023			December 25, 2022			March 26, 2023			March 27, 2022
	(in thousands, except percentages)
Research & development (“R&D”)	$	429,451		$	462,385		$	1,325,211		$	1,193,091
Percent of revenue	11.1		%	8.8		%	9.3		%	9.5		%

We continued to make significant R&D investments in the March 2023 quarter focused on leading-edge deposition, etch, clean and other semiconductor manufacturing processes. The decrease in R&D expense in the March 2023 quarter compared to the December 2022 quarter was primarily driven by a decrease of $22.1 million in supplies expense and $11.5 million in outside services.

Lam Research Corporation 2023 Q3 10-Q 25

The increase in R&D expense in the nine months ended March 26, 2023 compared to the same period in the prior year was primarily driven by a $46.8 million increase in employee-related expenses mainly as a result of increased headcount and a $31.9 million increase in spending for supplies.

Selling, General, and Administrative

	Three Months Ended						Nine Months Ended
	March 26, 2023			December 25, 2022			March 26, 2023			March 27, 2022
	(in thousands, except percentages)
Selling, general, and administrative (“SG&A”)	$	193,500		$	233,802		$	632,922		$	675,735
Percent of revenue	5.0		%	4.4		%	4.5		%	5.4		%

SG&A expense during the March 2023 quarter decreased in comparison to the December 2022 quarter, primarily driven by a decrease of $24.5 million in outside service spending.

SG&A expense during the nine months ended March 26, 2023 decreased compared to the same period in the prior year, primarily driven by a decrease of $34.6 million in amortization for intangible assets, as the intangible assets associated with our Novellus Systems, Inc. transactions have fully amortized.

Restructuring Charges, Net

	Three Months Ended						Nine Months Ended
	March 26, 2023			December 25, 2022			March 26, 2023			March 27, 2022
	(in thousands, except percentages)
Restructuring charges, net	$	107,128		$	—		$	107,128		$	—
Percent of revenue	2.8		%	—		%	0.8		%	—		%

In the three and nine months ended March 26, 2023, we initiated a restructuring plan designed to better align our cost structure with our outlook for the economic environment and business opportunities. Under the plan we terminated approximately 1,400 employees, incurring expenses related to employee severance and separation costs. Employee severance and separation costs primarily relate to severance, non-cash severance, including equity award compensation expense, pension and other termination benefits. Additionally, we made a strategic decision to relocate certain manufacturing activities to pre-existing facilities.

During the three and nine months ended March 26, 2023 net restructuring costs of $66.7 million and $40.4 million were recorded in restructuring charges, net - cost of goods sold, and restructuring charges, net - operating expenses, respectively of our Condensed Consolidated Financial Statements, included in Part I of this Form 10-Q. Please refer to Note 18, “Restructuring charges, net,” to our Condensed Consolidated Financial Statements, included in Part I of this Form 10-Q for additional information.

Other Income (Expense), Net

Other income (expense), net consisted of the following:

	Three Months Ended				Nine Months Ended
	March 26, 2023		December 25, 2022		March 26, 2023		March 27, 2022
	(in thousands)
Interest income	$	41,974	$	26,125	$	83,155	$	8,988
Interest expense	(47,217)		(46,661)		(139,930)		(138,531)
Gains (losses) on deferred compensation plan-related assets, net	5,443		10,871		3,588		(5,737)
Foreign exchange (losses) gains, net	(5,519)		(10,114)		(8,812)		1,657
Other, net	1,988		(8,455)		(12,661)		65,363
	$	(3,331)	$	(28,234)	$	(74,660)	$	(68,260)

Interest income increased for the March 2023 quarter compared to the December 2022 quarter, primarily because of higher yields and higher average balances. Interest income increased for the nine months ended March 26, 2023, compared to the same period in 2022, primarily because of higher yields.

Lam Research Corporation 2023 Q3 10-Q 26

Interest expense is consistent across all periods presented.

The gains and losses on deferred compensation plan-related assets were driven by fluctuations in the fair market value of the underlying funds for all periods presented.

Foreign exchange fluctuations were primarily due to currency movements against portions of our unhedged balance sheet exposures for all periods presented.

The gains and losses in other, net for the three and nine months ended March 26, 2023, were driven by fluctuations in fair value of equity investments. For the nine months ended March 27, 2022, other, net includes an unrealized gain totaling $63.6 million associated with an equity investment that completed a business combination and public offering during that period.

Income Tax Expense

Our provision for income taxes and effective tax rate for the periods indicated were as follows:

	Three Months Ended						Nine Months Ended
	March 26, 2023			December 25, 2022			March 26, 2023			March 27, 2022
	(in thousands, except percentages)
Income tax expense	$	124,914		$	183,421		$	537,201		$	437,857
Effective tax rate	13.3		%	11.1		%	12.7		%	11.4		%

The increase in the effective tax rate for the March 2023 quarter compared to the December 2022 quarter was primarily due to the change in level and proportion of income in higher and lower tax jurisdictions, recognition of previously unrecognized tax benefits from lapses of statutes of limitation, and a net tax benefit associated with legal entity restructuring in the December 2022 quarter.

The increase in the effective tax rate for the nine months ended March 26, 2023 compared to the same period in the prior year was primarily due to the change in level and proportion of income in higher and lower tax jurisdictions and lower stock-based compensation excess tax benefits in the nine months ended March 26, 2023.

International revenues account for a significant portion of our total revenues, such that a material portion of our pre-tax income is earned and taxed outside the United States. International pre-tax income is taxable in the United States at a lower effective tax rate than the federal statutory tax rate. Please refer to Note 7, “Income Taxes,” to our Consolidated Financial Statements in Part II, Item 8 of our 2022 Form 10-K for additional information.

We re-evaluate uncertain tax positions on a quarterly basis. This evaluation is based on factors including, but not limited to, changes in facts or circumstances, changes in tax law, effectively settled issues under audit, and new audit activity. Any change in recognition or measurement would result in the recognition of a tax benefit or an additional charge to the tax provision.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Refer to our “Critical Accounting Policies and Estimates” included in Part II, Item 7 of our 2022 Form 10-K for a discussion of our critical accounting policies and estimates.

Recent Accounting Pronouncements

For a description of recent accounting pronouncements, including the expected dates of adoption and estimated effects, if any, on our Condensed Consolidated Financial Statements, see Note 2 - Recent Accounting Pronouncements, of our Condensed Consolidated Financial Statements, included in Part 1 of this Form 10-Q.

LIQUIDITY AND CAPITAL RESOURCES

Total gross cash, cash equivalents, investments, and restricted cash and investments balances were $5.6 billion at March 26, 2023 compared to $3.9 billion as of June 26, 2022. This increase was primarily driven by $4,056.2 million of cash generated from operating activities, partially offset by $1,148.0 million of share repurchases, including net share settlement on employee stock-based compensation; $675.6 million in dividends paid; and $422.9 million of capital expenditures.

Lam Research Corporation 2023 Q3 10-Q 27

Net cash provided by operating activities of $4,056.2 million during the nine months ended March 26, 2023, consisted of (in thousands):

Net income	$	3,708,394
Non-cash charges:
Depreciation and amortization	252,828
Equity-based compensation expense	218,105
Deferred income taxes	(133,101)
Changes in operating asset and liability accounts	(1,550)
Other	11,537
	$	4,056,213

Significant changes in operating asset and liability accounts, net of foreign exchange impact, included the following uses of cash: increases in inventory of $964.0 million, along with a decrease in trade accounts payable of $392.0 million, and accrued expenses and other liabilities of $101.5 million. The uses of cash are offset by the following sources of cash: decreases in accounts receivable of $1,058.5 million, deferred profit of $268.9 million, and prepaid expense and other assets of $128.5 million.

Cash Flow from Investing Activities

Net cash used for investing activities during the nine months ended March 26, 2023, was $479.4 million, primarily consisting of $422.9 million in capital expenditures and $120.0 million of net cash disbursed for business acquisitions, partially offset by proceeds from maturities of available-for-sale securities of $71.9 million.

Cash Flow from Financing Activities

Net cash used for financing activities during the nine months ended March 26, 2023, was $1,792.7 million, primarily consisting of $1,148.0 million in treasury stock repurchases, including net share settlement on employee stock-based compensation, and $675.6 million in dividends paid, partially offset by $52.7 million combined proceeds from issuance of common stock.

Liquidity

Given that the semiconductor industry is highly competitive and has historically experienced rapid changes in demand, we believe that maintaining sufficient liquidity reserves is important to support sustaining levels of investment in R&D and capital infrastructure. Anticipated cash flows from operations based on our current business outlook, combined with our current levels of cash, cash equivalents, and short-term investments as of March 26, 2023, are expected to be sufficient to support our anticipated levels of operations, investments, debt service requirements, capital expenditures, capital redistributions, and dividends through at least the next twelve months. However, factors outside of our control, including uncertainty in the global economy and the semiconductor industry, as well as disruptions in credit markets, have in the past, are currently, and could in the future, impact customer demand for our products, as well as our ability to manage normal commercial relationships with our customers, suppliers, and creditors.

In the longer term, liquidity will depend to a great extent on our future revenues and our ability to appropriately manage our costs based on demand for our products and services. While we have substantial cash balances, we may require additional funding and need or choose to raise the required funds through borrowings or public or private sales of debt or equity securities. We believe that, if necessary, we will be able to access the capital markets on terms and in amounts adequate to meet our objectives. However, domestic and global macroeconomic and political conditions, or the ongoing COVID-19 pandemic, could cause disruptions to the capital markets and otherwise make any financing more challenging, and there can be no assurance that we will be able to obtain such financing on commercially reasonable terms or at all.

ITEM 3.    Quantitative and Qualitative Disclosures about Market Risk

For financial market risks related to changes in interest rates, marketable equity security prices, and foreign currency exchange rates, refer to Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk”, in our 2022 Form 10-K. Our exposure related to market risk has not changed materially since June 26, 2022.

ITEM 4.    Controls and Procedures

Design of Disclosure Controls and Procedures and Internal Control over Financial Reporting

We maintain disclosure controls and procedures and internal control over financial reporting that are designed to comply with Rule 13a-15 of the Exchange Act. In designing and evaluating the controls and procedures associated with each, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and that the effectiveness of controls cannot be absolute because the cost to design

Lam Research Corporation 2023 Q3 10-Q 28

and implement a control to identify errors or mitigate the risk of errors occurring should not outweigh the potential loss caused by the errors that would likely be detected by the control. Moreover, we believe that a control system cannot be guaranteed to be 100% effective all of the time. Accordingly, a control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met.

Disclosure Controls and Procedures

As required by Exchange Act Rule 13a-15(b), as of March 26, 2023, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rule 13a-15(e). Based upon that evaluation, our Chief Executive Officer, along with our Chief Financial Officer, concluded that our disclosure controls and procedures are effective at the reasonable assurance level.

We intend to review and evaluate the design and effectiveness of our disclosure controls and procedures on an ongoing basis and to correct any material deficiencies that we may discover. Our goal is to ensure that our senior management has timely access to material information that could affect our business.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Effectiveness of Controls

While we believe the present design of our disclosure controls and procedures and internal control over financial reporting is effective, future events affecting our business may cause us to modify our disclosure controls and procedures or internal control over financial reporting.

Lam Research Corporation 2023 Q3 10-Q 29

PART II.    OTHER INFORMATION

ITEM 1.    Legal Proceedings

Please refer to the subsection entitled “Legal Proceedings” within Note 14 “Commitments and Contingencies," to our Condensed Consolidated Financial Statements in this quarterly report on Form 10-Q.

ITEM 1A.    Risk Factors

In addition to the other information in this Form 10-Q, the following risk factors should be carefully considered in evaluating us and our business because such factors may significantly impact our business, operating results, and financial condition. Many of the following risk factors have been, and could be further, exacerbated by the COVID-19 pandemic and any worsening of the global business and economic environment as a result. As a result of these risk factors, as well as other risks discussed in our other SEC filings, our actual results could differ materially from those projected in any forward-looking statements. No priority or significance is intended by, nor should be attached to, the order in which the risk factors appear.

INDUSTRY AND CUSTOMER RISKS

The Semiconductor Capital Equipment Industry Is Subject to Variability and Periods of Rapid Growth or Decline; We Therefore Face Risks Related to Our Strategic Resource Allocation Decisions

The semiconductor capital equipment industry has historically been characterized by rapid changes in demand. The industry environment has moved toward being more characterized by variability across segments and customers, accentuated by consolidation within the industry. Variability in our customers’ business plans may lead to changes in demand for our equipment and services, which could negatively impact our results. The variability in our customers’ investments during any particular period is dependent on several factors, including but not limited to electronics demand, economic conditions (both general and in the semiconductor and electronics industries), industry supply and demand, prices for semiconductors, and our customers’ ability to develop and manufacture increasingly complex and costly semiconductor devices. The changes in demand may require our management to adjust spending and other resources allocated to operating activities.

During periods of rapid growth or decline in demand for our products and services, we face significant challenges in maintaining adequate financial and business controls, management processes, information systems, and procedures for training, assimilating, and managing our workforce, and in appropriately sizing our supply chain infrastructure and facilities, work force, and other components of our business on a timely basis. If we do not adequately meet these challenges during periods of increasing or declining demand, our gross margins and earnings may be negatively impacted. For example, the COVID-19 pandemic has impacted and could in the future impact our ability to meet the demand for our products due to production, sourcing, logistics and other challenges resulting from quarantines, shelter in place or “stay at home” orders, facility closures, workforce challenges, and travel and logistics restrictions in connection with the pandemic.

We continuously reassess our strategic resource allocation choices in response to the changing business environment. If we do not adequately adapt to the changing business environment, we may lack the infrastructure and resources to scale up our business to meet customer expectations and compete successfully during a period of growth, or we may expand our capacity and resources too rapidly and/or beyond what is appropriate for the actual demand environment, resulting in excess fixed costs.

Especially during transitional periods, resource allocation decisions can have a significant impact on our future performance, particularly if we have not accurately anticipated industry changes. Our success will depend, to a significant extent, on the ability of our executive officers and other members of our senior management to identify and respond to these challenges effectively.

Future Declines in the Semiconductor Industry, and the Overall World Economic Conditions on Which It Is Significantly Dependent, Could Have a Material Adverse Impact on Our Results of Operations and Financial Condition

Our business depends on the capital equipment expenditures of semiconductor manufacturers, which in turn depend on the current and anticipated market demand for integrated circuits. With the consolidation of customers within the industry, the semiconductor capital equipment market may experience rapid changes in demand driven both by changes in the market generally and the plans and requirements of particular customers. The economic, political, and business conditions occurring nationally, globally, or in any of our key sales regions, which are often unpredictable, have historically impacted customer demand for our products and normal commercial relationships with our customers, suppliers, and creditors. Additionally, in times of economic uncertainty, our customers’ budgets for our products, or their ability to access credit to purchase them, could be adversely affected. This would limit their ability to purchase our products and services. As a result, changing economic, political or business conditions can cause material adverse changes to our results of operations and financial condition, including but not limited to: 

•a decline in demand for our products or services;

Lam Research Corporation 2023 Q3 10-Q 30

•an increase in reserves on accounts receivable due to our customers’ inability to pay us;

•an increase in reserves on inventory balances due to excess or obsolete inventory as a result of our inability to sell such inventory;

•valuation allowances on deferred tax assets;

•restructuring charges;

•asset impairments including the potential impairment of goodwill and other intangible assets;

•a decline in the value of our investments;

•exposure to claims from our suppliers for payment on inventory that is ordered in anticipation of customer purchases that do not come to fruition;

•a decline in the value of certain facilities we lease to less than our residual value guarantee with the lessor; and

•challenges maintaining reliable and uninterrupted sources of supply.

Fluctuating levels of investment by semiconductor manufacturers may materially affect our aggregate shipments, revenues, operating results, and earnings. Where appropriate, we will attempt to respond to these fluctuations with cost management programs aimed at aligning our expenditures with anticipated revenue streams, which sometimes result in restructuring charges. Even during periods of reduced revenues, we must continue to invest in R&D and maintain extensive ongoing worldwide customer service and support capabilities to remain competitive, which may temporarily harm our profitability and other financial results.

We Have a Limited Number of Key Customers

Sales to a limited number of large customers constitute a significant portion of our overall revenue, shipments, cash flows, collections, and profitability. As a result, the actions of even one customer may subject us to variability in those areas that is difficult to predict. In addition, large customers may be able to negotiate requirements that result in decreased pricing, increased costs, and/or lower margins for us; compliance with specific environmental, social, and corporate governance standards; and limitations on our ability to share technology with others. Similarly, significant portions of our credit risk may, at any given time, be concentrated among a limited number of customers so that the failure of even one of these key customers to pay its obligations to us could significantly impact our financial results.

We Face a Challenging and Complex Competitive Environment

We face significant competition from multiple competitors, and with increased consolidation efforts in our industry, as well as the emergence and strengthening of new, regional competitors, we may face increasing competitive pressures. Other companies continue to develop systems and/or acquire businesses and products that are competitive to ours and may introduce new products and product capabilities that may affect our ability to sell and support our existing products. We face a greater risk if our competitors enter into strategic relationships with leading semiconductor manufacturers covering products similar to those we sell or may develop, as this could adversely affect our ability to sell products to those manufacturers.

We believe that to remain competitive we must devote significant financial resources to offer products that meet our customers’ needs, to maintain customer service and support centers worldwide, and to invest in product and process R&D. Technological changes and developing technologies, have required, and are expected to continue to require, new and costly investments. Certain of our competitors, including those that are created and financially backed by foreign governments, have substantially greater financial resources and more extensive engineering, manufacturing, marketing, and customer service and support resources than we do and therefore have the potential to offer customers a more comprehensive array of products and/or product capabilities and to therefore achieve additional relative success in the semiconductor equipment industry. These competitors may deeply discount or give away products similar to those that we sell, challenging or even exceeding our ability to make similar accommodations and threatening our ability to sell those products. We also face competition from our own customers, who in some instances have established affiliated entities that manufacture equipment similar to ours. In addition, we face competition from companies that exist in a more favorable legal or regulatory environment than we do, allowing the freedom of action in ways that we may be unable to match. In many cases speed to solution is necessary for customer satisfaction and our competitors may be better positioned to achieve these objectives. For these reasons, we may fail to continue to compete successfully worldwide.

In addition, our competitors may be able to develop products comparable or superior to those we offer or may adapt more quickly to new technologies or evolving customer requirements. In particular, while we continue to develop product enhancements that we believe will address future customer requirements, we may fail in a timely manner to complete the development or introduction of these additional product enhancements successfully, or these product enhancements may not achieve market acceptance or be competitive. Accordingly, competition may intensify, and we may be unable to continue to compete successfully in our markets, which could have a material adverse effect on our revenues, operating results, financial condition, and/or cash flows.

Lam Research Corporation 2023 Q3 10-Q 31

Once a Semiconductor Manufacturer Commits to Purchase a Competitor’s Semiconductor Manufacturing Equipment, the Manufacturer Typically Continues to Purchase That Competitor’s Equipment, Making It More Difficult for Us to Sell Our Equipment to That Customer

Semiconductor manufacturers must make a substantial investment to qualify and integrate wafer processing equipment into a semiconductor production line. We believe that once a semiconductor manufacturer selects a particular supplier’s processing equipment, the manufacturer generally relies upon that equipment for that specific production line application for an extended period of time, especially for customers that are more focused on tool reuse. Accordingly, we expect it to be more difficult to sell our products to a given customer for a product line application if that customer initially selects a competitor’s equipment for the same product line application.

We Depend on Creating New Products and Processes and Enhancing Existing Products and Processes for Our Success; Consequently, We Are Subject to Risks Associated with Rapid Technological Change

Rapid technological changes in semiconductor manufacturing processes subject us to increased pressure to develop technological advances that enable those processes. We believe that our future success depends in part upon our ability to develop and offer new products with improved capabilities and to continue to enhance our existing products. If new products or existing products have reliability, quality, design, or safety problems, our performance may be impacted by reduced orders, higher manufacturing costs, delays in acceptance of and payment for new products, and additional service and warranty expenses. We may be unable to develop and manufacture products successfully, or products that we introduce may fail in the marketplace. For more than 25 years, the primary driver of technology advancement in the semiconductor industry has been to shrink the lithography that prints the circuit design on semiconductor chips. That driver could be approaching its technological limit, leading semiconductor manufacturers to investigate more complex changes in multiple technologies in an effort to continue technology development. In addition, the emergence of “big data” and new tools such as machine learning and artificial intelligence that capitalize on the availability of large data sets is leading semiconductor manufacturers and equipment manufacturers to pursue new products and approaches that exploit those tools to advance technology development. In the face of uncertainty on which technology solutions will become successful, we will need to focus our efforts on developing the technology changes that are ultimately successful in supporting our customer requirements. Our failure to develop and offer the correct technology solutions in a timely manner with productive and cost-effective products could adversely affect our business in a material way. Our failure to commercialize new products in a timely manner could result in loss of market share, unanticipated costs, and inventory obsolescence, which would adversely affect our financial results.

In order to develop new products and processes and enhance existing products and processes, we expect to continue to make significant investments in R&D, to investigate the acquisition of new products and technologies, to invest in or acquire such business or technologies, and to pursue joint development relationships with customers, suppliers, or other members of the industry. Our investments and acquisitions may not be as successful as we may expect, particularly in the event that we invest in or acquire product lines and technologies that are new to us. We may find that acquisitions are not available to us, for regulatory or other reasons, and that we must therefore limit ourselves to collaboration and joint venture development activities, which do not have the same benefits as acquisitions. Pursuing development through collaboration and/or joint development activities rather than through an acquisition poses substantial challenges for management, including those related to aligning business objectives; sharing confidential information, intellectual property and data; sharing value with third parties; and realizing synergies that might have been available in an acquisition but are not available through a joint development project. We must manage product transitions and joint development relationships successfully, as the introduction of new products could adversely affect our sales of existing products and certain jointly developed technologies may be subject to restrictions on our ability to share that technology with other customers, which could limit our market for products incorporating those technologies. Future technologies, processes, or product developments may render our current product offerings obsolete, leaving us with non-competitive products, obsolete inventory, or both. Moreover, customers may adopt new technologies or processes to address the complex challenges associated with next-generation devices. This shift may result in a reduction in the size of our addressable markets or could increase the relative size of markets in which we either do not compete or have relatively low market share.

Strategic Alliances and Customer Consolidation May Have Negative Effects on Our Business

Increasingly, semiconductor manufacturing companies are entering into strategic alliances or consolidating with one another to expedite the development of processes and other manufacturing technologies and/or achieve economies of scale. The outcomes of such an alliance can be the definition of a particular tool set for a certain function and/or the standardization of a series of process steps that use a specific set of manufacturing equipment, while the outcomes of consolidation can lead to an overall reduction in the market for semiconductor manufacturing equipment as customers’ operations achieve economies of scale and/or increased purchasing power based on their higher volumes. In certain instances, this could work to our disadvantage if a competitor’s tools or equipment become the standard equipment for such functions or processes. Additional outcomes of such consolidation may include our customers re-evaluating their future supplier relationships to consider our competitors’ products and/or gaining additional influence over the pricing of products and the control of intellectual property or data.

Similarly, our customers may partner with, or follow the lead of, educational or research institutions that establish processes for accomplishing various tasks or manufacturing steps. If those institutions utilize a competitor’s equipment when they establish those processes, it is likely that customers will tend to use the same equipment in setting up their own manufacturing lines. Even

Lam Research Corporation 2023 Q3 10-Q 32

if they select our equipment, the institutions and the customers that follow their lead could impose conditions on acceptance of that equipment, such as adherence to standards and requirements or limitations on how we license our proprietary rights, that increase our costs or require us to take on greater risk. These actions could adversely impact our market share and financial results.

BUSINESS AND OPERATIONAL RISKS

Our Revenues and Operating Results Are Variable

Our revenues and operating results may fluctuate significantly from quarter to quarter or year to year due to a number of factors, not all of which are in our control. We manage our expense levels based in part on our expectations of future revenues. Because our operating expenses are based in part on anticipated future revenues, and a certain amount of those expenses are relatively fixed, a change in the timing of recognition of revenue and/or the level of gross profit from a small number of transactions can unfavorably affect operating results in a particular quarter or year. Factors that may cause our financial results to fluctuate unpredictably include but are not limited to:

•legal, tax, accounting, or regulatory changes (including but not limited to changes in import/export regulations and tariffs, such as regulations imposed by the U.S. government restricting exports to China) or changes in the interpretation or enforcement of existing requirements;

•macroeconomic conditions, increased risk of recession, and geopolitical issues;

•changes in average selling prices, customer mix, and product mix;

•foreign currency exchange rate fluctuations;

•economic conditions in the electronics and semiconductor industries in general and specifically the semiconductor equipment industry;

•the size and timing of orders from customers;

•changes in our deferred revenue balance, including as a result of factors such as volume purchase agreements, multi-year service contracts, back orders, and down payments toward purchases;

•consolidation of the customer base, which may result in the investment decisions of one customer or market having a significant effect on demand for our products or services;

•procurement shortages;

•the failure of our suppliers or outsource providers to perform their obligations in a manner consistent with our expectations;

•manufacturing difficulties;

•customer cancellations or delays in shipments, installations, customer payments, and/or customer acceptances;

•the extent that customers continue to purchase and use our products and services in their business;

•our customers’ reuse of existing and installed products, to the extent that such reuse decreases their need to purchase new products or services;

•our ability to develop, introduce, and market new, enhanced, and competitive products in a timely manner;

•our competitors’ introduction of new products;

•legal or technical challenges to our products and technologies;

•transportation, communication, demand, information technology, or supply disruptions based on factors outside our control, such as strikes, acts of God, wars, terrorist activities, widespread outbreak of illness, natural or man-made disasters, or climate change;

•rising inflation or interest rates; and

•changes in our estimated effective tax rate.

For example, the COVID-19 pandemic has impacted and could in the future impact our ability to meet the demand for our products due to production, sourcing, logistics and other challenges resulting from quarantines, shelter in place or stay at home orders, facility closures, workforce challenges, and travel and logistics restrictions in connection with the pandemic.

Our Future Success Depends Heavily on International Sales and the Management of Global Operations

Non-U.S. sales, as reflected in Part I Item 2. Results of Operations of this quarterly report on Form 10-Q, accounted for approximately 91%, 92%, and 94% of total revenue in the nine months ended March 26, 2023 and fiscal years 2022, and 2021, respectively. We expect that international sales will continue to account for a substantial majority of our total revenue in future years.

We are subject to various challenges related to international sales and the management of global operations including, but not limited to:

•domestic and international trade regulations, policies, practices, relations, disputes and issues;

•domestic and international tariffs, export controls and other barriers;

•developing customers and/or suppliers, who may have limited access to capital resources;

•global or national economic and political conditions;

•changes in currency controls;

•differences in the enforcement of intellectual property and contract rights in varying jurisdictions;

Lam Research Corporation 2023 Q3 10-Q 33

•our ability to respond to customer and foreign government demands for locally sourced systems, spare parts, and services and develop the necessary relationships with local suppliers;

•changes in and compliance with U.S. and international laws and regulations affecting foreign operations, including U.S. and international trade restrictions and sanctions, anti-bribery, anti-corruption, anti-boycott, environmental, tax, and labor laws;

•fluctuations in interest and foreign currency exchange rates;

•the need for technical support resources in different locations; and

•our ability to secure and retain qualified people, and effectively manage people, in all necessary locations for the successful operation of our business.

For example, the COVID-19 pandemic has impacted and could in the future impact our manufacturing operations, supply chain, and customer support due to production, sourcing, logistics and other challenges resulting from quarantines, stay at home orders, facility closures, workforce challenges, and travel and logistics restrictions in connection with the pandemic.

There is inherent risk, based on the complex relationships among China, Japan, Korea, Taiwan, and the United States, that political, diplomatic and national security influences can lead to trade disputes, impacts and/or disruptions, in particular those affecting the semiconductor industry. This can adversely affect our business with China, Japan, Korea, and/or Taiwan and perhaps the entire Asia Pacific region or global economy. A significant trade dispute, impact and/or disruption in any area where we do business could have a materially adverse impact on our future revenue and profits.

Tariffs, export controls, additional taxes, trade barriers, sanctions, the termination or modification of trade agreements, trade zones, and other duty mitigation initiatives, and any reciprocal retaliatory actions, can increase our manufacturing costs, decrease margins, reduce the competitiveness of our products, disrupt our supply chain operations, or inhibit our ability to sell products or provide services, which has had and in the future could have a material adverse effect on our business, results of operations, or financial conditions. Certain of our international sales depend on our ability to obtain export licenses from the U.S. or foreign governments, and our inability to obtain such licenses, or an expansion of the number or kinds of sales for which export licenses are required, has limited and could in the future further limit the market for our products and has had and could in the future have an adverse impact on our revenues. As is discussed below under the heading “Our Sales to Customers in China, a Significant Region for Us, Have Been Impacted, and are Likely to Be Materially and Adversely Affected by Export License Requirements and Other Regulatory Changes, or Other Governmental Actions in the Course of the Trade Relationship Between the U.S. and China,” the U.S. government has recently imposed new controls, including expanded export license requirements, that significantly impact trade with China. In addition, the U.S. government has an ongoing process of assessing technologies that may be subject to new or additional export controls, and it is possible that such additional controls, if and when imposed, could further adversely impact our ability to sell our products outside the U.S. The implementation by the U.S. government of broad export controls restricting access to our technology (such as recent controls limiting exports to China) may cause customers with international operations to reconsider their use of and reliance on our products, which could adversely impact our future revenue and profits. Furthermore, there are risks that foreign governments may, among other things, take retaliatory actions; insist on the use of local suppliers; compel companies to partner with local companies to design and supply equipment on a local basis, requiring the transfer of intellectual property rights and/or local manufacturing; utilize their influence over their judicial systems to respond to intellectual property disputes or issues; and provide special incentives to government-backed local customers to buy from local competitors, even if their products are inferior to ours; all of which could adversely impact our revenues and margins.

We are exposed to potentially adverse movements in foreign currency exchange rates. The majority of our sales and expenses are denominated in U.S. dollars. However, we are exposed to foreign currency exchange rate fluctuations primarily related to revenues denominated in Japanese yen and expenses denominated in euro, Korean won, Malaysian ringgit, and Indian rupee. Further, in periods in which the U.S. dollar is strong relative to the local currencies of our international customers can potentially reduce demand for our products, which may compound the adverse effect of foreign exchange translation on our revenue. Currently, we hedge certain anticipated foreign currency cash flows, primarily anticipated revenues denominated in Japanese yen and expenses dominated in euro, Korean won, Malaysian ringgit, and Indian rupee. In addition, we enter into foreign currency hedge contracts to minimize the short-term impact of the foreign currency exchange rate fluctuations on certain foreign currency denominated monetary assets and liabilities, primarily third-party accounts receivables, accounts payables, and intercompany receivables and payables. We believe these are our primary exposures to currency rate fluctuation. We expect to continue to enter into hedging transactions, for the purposes outlined, for the foreseeable future. However, these hedging transactions may not achieve their desired effect because differences between the actual timing of the underlying exposures and our forecasts of those exposures may leave us either over or under hedged on any given transaction. Moreover, by hedging these foreign currency denominated revenues, expenses, monetary assets, and liabilities, we may miss favorable currency trends that would have been advantageous to us but for the hedges. Additionally, we are exposed to short-term foreign currency exchange rate fluctuations on non-U.S. dollar-denominated monetary assets and liabilities (other than those currency exposures previously discussed), and currently we do not enter into foreign currency hedge contracts against these exposures. In addition, our currency hedges do not necessarily mitigate the potential negative impact of a strong U.S. dollar on demand for our products. Therefore, we are subject to potential unfavorable foreign currency exchange rate fluctuations to the extent that we transact business (including intercompany transactions) in these currencies.

Lam Research Corporation 2023 Q3 10-Q 34

The magnitude of our overseas business also affects where our cash is generated. Certain uses of cash, such as share repurchases, payment of dividends, or the repayment of our notes, can usually only be made with onshore cash balances. Since the majority of our cash is generated outside of the United States, this may impact certain business decisions and outcomes.

Our Business Relies on Technology, Data, Intellectual Property and Other Sensitive Information That is Susceptible to Cybersecurity and Other Threats or Incidents

Our business is dependent upon the use and protection of technology, data, intellectual property and other sensitive information, which may be owned by, or licensed to, us or third parties, such as our customers and vendors. We maintain and rely upon certain critical information systems for the creation, transmission, use and storage of much of this information, and for the effective operation of our business. These information systems include but are not limited to, telecommunications, the Internet, our corporate intranet, various computer hardware and software applications, (some of which may be integrated into the products that we sell or be required in order to provide the services that we offer), network communications, and email. These information systems may be owned and maintained by us, our outsourced providers, or third parties such as vendors, contractors, customers and Cloud providers. In addition, we make use of Software-as-a-Service (SaaS) products for certain important business functions that are provided by third parties and hosted on their own networks and servers, or third-party networks and servers, all of which rely on networks, email and/or the Internet for their function.

The technology, data, intellectual property and other sensitive information we seek to protect are subject to loss, release, misappropriation or misuse, and the information systems containing or transmitting such technology, data, intellectual property and other sensitive information are subject to disruption, breach or failure, in each case as a result of various possible causes. Such causes may include mistakes or unauthorized actions by our employees or contractors, phishing schemes and other third-party attacks, and degradation or loss of service or access to data due to viruses, malware, denial of service attacks, destructive or inadequate code, power failures, or physical damage to computers, hard drives, communication lines, or networking equipment. Such causes may also include the use of techniques that change frequently or may be disguised or difficult to detect, or designed to remain dormant until a triggering event, or that may continue undetected for an extended period of time.

We have experienced cybersecurity and other threats and incidents in the past. Although past threats and incidents have not resulted in a material adverse effect, we may incur material losses related to cybersecurity and other threats or incidents in the future. If we were subject to a cybersecurity or other incident, it could have a material adverse effect on our business. Such adverse effects might include:

•loss of (or inability to access, e.g. through ransomware) confidential and/or sensitive information stored on these critical information systems or transmitted to or from those systems;

•the disruption of the proper function of our products, services and/or operations;

•the failure of our or our customers’ manufacturing processes;

•errors in the output of our work or our customers’ work;

•the loss or public exposure of the personal or other confidential information of our employees, customers or other parties;

•the public release of customer financial and business plans, customer orders and operational results;

•exposure to claims from our employees or third parties who are adversely impacted by such incidents;

•misappropriation or theft of our or a customer’s, supplier’s or other party’s assets or resources, including technology data, intellectual property or other sensitive information and costs associated therewith;

•reputational damage;

•diminution in the value of our investment in research, development and engineering; or

•our failure to meet, or violation of, regulatory or other legal obligations, such as the timely publication or filing of financial statements, tax information and other required communications.

While we have implemented ISO 27001 compliant security procedures and virus protection software, intrusion prevention systems, identity and access control, and emergency recovery processes, and we carefully select our third-party providers of information systems, to mitigate risks to the information systems that we rely on and to the technology, data, intellectual property and other sensitive information we seek to protect, those security procedures and mitigation and protection systems cannot be guaranteed to be fail-safe, and we may still suffer cybersecurity and other incidents. It has been difficult and may continue to be difficult to hire and retain employees with substantial cybersecurity acumen. In addition, there have been and may continue to be instances of our policies and procedures not being effective in enabling us to identify risks, threats and incidents in a timely manner, or at all, or to respond expediently, appropriately and effectively when incidents occur and repair any damage caused by such incidents, and such occurrences could have a material adverse effect on our business.

We May Not Achieve the Expected Benefits of Our Restructuring Plans and Business Transformation Initiatives, and These Efforts Could Have a Material Adverse Effect on Our Business, Operations, Financial Condition, Results of Operations and Competitive Position

In January 2023 we announced that we are implementing a restructuring plan consisting of a workforce reduction, and that we anticipate undertaking, and may in the future undertake, additional business restructuring, realignment and transformation initiatives. We expect to incur material costs and charges in connection with these plans and initiatives. While the restructuring plan is intended to better align our cost structure with the current economic environment and future business opportunities, and

Lam Research Corporation 2023 Q3 10-Q 35

our anticipated transformation initiatives have the goal of strengthening our operations and achieving operational efficiencies, there can be no assurance that we will be successful in these plans and initiatives. Implementation of these plans and initiatives may be costly and disruptive to our business, we may not be able to complete them at the cost or within the time frame contemplated, and we may not be able to obtain the anticipated benefits within the projected timing or at all. Restructuring and transformation may adversely affect our internal programs and our ability to recruit and retain skilled and motivated personnel, may result in a loss of continuity, loss of accumulated knowledge and/or inefficiency during transitional periods, may require a significant amount of management and other employees' time and focus, and may be distracting to employees and management, which may divert attention from operating and growing our business. If we fail to achieve some or all of the expected benefits, it could have a material adverse effect on our business, operations, financial condition, results of operations and competitive position. For more information about our restructuring plan, see Note 18 to our Condensed Consolidated Financial Statements in Part I.

Disruptions to Our Supply Chain and Outsource Providers Could Impact Our Ability to Meet Demand, Increase Our Costs, and Adversely Impact Our Revenue and Operating Results

Our supply chain has played and will continue to play a key role in our product development, manufacturing operations, field installation and support. Our business depends on our timely supply of products and services to meet the demand from our customers, which depends in significant part on the timely delivery of parts, materials and services, including components and subassemblies, from our direct suppliers to us, and to our direct suppliers by other companies. In addition, outsource providers have played and will continue to play a key role both in the manufacturing and customer-focused operations described above, and in many of our transactional and administrative functions, such as information technology, facilities management, and certain elements of our finance organization. These providers and suppliers might suffer financial setbacks, be acquired by third parties, become subject to exclusivity arrangements that preclude further business with us, or be unable to meet our requirements or expectation due to their independent business decisions or force majeure events that could interrupt or impair their continued ability to perform as we expect. We may also experience significant interruptions of our manufacturing operations, delays in our ability to deliver or install products or perform services or to recognize revenue, increased costs or customer order cancellations as a result of:

•the failure or inability to accurately forecast demand and obtain sufficient quantities of quality parts on a cost-effective basis;

•volatility in the availability and cost of parts, materials or services, including increased costs due to rising inflation or interest rates or other market conditions;

•difficulties or delays in obtaining required import or export approvals;

•shipment delays and increased costs of shipment due to transportation interruptions, capacity constraints, or fuel shortages;

•shortages of semiconductor or other components or materials as a result of increases in demand;

•information technology or infrastructure failures, including those of a third-party supplier or service provider; and

•transportation or supply disruptions based on factors outside our control, such as strikes, acts of God, wars, terrorist activities, widespread outbreak of illness, natural or man-made disasters, or climate change.

Demand for electronic products and other factors, such as the COVID-19 pandemic and the conflict in Ukraine, have resulted in, and may continue to result in, a shortage of parts, materials and services needed to manufacture, deliver and install our products, as well as delays in and unpredictability of shipments due to transportation interruptions. Such shortages, delays and unpredictability have adversely impacted, and may continue to adversely impact, our suppliers’ ability to meet our demand requirements. Difficulties in obtaining sufficient and timely supply of parts, materials or services, and delays in and unpredictability of shipments due to transportation interruptions, have adversely impacted, and may continue to adversely impact, our manufacturing operations and our ability to meet customer demand. In addition, difficulties in obtaining parts, materials or services necessary to deliver or install products or perform services have adversely impacted, and may continue to adversely impact, our ability to recognize revenue, our gross margins on the revenue we recognize, and our other operating results. Although we are endeavoring to pass along some of the impact of increased costs to our customers to counteract adverse impacts to our gross margins and other operating results, such measures could be unsuccessful, or could have the effect of reducing demand, which would adversely impact our revenue.

Further, increased restrictions imposed on a class of chemicals known as per- and polyfluoroalkyl substances (“PFAS”), which are widely used in a large number of products, including parts and materials that are incorporated into our products, may negatively impact our supply chain due to the potentially decreased availability, or non-availability, of PFAS-containing products. Proposed regulations under consideration could require that we transition away from the usage of PFAS-containing products, which could adversely impact our business, operations, revenue, costs, and competitive position. There is no assurance that suitable replacements for PFAS-containing parts and materials will be available at similar costs, or at all.

Although we attempt to select reputable providers and suppliers and we attempt to secure their performance on terms documented in written contracts, it is possible that one or more of these providers or suppliers could fail to perform as we expect, or fail to secure or protect intellectual property rights, and such failure could have an adverse impact on our business. In some cases, the requirements of our business mandate that we obtain certain components and sub-assemblies included in our products from a single supplier or a limited group of suppliers. Where practical, we endeavor to establish alternative sources to mitigate the risk that the failure of any single provider or supplier will adversely affect our business, but this is not feasible in all circumstances. Some key parts are subject to long lead-times or available only from a single supplier or limited group of

Lam Research Corporation 2023 Q3 10-Q 36

suppliers, and some sourcing or subassembly is provided by suppliers located in countries other than the countries where we conduct our manufacturing. There is therefore a risk that a prolonged inability to obtain certain components or secure key services could impair our ability to manage operations, ship products, and generate revenues, which could adversely affect our operating results and damage our customer relationships. For example, the COVID–19 pandemic has impacted and could in the future impact our manufacturing operations, supply chain, and customer support due to production, sourcing, logistics and other challenges resulting from quarantines, stay at home orders, facility closures, workforce challenges, and travel and logistics restrictions in connection with the pandemic.

The COVID-19 Pandemic Has Adversely Impacted, and May in the Future Adversely Impact, Our Business, Operations, and Financial Results

The COVID-19 pandemic and efforts by national, state and local governments worldwide to control its spread have resulted in measures aimed at containing the disease such as quarantines, travel bans, shutdowns, and shelter in place or “stay at home” orders, which collectively have significantly restricted the movement of people and goods and the ability of businesses to operate. These restrictions and measures, incidents of confirmed or suspected infections within our workforce or those of our suppliers or other business partners, and our efforts to act in the best interests of our employees, customers, and suppliers, have affected and in the future may affect our business and operations by, among other things, causing facility closures, production delays and capacity limitations; disrupting production by our supply chain; disrupting the transport of goods from our supply chain to us and from us to our customers; requiring modifications to our business processes; requiring the implementation of business continuity plans; requiring the development and qualification of alternative sources of supply; requiring the implementation of social distancing measures that impede manufacturing processes; disrupting business travel; disrupting our ability to staff our on-site manufacturing and research and development facilities; delaying capital expansion projects; and necessitating teleworking by portions of our workforce. These impacts have caused and in the future may cause delays in product shipments and product development, increases in costs, and decreases in revenue, profitability and cash from operations, which have caused and in the future may cause an adverse effect on our results of operations that may be material. The potential duration and impact of the pandemic on the global economy and on our business are difficult to predict and cannot be estimated with any degree of certainty, but the pandemic has resulted at various times in significant disruption of global financial markets, increases in levels of unemployment, and economic uncertainty, which has adversely impacted our business and may do so in the future, and may lead to significant negative impacts on customer spending, demand for our products, the ability of our customers to pay, our financial condition and the financial condition of our suppliers, and our access to external sources of financing to fund our operations and capital expenditures.

We Face Risks Related to the Disruption of Our Primary Manufacturing and R&D Facilities

While we maintain business continuity plans, our manufacturing and R&D facilities are concentrated in a limited number of locations. These locations are subject to disruption for a variety of reasons, such as natural or man-made disasters, widespread outbreaks of illness, terrorist activities, political or governmental unrest or instability, disruptions of our information technology resources, utility interruptions, the effects of climate change, or other events beyond our control. Such disruptions may cause delays in developing or shipping our products, in engaging with customers on new product applications, or in supporting customers, which could result in the loss of business or customer trust, adversely affecting our business and operating results. For example, the COVID-19 pandemic has impacted and could in the future impact our manufacturing operations, supply chain, R&D and customer support due to production, sourcing, logistics and other challenges resulting from quarantines, “stay at home” orders, facility closures, workforce challenges, and travel and logistics restrictions in connection with the pandemic.

We Are Subject to Risks Relating to Product Concentration and Lack of Product Revenue Diversification

We derive a substantial percentage of our revenues from a limited number of products. Our products are priced up to the tens of millions of dollars per system. As a result, the inability to recognize revenue on even a few systems can cause a significantly adverse impact on our revenues for a given quarter, and, in the longer term, the continued market acceptance of these products is critical to our future success. Our business, operating results, financial condition, and cash flows could therefore be adversely affected by:

•a decline in demand for even a limited number of our products;

•a failure to achieve continued market acceptance of our key products;

•export restrictions or other regulatory or legislative actions that could limit our ability to sell those products to key customers or customers within certain markets;

•an improved version of products being offered by a competitor in the markets in which we participate;

•increased pressure from competitors that offer broader product lines;

•increased pressure from regional competitors;

•technological changes that we are unable to address with our products; or

•a failure to release new or enhanced versions of our products on a timely basis.

In addition, the fact that we offer limited product lines creates the risk that our customers may view us as less important to their business than our competitors that offer additional products and/or product capabilities, including new products that take advantage of “big data” or other new technologies such as machine learning and artificial intelligence. This may impact our ability to maintain or expand our business with certain customers. Such product concentration may also subject us to additional risks

Lam Research Corporation 2023 Q3 10-Q 37

associated with technology changes. Our business is affected by our customers’ use of our products in certain steps in their wafer fabrication processes. Should technologies change so that the manufacture of semiconductors requires fewer steps using our products, this could have a larger impact on our business than it would on the business of our less concentrated competitors.

We May Fail to Protect Our Critical Proprietary Technology Rights, Which Could Affect Our Business

Our success depends in part on our proprietary technology and our ability to protect key components of that technology through patents, copyrights, trade secrets and other forms of protection. Protecting our key proprietary technology helps us achieve our goals of developing technological expertise and new products and systems that give us a competitive advantage; increasing market penetration and growth of our installed base; and providing comprehensive support and service to our customers. As part of our strategy to protect our technology, we currently hold a number of U.S. and foreign patents and pending patent applications, and we keep certain information, processes, and techniques confidential and/or as trade secrets. However, other parties may challenge or attempt to invalidate or circumvent any patents the U.S. or foreign governments issue to us; these governments may fail to issue patents for pending applications; or we may lose trade secret protection over valuable information due to our or third parties’ intentional or unintentional actions or omissions or even those of our own employees. Additionally, intellectual property litigation can be expensive and time-consuming and even when patents are issued, or trade secret processes are followed, the legal systems in certain of the countries in which we do business might not enforce patents and other intellectual property rights as rigorously or effectively as the United States or may favor local entities in their intellectual property enforcement. The rights granted or anticipated under any of our patents, pending patent applications, or trade secrets may be narrower than we expect or, in fact, provide no competitive advantages. Moreover, because we selectively file for patent protection in different jurisdictions, we may not have adequate protection in all jurisdictions based on such filing decisions. Any of these circumstances could have a material adverse impact on our business.

Our Ability to Attract, Retain, and Motivate Key Employees Is Critical to Our Success

Our ability to compete successfully depends in large part on our ability to attract, retain, and motivate key employees with the appropriate skills, experiences and competencies. This is an ongoing challenge due to intense competition for top talent, fluctuations in industry or business economic conditions, as well as increasing geographic expansion, and these factors in combination may result in cycles of hiring activity and workforce reductions. Our success in hiring depends on a variety of factors, including the attractiveness of our compensation and benefit programs, global economic or political and industry conditions, our organizational structure, global competition for talent and the availability of qualified employees, the availability of career development opportunities, the ability to obtain necessary authorizations for workers to provide services outside their home countries, and our ability to offer a challenging and rewarding work environment. We periodically evaluate our overall compensation and benefit programs and make adjustments, as appropriate, to maintain or enhance their competitiveness. If we are not able to successfully attract, retain, and motivate key employees, we may be unable to capitalize on market opportunities and our operating results may be materially and adversely affected.

If We Choose to Acquire or Dispose of Businesses, Product Lines, and Technologies, We May Encounter Unforeseen Costs and Difficulties That Could Impair Our Financial Performance

An important element of our management strategy is to review acquisition prospects that would complement our existing products, augment our market coverage and distribution ability, enhance our technological capabilities, or accomplish other strategic objectives. As a result, we may seek to make acquisitions of complementary companies, products, or technologies, or we may reduce or dispose of certain product lines or technologies that no longer fit our long-term strategies. For regulatory or other reasons, we may not be successful in our attempts to acquire or dispose of businesses, products, or technologies, resulting in significant financial costs, reduced or lost opportunities, and diversion of management’s attention. Managing an acquired business, disposing of product technologies, or reducing personnel entails numerous operational and financial risks, including difficulties in assimilating acquired operations and new personnel or separating existing business or product groups, diversion of management’s attention away from other business concerns, amortization of acquired intangible assets, adverse customer reaction to our decision to cease support for a product, and potential loss of key employees or customers of acquired or disposed operations. There can be no assurance that we will be able to achieve and manage successfully any such integration of potential acquisitions, disposition of product lines or technologies, or reduction in personnel, or that our management, personnel, or systems will be adequate to support continued operations. Any such inabilities or inadequacies could have a material adverse effect on our business, operating results, financial condition, and/or cash flows.

In addition, any acquisition could result in changes such as potentially dilutive issuances of equity securities, the incurrence of debt and contingent liabilities, the amortization of related intangible assets, and goodwill impairment charges, any of which could materially adversely affect our business, financial condition, results of operations, cash flows, and/or the price of our Common Stock.

Lam Research Corporation 2023 Q3 10-Q 38

LEGAL, REGULATORY AND TAX RISKS

Our Sales to Customers in China, a Significant Region for Us, Have Been Impacted, and are Likely to Be Materially and Adversely Affected by Export License Requirements and Other Regulatory Changes, or Other Governmental Actions in the Course of the Trade Relationship Between the U.S. and China

China represents a large and fast-developing market for the semiconductor equipment industry and therefore is important to our business. Revenue in China, which includes global customers and domestic Chinese customers with manufacturing facilities in China, represented approximately 26%, 31%, and 35% of our total revenue for the nine months ended March 26, 2023 and fiscal years 2022 and 2021, respectively. The U.S. and China have historically had a complex relationship that has included actions that have impacted trade between the two countries. Recently, these actions have included an expansion of export license requirements imposed by the U.S. government, which have limited the market for our products, adversely impacted our revenues, and increased our exposure to foreign competition, and could potentially do so to an even greater extent in the future. Most recently, the U.S. government has enacted new rules aimed at restricting China’s ability to manufacture advanced semiconductors, which include restrictions on exports, reexports or transfers to, or shipping, transmitting, transferring, or facilitating such movement to, or performing services at, customer facilities in China engaged in certain technology end-uses, without appropriate authorizations obtained from U.S. authorities. In addition, the U.S. Department of Commerce has enacted new rules that have expanded export license requirements for U.S. companies to sell certain items to companies and other end-users in China that are designated as military end-users or have operations that could support military end uses; has added additional Chinese companies to its restricted entity list and unverified list under suspicion of military-civil fusion, support of Russia, or other factors associated with a broadening scope of national security concerns (including Semiconductor Manufacturing International Corporation, or SMIC, and related entities, and Yangtze Memory Technologies Co., Ltd., or YMTC, and related entities); and has expanded an existing rule (referred to as the foreign direct product rule) in a manner that could cause foreign-made wafers, chipsets, and certain related items produced with many of our products to be subject to U.S. licensing requirements if Huawei Technologies Co. Ltd (“Huawei”) or its affiliates are parties to a transaction involving the items. These rules have required and may require us to apply for and obtain additional export licenses to supply certain of our products to customers in China, such as SMIC, YMTC and ChangXin Memory Technologies, Inc., and there is no assurance that we will be issued licenses that we apply for on a timely basis or at all. In addition, our customers (including but not limited to Chinese customers) may require U.S. export licenses for the use of our products in order to manufacture products, including semiconductor wafers and integrated circuits, for those of their customers (i.e. Huawei and its affiliates) that are subject to the expanded foreign direct product rule, which may adversely impact the demand for our products. The U.S. Department of Commerce could in the future add additional Chinese companies to its restricted entity list or unverified list or take other actions that could expand licensing requirements or otherwise impact the market for our products and our revenue. The implementation, interpretation and impact on our business of these rules and other regulatory actions taken by the U.S. government is uncertain and evolving, and these rules, other regulatory actions or changes, and other actions taken by the governments of either the U.S. or China, or both, that have occurred and may occur in the future could materially and adversely affect our results of operations.

We Are Exposed to Various Risks from Our Regulatory Environment

We are subject to various risks related to (1) new, different, inconsistent, or even conflicting laws, rules, and regulations that may be enacted by legislative or executive bodies and/or regulatory agencies in the countries that we operate; (2) disagreements or disputes related to international trade; and (3) the interpretation and application of laws, rules, and regulations. As a public company with global operations, we are subject to the laws of multiple jurisdictions and the rules and regulations of various governing bodies, including those related to export controls, financial and other disclosures, corporate governance, privacy, anti-corruption, such as the Foreign Corrupt Practices Act and other local laws prohibiting corrupt payments to governmental officials, anti-boycott compliance, conflict minerals or other social responsibility legislation, immigration or travel regulations, antitrust regulations, and laws or regulations relating to carbon emissions, as well as other laws or regulations imposed in response to climate change concerns, among others. Each of these laws, rules, and regulations imposes costs on our business, including financial costs and potential diversion of our management’s attention associated with compliance, and may present risks to our business, including potential fines, restrictions on our actions, and reputational damage if we do not fully comply.

To maintain high standards of corporate governance and public disclosure, we intend to invest appropriate resources to comply with evolving standards. Changes in or ambiguous interpretations of laws, regulations, and standards may create uncertainty regarding compliance matters. Efforts to comply with new and changing regulations have resulted in, and are likely to continue to result in, reduced operating income, and a diversion of management’s time and attention from revenue-generating activities to compliance activities. If we are found by a court or regulatory agency not to be in compliance with the laws and regulations, our business, financial condition, and/or results of operations could be adversely affected.

Intellectual Property, Indemnity, and Other Claims Against Us Can Be Costly and We Could Lose Significant Rights That Are Necessary to Our Continued Business and Profitability

Third parties may assert infringement, misappropriation, unfair competition, product liability, breach of contract, or other claims against us. From time to time, other persons send us notices alleging that our products infringe or misappropriate their patent or other intellectual property rights. In addition, law enforcement authorities may seek criminal charges relating to intellectual property or other issues. We also face risks of claims arising from commercial and other relationships. In addition, our bylaws

Lam Research Corporation 2023 Q3 10-Q 39

and other indemnity obligations provide that we will indemnify officers and members of our Board of Directors against losses that they may incur in legal proceedings resulting from their service to us. From time to time, in the normal course of business, we indemnify third parties with whom we enter into contractual relationships, including customers and suppliers, with respect to certain matters. We have agreed, under certain conditions, to hold these third parties harmless against specified losses, such as those arising from a breach of representations or covenants, other third-party claims that our products when used for their intended purposes infringe the intellectual property rights of such other third parties, or other claims made against certain parties. In such cases, it is our policy either to defend the claims or to negotiate licenses or other settlements on commercially reasonable terms. However, we may be unable in the future to negotiate necessary licenses or reach agreement on other settlements on commercially reasonable terms, or at all, and any litigation resulting from these claims by other parties may materially and adversely affect our business and financial results, and we may be subject to substantial damage awards and penalties. Moreover, although we have insurance to protect us from certain claims and cover certain losses to our property, such insurance may not cover us for the full amount of any losses, or at all, and may be subject to substantial exclusions and deductibles.

Our Financial Results May Be Adversely Impacted by Higher than Expected Tax Rates or Exposure to Additional Tax Liabilities

We are subject to income, transaction, and other taxes in the United States and various foreign jurisdictions, and significant judgment is required to determine worldwide tax liabilities. The amount of taxes we pay is subject to ongoing audits in various jurisdictions, and a material assessment by a governing tax authority could affect our profitability. As a global company, our effective tax rate is highly dependent upon the geographic composition of worldwide earnings and tax regulations governing each region. Our effective tax rate could be adversely affected by changes in the split of earnings between countries with differing statutory tax rates, in the valuation allowance of deferred tax assets, in tax laws, by material audit assessments, or by changes in or expirations of agreements with tax authorities. These factors could affect our profitability. In particular, the carrying value of deferred tax assets, which are predominantly in the United States, is dependent on our ability to generate future taxable income in the United States.

On August 16, 2022, the Inflation Reduction Act (the “IRA”) was signed into law. In general, the provisions of the IRA will be effective beginning with our fiscal year 2024, with certain exceptions. The IRA includes a new 15% corporate minimum tax. We have evaluated the potential impacts of the IRA and do not expect it to have a material impact on our effective tax rate. However, we expect future guidance from the Treasury Department and will further analyze when the guidance is issued.

Recommendations made by the Organization for Economic Co-operation and Development’s Base Erosion and Profit Shifting 2.0 (“BEPS 2.0”) project have the potential to lead to changes in the tax laws in numerous countries. Several countries around the world have enacted or proposed changes to their existing tax laws based on these recommendations. As each country in which we operate evaluates their alignment with the recommendations, the timing and ultimate impact of any such changes on our effective tax rate remain uncertain. When fully enacted, such changes could have a material impact on our effective tax rate. We will continue to monitor the progress of the BEPS 2.0 implementation.

In addition, President Joseph Biden has made several corporate income tax proposals, including changes in the taxation of non-U.S. income. If enacted, such changes could have a material impact on our effective tax rate.

A Failure to Comply with Environmental Regulations May Adversely Affect Our Operating Results

We are subject to a variety of domestic and international governmental regulations related to the handling, discharge, sale, and disposal of toxic, volatile, or otherwise hazardous or potentially hazardous substances. Failure to comply with present or future environmental regulations (such as regulations imposed on the use or sale of PFAS or PFAS-containing products) could result in fines being imposed on us, require us to undertake remediation activities, suspend production, and/or cease operations, or cause our customers to not accept our products. These regulations could require us to alter our current operations, acquire significant additional equipment, incur substantial other expenses to comply with environmental regulations, or take other actions. Any failure to comply with regulations governing the use, handling, sale, transport, or disposal of hazardous or potentially hazardous substances (including PFAS) could subject us to future liabilities that may adversely affect our operating results, financial condition, and ability to operate our business.

Our Bylaws Designate the Court of Chancery of the State of Delaware as the Sole and Exclusive Judicial Forum for Certain Legal Actions Between the Company and its Stockholders, Which May Discourage Lawsuits with Respect to Such Claims 

Our bylaws provide that, unless we consent otherwise, the Court of Chancery of the State of Delaware will be the sole and exclusive forum for lawsuits asserting certain stockholder claims (including claims asserted derivatively for our benefit), such as claims against directors and officers for breach of a fiduciary duty, claims arising under any provision of the General Corporation Law of Delaware or our certificate of incorporation or our bylaws, or claims governed by the internal affairs doctrine. This is a general summary of the bylaw provision; you should refer to the language of the bylaws for details. While the forum provision does not generally apply to direct claims arising under the Securities Exchange Act of 1934 or the Securities Act of 1933, derivative lawsuits that assert legal claims arising under these statutes could fall within the provision, as recent court decisions have held. 

Lam Research Corporation 2023 Q3 10-Q 40

As a Delaware corporation, Delaware law controls issues of our internal affairs, including duties that our directors, officers, employees, and others owe to the Company and its stockholders. We believe that our exclusive forum provision benefits us, and our stockholders, by permitting relatively prompt resolution of lawsuits concerning our internal affairs, promoting consistent application of Delaware law in these lawsuits, and reducing the possibility of duplicative, costly, multi-jurisdictional litigation with the potential for inconsistent outcomes. However, the forum provision limits a stockholder’s ability to bring a claim in a judicial forum that it believes may be more favorable than Delaware, and this could discourage the filing of such lawsuits.

FINANCIAL, ACCOUNTING AND CAPITAL MARKETS RISKS

The Market for Our Common Stock Is Volatile, Which May Affect Our Ability to Raise Capital or Make Acquisitions or May Subject Our Business to Additional Costs

The market price for our Common Stock is volatile and has fluctuated significantly over the past years. The trading price of our Common Stock could continue to be highly volatile and fluctuate widely in response to a variety of factors, many of which are not within our control or influence. These factors include but are not limited to the following:

•general market, semiconductor, or semiconductor equipment industry conditions;

•economic or political events, trends, and unexpected developments occurring nationally, globally, or in any of our key sales regions;

•changes in macroeconomic conditions, increased risk of recession, and geopolitical issues;

•variations in our quarterly operating results and financial condition, including our liquidity;

•variations in our revenues, earnings, or other business and financial metrics from forecasts by us or securities analysts or from those experienced by other companies in our industry;

•announcements of restructurings, reductions in force, departure of key employees, and/or consolidations of operations;

•margin trading, short sales, hedging and derivative transactions involving our Common Stock;

•government regulations;

•developments in, or claims relating to, patent or other proprietary rights;

•technological innovations and the introduction of new products by us or our competitors;

•commercial success or failure of our new and existing products; or

•disruptions of relationships with key customers or suppliers.

In addition, the stock market experiences significant price and volume fluctuations. Historically, we have witnessed significant volatility in the price of our Common Stock due in part to the price of and markets for semiconductors. These and other factors have adversely affected and may again adversely affect the price of our Common Stock, regardless of our actual operating performance. In the past, following volatile periods in the price of their stock, many companies became the object of securities class action litigation. If we are sued in a securities class action, we could incur substantial costs, and it could divert management’s attention and resources and have an unfavorable impact on our financial performance and the price for our Common Stock.

We May Incur Impairments to Goodwill or Long-lived Assets

We review our goodwill identified in business combinations for impairment annually or whenever events or changes in circumstances indicate that the carrying amount of these assets may exceed the fair value. We review all other long-lived assets, including finite-lived intangible assets, whenever events or changes in circumstance indicate that these assets may not be recoverable. The process of evaluating the potential impairment of goodwill and other long-lived assets requires significant judgement. Negative industry or economic trends, including reduced market prices of our Common Stock, reduced estimates of future cash flows, disruptions to our business, slower growth rates, or lack of growth in our relevant business units, could lead to impairment charges against our long-lived assets, including goodwill and other intangible assets.

When evaluating goodwill, if we conclude that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then a quantitative impairment test is performed and we may be required to record an impairment charge in that period, which could adversely affect our result of operations.

When evaluating other long-lived assets, if we conclude that the estimated undiscounted cash flows attributable to the assets are less than their carrying value, we recognize an impairment loss based on the excess of the carrying amount of the assets over their respective fair values, which could adversely affect our results of operations.

Our valuation methodology for assessing impairment requires management to make judgments and assumptions based on historical experience and to rely heavily on projections of future operating performance. We operate in a highly competitive environment and projections of future operating results and cash flows may vary significantly from actual results. Additionally, if our analysis indicates potential impairment, we may be required to record additional charges to earnings in our financial statements, which could negatively affect our results of operations.

Lam Research Corporation 2023 Q3 10-Q 41

Our Leverage and Debt Service Obligations May Adversely Affect Our Financial Condition, Results of Operations, and Earnings per Share

We have $5.0 billion in aggregate principal amount of senior unsecured notes outstanding. Additionally, we have funding available to us under our $1.5 billion commercial paper program and our $1.5 billion revolving credit facility, which serves as a backstop to our commercial paper program. Our revolving credit facility also includes an option to increase the amount up to an additional $600.0 million, for a potential total commitment of $2.1 billion. We may, in the future, decide to enter into additional debt arrangements.

In addition, we have entered, and in the future may enter, into derivative instrument arrangements to hedge against the variability of cash flows due to changes in the benchmark interest rate of fixed rate debt. We could be exposed to losses in the event of nonperformance by the counterparties to our derivative instruments.

Our indebtedness could have adverse consequences, including:

•risk associated with the alternative reference rate reform (e.g. LIBOR transition);

•risk associated with any inability to satisfy our obligations;

•a portion of our cash flows that may have to be dedicated to interest and principal payments and may not be available for operations, working capital, capital expenditures, expansion, acquisitions, or general corporate or other purposes; and

•impairment of our ability to obtain additional financing in the future.

Our ability to meet our expenses and debt obligations will depend on our future performance, which will be affected by financial, business, economic, regulatory, and other factors. Furthermore, our operations may not generate sufficient cash flows, to enable us to meet our expenses and service our debt. As a result, we may need to enter into new financing arrangements to obtain the necessary funds. If we determine it is necessary to seek additional funding for any reason, we may not be able to obtain such funding or, if funding is available, obtain it on acceptable terms. If we fail to make a payment on our debt, we could be in default on such debt, and this default could cause us to be in default on our other outstanding indebtedness.

Our Credit Agreements Contain Covenant Restrictions That May Limit Our Ability to Operate Our Business

We may be unable to respond to changes in business and economic conditions, engage in transactions that might otherwise be beneficial to us, or obtain additional financing because our debt agreements contain, and any of our other future similar agreements may contain, covenant restrictions that limit our ability to, among other things:

•incur additional debt, assume obligations in connection with letters of credit, or issue guarantees;

•create liens;

•enter into transactions with our affiliates;

•sell certain assets; and

•merge or consolidate with any person.

Our ability to comply with these covenants is dependent on our future performance, which will be subject to many factors, some of which are beyond our control, including prevailing economic conditions. In addition, our failure to comply with these covenants could result in a default under the Senior Notes, or our other debt, which could permit the holders to accelerate such debt. If any of our debt is accelerated, we may not have sufficient funds available to repay such debt, which could materially and negatively affect our financial condition and results of operation.

There Can Be No Assurance That We Will Continue to Declare Cash Dividends or Repurchase Our Shares at All or in Any Particular Amounts

Our Board of Directors has declared quarterly dividends since April 2014. Our intent to continue to pay quarterly dividends and to repurchase our shares is subject to capital availability and periodic determinations by our Board of Directors that cash dividends and share repurchases are in the best interest of our stockholders and are in compliance with all laws and agreements applicable to the declaration and payment of cash dividends or the repurchasing of shares by us. Future dividends and share repurchases may also be affected by, among other factors, our views on potential future capital requirements for investments in acquisitions and the funding of our research and development; legal risks; changes in federal, state, and international tax laws or corporate laws; contractual restrictions, such as financial or operating covenants in our debt arrangements; availability of onshore cash flow; and changes to our business model. Our dividend payments and share repurchases may change from time to time, and we cannot provide assurance that we will continue to declare dividends or repurchase shares at all or in any particular amounts. A reduction or suspension in our dividend payments or share repurchases could have a negative effect on the price of our Common Stock.

Lam Research Corporation 2023 Q3 10-Q 42

ITEM 2.    Unregistered Sales of Equity Securities and Use of Proceeds

Repurchases of Company Shares

In May 2022, the Board of Directors authorized management to repurchase up to an additional $5.0 billion of Common Stock; this authorization supplements the remaining balance from any prior authorization. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. This repurchase program has no termination date and may be suspended or discontinued at any time.

Share repurchases, including those under the repurchase program, were as follows:

	Total Number of Shares Repurchased (1)	Average Price Paid Per Share (2, 3)			Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Amount Available Under Repurchase Program (3)
	(in thousands, except per share data)
Available balance as of June 26, 2022						$	5,514,636
Quarter ended September 25, 2022	686	$	433.47		675	5,409,654
Quarter ended December 25, 2022	1,133	$	429.27		1,125	4,926,428
December 26, 2022 - January 22, 2023	387	$	441.72		386	4,755,865
January 23, 2023 - February 19, 2023	223	$	507.02		221	4,643,892
February 20, 2023 - March 26, 2023	555	$	489.86		410	4,443,010
Quarter ended March 26, 2023	1,165	$	477.15	(4)	1,017	$	4,443,010

(1)    During the three and nine months ended March 26, 2023, we acquired 148 thousand shares at a total cost of $72.5 million, and 167 thousand shares at a total cost of $80.4 million, respectively, which we withheld through net share settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under our equity compensation plans. The shares retained by us through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under our equity compensation plan.

(2)    Average price paid per share excludes the effect of accelerated share repurchase activities. See additional disclosure below regarding our accelerated share repurchase activity during the nine months ended March 26, 2023.

(3)    As of January 1, 2023, our net share repurchases are subject to a 1% excise tax under the Inflation Reduction Act. Excise tax incurred reduces the amount available under repurchase program, as applicable, and is included in the cost of share repurchased in the Condensed Consolidated Statement of Stockholders’ Equity.

(4)    Average price paid per share presented is for the quarter ended March 26, 2023.

Accelerated Share Repurchase Agreements

On June 2, 2022, we entered into an accelerated share repurchase agreement (the "June 2022 ASR") with two financial institutions to repurchase a total of $500 million of Common Stock. We took an initial delivery of approximately 717 thousand shares, which represented 75% of the prepayment amount divided by our closing stock price on June 2, 2022. The total number of shares received under the June 2022 ASR was based upon the average daily volume weighted average price of our Common Stock during the repurchase period, less an agreed upon discount. Final settlement of the June 2022 ASR occurred in September 2022, resulting in the receipt of approximately 433 thousand additional shares, which yielded a weighted-average share price of $435.20 for the transaction period.

ITEM 3.    Defaults Upon Senior Securities

None.

ITEM 4.    Mine Safety Disclosures

Not applicable.

ITEM 5.    Other Information

None.

Lam Research Corporation 2023 Q3 10-Q 43

ITEM 6.    Exhibits

Exhibit Number	Description
31.1	Rule 13a-14(a)/15d-14(a) Certification (Principal Executive Officer)
31.2	Rule 13a-14(a)/15d-14(a) Certification (Principal Financial Officer)
32.1	Section 1350 Certification (Principal Executive Officer)
32.2	Section 1350 Certification (Principal Financial Officer)
101.INS	Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

Lam Research Corporation 2023 Q3 10-Q 44

LAM RESEARCH CORPORATION

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

Date:	April 24, 2023	LAM RESEARCH CORPORATION (Registrant)
		/s/ Douglas R. Bettinger
		Douglas R. Bettinger
		Executive Vice President and Chief Financial Officer (Principal Financial Officer)

Lam Research Corporation 2023 Q3 10-Q 45

EX-31.1

Exhibit 31.1

RULE 13a-14(a)/15d-14(a) CERTIFICATION (PRINCIPAL EXECUTIVE OFFICER)

I, Timothy M. Archer, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Lam Research Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

April 24, 2023

/s/ Timothy M. Archer

Timothy M. Archer

President and Chief Executive Officer

EX-31.2

Exhibit 31.2

RULE 13a-14(a)/15d-14(a) CERTIFICATION (PRINCIPAL FINANCIAL OFFICER)

I, Douglas R. Bettinger, certify that:

1. I have reviewed this quarterly report on Form 10-Q of Lam Research Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

April 24, 2023

/s/ Douglas R. Bettinger

Douglas R. Bettinger

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

EX-32.1

Exhibit 32.1

SECTION 1350 CERTIFICATION (PRINCIPAL EXECUTIVE OFFICER)

In connection with the Quarterly Report of Lam Research Corporation (the “Company”) on Form 10-Q for the fiscal period ending March 26, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Timothy M. Archer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

April 24, 2023

/s/ Timothy M. Archer

Timothy M. Archer

President and Chief Executive Officer

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liability of that section. Such certification will not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

EX-32.2

Exhibit 32.2

SECTION 1350 CERTIFICATION (PRINCIPAL FINANCIAL OFFICER)

In connection with the Quarterly Report of Lam Research Corporation (the “Company”) on Form 10-Q for the fiscal period ending March 26, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Douglas R. Bettinger, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:

(1) The Report fully complies with the requirements of section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

April 24, 2023

/s/ Douglas R. Bettinger

Douglas R. Bettinger

Executive Vice President and Chief Financial Officer

(Principal Financial Officer)

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liability of that section. Such certification will not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.

XML

Cover Page - shares	9 Months Ended
	Mar. 26, 2023	Apr. 20, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 26, 2023
Document Transition Report	false
Entity File Number	0-12933
Entity Registrant Name	LAM RESEARCH CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	94-2634797
Entity Address, Address Line One	4650 Cushing Parkway,
Entity Address, City or Town	Fremont,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94538
City Area Code	510
Local Phone Number	572-0200
Title of 12(b) Security	Common Stock, Par Value $0.001 Per Share
Trading Symbol	LRCX
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		134,340,474
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Entity Central Index Key	0000707549
Current Fiscal Year End Date	--06-25

XML

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 26, 2023	Mar. 27, 2022	Mar. 26, 2023	Mar. 27, 2022
Income Statement [Abstract]
Revenue	$ 3,869,569	$ 4,060,416	$ 14,221,259	$ 12,591,485
Cost of goods sold	2,197,237	2,243,791	7,835,743	6,820,190
Restructuring charges, net - cost of goods sold	66,720	0	66,720	0
Total cost of goods sold	2,263,957	2,243,791	7,902,463	6,820,190
Gross margin	1,605,612	1,816,625	6,318,796	5,771,295
Research and development	429,451	407,120	1,325,211	1,193,091
Selling, general, and administrative	193,500	217,408	632,922	675,735
Restructuring charges, net - operating expenses	40,408	0	40,408	0
Total operating expenses	663,359	624,528	1,998,541	1,868,826
Operating income	942,253	1,192,097	4,320,255	3,902,469
Other income (expense), net	(3,331)	(57,402)	(74,660)	(68,260)
Income before income taxes	938,922	1,134,695	4,245,595	3,834,209
Income tax expense	(124,914)	(112,917)	(537,201)	(437,857)
Net income	$ 814,008	$ 1,021,778	$ 3,708,394	$ 3,396,352
Net income per share:
Basic (in dollars per share)	$ 6.03	$ 7.34	$ 27.28	$ 24.17
Diluted (in dollars per share)	$ 6.01	$ 7.30	$ 27.20	$ 24.02
Number of shares used in per share calculations:
Basic (in shares)	134,924	139,229	135,945	140,534
Diluted (in shares)	135,395	140,057	136,314	141,400

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 26, 2023	Mar. 27, 2022	Mar. 26, 2023	Mar. 27, 2022
Statement of Comprehensive Income [Abstract]
Net income	$ 814,008	$ 1,021,778	$ 3,708,394	$ 3,396,352
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustment	3,727	(14,958)	11,588	(28,810)
Cash flow hedges:
Net unrealized (losses) gains during the period	(3,320)	12,506	(3,135)	16,293
Net losses (gains) reclassified into net income	2,546	(5,759)	(5,478)	(17,205)
Net change	(774)	6,747	(8,613)	(912)
Available-for-sale investments:
Net unrealized gains (losses) during the period	652	(1,333)	1,222	(4,523)
Net (gains) losses reclassified into net income	(105)	(34)	(158)	1,456
Net change	547	(1,367)	1,064	(3,067)
Defined benefit plans, net change in unrealized component	276	58	848	(749)
Other comprehensive income (loss), net of tax	3,776	(9,520)	4,887	(33,538)
Comprehensive income	$ 817,784	$ 1,012,258	$ 3,713,281	$ 3,362,814

XML

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 26, 2023	Jun. 26, 2022	[1]
ASSETS
Cash and cash equivalents	$ 5,305,648	$ 3,522,001
Investments	63,849	135,731
Accounts receivable, less allowance of $5,359 as of March 26, 2023, and $5,606 as of June 26, 2022	3,262,140	4,313,818
Inventories	4,881,935	3,966,294
Prepaid expenses and other current assets	216,455	347,391
Total current assets	13,730,027	12,285,235
Property and equipment, net	1,855,117	1,647,587
Restricted cash and investments	250,688	251,534
Goodwill	1,622,172	1,515,113
Intangible assets, net	179,647	101,850
Other assets	1,605,710	1,394,313
Total assets	19,243,361	17,195,632
LIABILITIES AND STOCKHOLDERS’ EQUITY
Trade accounts payable	601,930	1,011,208
Accrued expenses and other current liabilities	1,990,147	1,974,272
Deferred profit	1,840,795	1,571,898
Current portion of long-term debt and finance lease obligations	8,457	7,381
Total current liabilities	4,441,329	4,564,759
Long-term debt and finance lease obligations, less current portion	4,996,920	4,998,449
Income taxes payable	885,348	931,117
Other long-term liabilities	512,376	422,941
Total liabilities	10,835,973	10,917,266
Commitments and contingencies
Stockholders’ equity:
Preferred stock, at par value of $0.001 per share; authorized, 5,000 shares, none outstanding	0	0
Common stock, at par value of $0.001 per share; authorized, 400,000 shares as of March 26, 2023 and June 26, 2022; issued and outstanding, 134,692 shares as of March 26, 2023, and 136,975 shares as of June 26, 2022	135	137
Additional paid-in capital	7,680,059	7,414,916
Treasury stock, at cost; 159,940 shares as of March 26, 2023, and 157,087 shares as of June 26, 2022	(20,627,829)	(19,481,429)
Accumulated other comprehensive loss	(105,095)	(109,982)
Retained earnings	21,460,118	18,454,724
Total stockholders’ equity	8,407,388	6,278,366
Total liabilities and stockholders’ equity	$ 19,243,361	$ 17,195,632

[1] Derived from audited financial statements

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Mar. 26, 2023	Jun. 26, 2022
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 5,359	$ 5,606
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	5,000,000	5,000,000
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	400,000,000	400,000,000
Common stock, shares issued (in shares)	134,692,000	136,975,000
Common stock, shares outstanding (in shares)	134,692,000	136,975,000
Treasury stock (in shares)	159,940,000	157,087,000

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Mar. 26, 2023	Mar. 27, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 3,708,394	$ 3,396,352
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	252,828	245,807
Deferred income taxes	(133,101)	(83,451)
Equity-based compensation expense	218,105	189,476
Other, net	11,537	(78,325)
Changes in operating assets and liabilities	(1,550)	(1,014,119)
Net cash provided by operating activities	4,056,213	2,655,740
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible assets	(422,898)	(420,288)
Business acquisitions, net of cash acquired	(119,955)	0
Purchases of available-for-sale securities	0	(567,819)
Proceeds from maturities of available-for-sales securities	65,015	167,123
Proceeds from sales of available-for-sale securities	6,837	1,543,094
Other, net	(8,381)	(33,898)
Net cash (used for) provided by investing activities	(479,382)	688,212
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on debt	(21,145)	(9,857)
Treasury stock purchases	(1,147,998)	(2,989,574)
Dividends paid	(675,572)	(607,234)
Reissuance of treasury stock related to employee stock purchase plan	44,996	46,380
Proceeds from issuance of common stock	7,673	4,685
Other, net	(635)	197
Net cash used for financing activities	(1,792,681)	(3,555,403)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash	(1,349)	(13,544)
Net increase (decrease) in cash, cash equivalents, and restricted cash	1,782,801	(224,995)
Cash, cash equivalents, and restricted cash at beginning of period	3,773,535	4,670,750
Cash, cash equivalents, and restricted cash at end of period	5,556,336	4,445,755
Schedule of non-cash transactions:
Accrued payables for stock repurchases	4,081	4,624
Accrued payables for capital expenditures	38,225	57,930
Dividends payable	233,043	208,057
Transfers of finished goods inventory to property and equipment	64,932	62,116
Reconciliation of cash, cash equivalents, and restricted cash
Cash and cash equivalents	5,305,648	4,194,719
Restricted cash and cash equivalents	250,688	251,036
Total cash, cash equivalents, and restricted cash	$ 5,556,336	$ 4,445,755

XML

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total		Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Loss	Retained Earnings
Beginning balance (in shares) at Jun. 27, 2021			142,501
Beginning balance at Jun. 27, 2021	$ 6,027,188		$ 143	$ 7,052,962	$ (15,646,701)	$ (64,128)	$ 14,684,912
Increase (Decrease) in Stockholders' Equity
Issuance of common stock (in shares)			763
Issuance of common stock	4,685		$ 1	4,684
Purchase of treasury stock (in shares)			(4,654)
Purchase of treasury stock	(2,974,193)		$ (5)		(2,974,188)
Reissuance of treasury stock (in shares)			97
Reissuance of treasury stock	46,380			42,271	4,109
Equity-based compensation expense	189,476			189,476
Net income	3,396,352						3,396,352
Other comprehensive income (loss)	(33,538)					(33,538)
Cash dividends declared	(629,860)						(629,860)
Ending balance (in shares) at Mar. 27, 2022			138,707
Ending balance at Mar. 27, 2022	6,026,490		$ 139	7,289,393	(18,616,780)	(97,666)	17,451,404
Beginning balance (in shares) at Dec. 26, 2021			140,275
Beginning balance at Dec. 26, 2021	6,475,781		$ 140	7,220,359	(17,294,255)	(88,146)	16,637,683
Increase (Decrease) in Stockholders' Equity
Issuance of common stock (in shares)			664
Issuance of common stock	492		$ 1	491
Purchase of treasury stock (in shares)			(2,232)
Purchase of treasury stock	(1,322,527)		$ (2)		(1,322,525)
Equity-based compensation expense	68,543			68,543
Net income	1,021,778						1,021,778
Other comprehensive income (loss)	(9,520)					(9,520)
Cash dividends declared	(208,057)						(208,057)
Ending balance (in shares) at Mar. 27, 2022			138,707
Ending balance at Mar. 27, 2022	$ 6,026,490		$ 139	7,289,393	(18,616,780)	(97,666)	17,451,404
Beginning balance (in shares) at Jun. 26, 2022	136,975		136,975
Beginning balance at Jun. 26, 2022	$ 6,278,366	[1]	$ 137	7,414,916	(19,481,429)	(109,982)	18,454,724
Increase (Decrease) in Stockholders' Equity
Issuance of common stock (in shares)			570
Issuance of common stock	7,673		$ 1	7,672
Purchase of treasury stock (in shares)			(2,984)
Purchase of treasury stock	(1,152,033)		$ (3)		(1,152,030)
Reissuance of treasury stock (in shares)			131
Reissuance of treasury stock	44,996			39,366	5,630
Equity-based compensation expense	218,105			218,105
Net income	3,708,394						3,708,394
Other comprehensive income (loss)	4,887					4,887
Cash dividends declared	$ (703,000)						(703,000)
Ending balance (in shares) at Mar. 26, 2023	134,692		134,692
Ending balance at Mar. 26, 2023	$ 8,407,388		$ 135	7,680,059	(20,627,829)	(105,095)	21,460,118
Beginning balance (in shares) at Dec. 25, 2022			135,403
Beginning balance at Dec. 25, 2022	8,304,635		$ 135	7,606,149	(20,071,931)	(108,871)	20,879,153
Increase (Decrease) in Stockholders' Equity
Issuance of common stock (in shares)			454
Issuance of common stock	0		$ 1	(1)
Purchase of treasury stock (in shares)			(1,165)
Purchase of treasury stock	(555,899)		$ (1)		(555,898)
Equity-based compensation expense	73,911			73,911
Net income	814,008						814,008
Other comprehensive income (loss)	3,776					3,776
Cash dividends declared	$ (233,043)						(233,043)
Ending balance (in shares) at Mar. 26, 2023	134,692		134,692
Ending balance at Mar. 26, 2023	$ 8,407,388		$ 135	$ 7,680,059	$ (20,627,829)	$ (105,095)	$ 21,460,118

[1] Derived from audited financial statements

XML

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Mar. 26, 2023	Mar. 27, 2022	Mar. 26, 2023	Mar. 27, 2022
Statement of Stockholders' Equity [Abstract]
Dividends declared per share (in dollars per share)	$ 1.725	$ 1.50	$ 5.175	$ 4.50

XML

BASIS OF PRESENTATION

9 Months Ended

Mar. 26, 2023

Accounting Policies [Abstract]

BASIS OF PRESENTATION

BASIS OF PRESENTATION

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) for interim financial information and the instructions to Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The accompanying unaudited Condensed Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements of Lam Research Corporation (“Lam Research” or the “Company”) for the fiscal year ended June 26, 2022, which are included in the Company’s Annual Report on Form 10-K as of and for the year ended June 26, 2022 (the “2022 Form 10-K”). The Company’s reports on Form 10-K, Form 10-Q and Form 8-K are available online at the Securities and Exchange Commission website on the Internet. The address of that site is www.sec.gov. The Company also posts its reports on Form 10-K, Form 10-Q and Form 8-K on its corporate website at https://investor.lamresearch.com. The content on any website referred to in this Form 10-Q is not a part of or incorporated by reference in this Form 10-Q unless expressly noted.

The condensed consolidated financial statements include the accounts of Lam Research and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 25, 2023 and includes 52 weeks. The quarters ended March 26, 2023 (the “March 2023 quarter”) and March 27, 2022 included 13 weeks.

XML

RECENT ACCOUNTING PRONOUNCEMENTS

9 Months Ended

Mar. 26, 2023

Accounting Changes and Error Corrections [Abstract]

RECENT ACCOUNTING PRONOUNCEMENTS

RECENT ACCOUNTING PRONOUNCEMENTS

Recently Adopted or Effective

In March 2020, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides temporary optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued. In January 2021, the FASB issued ASU 2021-01, “Reference Rate Reform (Topic 848),” which permits entities to apply optional expedients in Topic 848 to derivative instruments modified because of discounting transition resulting from reference rate reform. In December 2022, the FASB issued ASU 2022-06, “Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848,” extending the relief offered in this series of ASUs through December 31, 2024.

In December 2022, the Company executed Amendment No. 1 To Second Amended and Restated Credit Agreement, the primary purpose of which was to change the reference rate for borrowings under the Credit Agreement by replacing LIBOR with the Secured Overnight Financing Rate (“SOFR”). The Company applied practical expedients provided in Topic 848 allowing for the changes in contractual terms to be accounted for prospectively. These modifications had no significant impact on our financial statements. Refer to Note 12 - Long-term debt and other borrowings for further information regarding the terms of the Credit Agreement.

In October 2021, the FASB issued ASU No. 2021-08, “Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,” which requires contract assets and contract liabilities (e.g., deferred revenue) acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, “Revenue from Contracts with Customers” as if the acquirer had originated the contracts. The guidance is applied prospectively to acquisitions occurring on or after the effective date. The Company early adopted ASU No. 2021-08 during the quarter ended December 25, 2022. The adoption of the new standard did not have a material impact on the Company’s Condensed Consolidated financial statements.

Updates Not Yet Effective

There are no new accounting pronouncements not yet adopted or effective that are expected to have a material impact on the Company’s Condensed Consolidated Financial Statements.

XML

REVENUE

9 Months Ended

Mar. 26, 2023

Revenue from Contract with Customer [Abstract]

REVENUE

REVENUE

Deferred Revenue

Revenue of $149.1 million and $1,881.8 million included in deferred profit at June 26, 2022 was recognized during the three and nine months ended March 26, 2023, respectively.

The following table summarizes the transaction price for contracts that have not yet been recognized as revenue as of March 26, 2023 and when the Company expects to recognize the amounts as revenue:

	Less than 1 Year		1-3 Years			More than 3 Years			Total
	(In thousands)
Deferred revenue	$	1,731,567	$	243,733	(1)	$	27,444	(1)	$	2,002,744

(1)This amount is reported in Deferred profit on the Company's Condensed Consolidated Balance Sheets as the customers can demand the liability to be performed at any time.

Disaggregation of Revenue

The Company operates in one reportable business segment: manufacturing and servicing of wafer processing semiconductor manufacturing equipment. The Company’s material operating segments qualify for aggregation due to their customer base and similarities in economic characteristics, nature of products and services, and processes for procurement, manufacturing, and distribution.

The Company operates in seven geographic regions: United States, China, Europe, Japan, Korea, Southeast Asia, and Taiwan. For geographical reporting, revenue is attributed to the geographic location in which the customers’ facilities are located. The Company serves three primary markets: memory, foundry, and logic/integrated device manufacturing.

The following table presents the Company’s revenues disaggregated between system and its customer support-related revenue:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(In thousands)
System revenue	$	2,256,033	$	2,650,842	$	8,985,538	$	8,315,898
Customer support-related revenue and other	1,613,536		1,409,574		5,235,721		4,275,587
	$	3,869,569	$	4,060,416	$	14,221,259	$	12,591,485

System revenue includes sales of new leading-edge equipment in deposition, etch and clean markets.

Customer support-related revenue includes sales of customer service, spares, upgrades, and non-leading-edge equipment from the Company’s Reliant product line.

The following table presents the Company’s revenues disaggregated by geographic region:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(In thousands)
Korea	$	847,728	$	961,300	$	2,780,158	$	2,947,657
China	839,710		1,277,502		3,633,692		3,966,185
Taiwan	713,708		663,494		2,825,827		2,074,681
United States	594,426		309,161		1,402,641		782,170
Japan	406,219		342,329		1,440,857		1,324,996
Europe	311,843		128,149		912,249		387,685
Southeast Asia	155,935		378,481		1,225,835		1,108,111
	$	3,869,569	$	4,060,416	$	14,221,259	$	12,591,485

The following table presents the percentages of leading- and non-leading-edge equipment and upgrade revenue to each of the primary markets the Company serves:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
Memory	32	%	66	%	46	%	62	%
Foundry	46	%	21	%	18	%	26	%
Logic/integrated device manufacturing	22	%	13	%	36	%	12	%

XML

EQUITY-BASED COMPENSATION PLANS

9 Months Ended

Mar. 26, 2023

Share-Based Payment Arrangement [Abstract]

EQUITY-BASED COMPENSATION PLANS

EQUITY-BASED COMPENSATION PLANS

The Lam Research Corporation 2015 Stock Incentive Plan, as amended, provides for the grant of non-qualified equity-based awards of the Company’s Common Stock to eligible employees and non-employee directors, including stock options, restricted stock units (“RSUs”), and market-based performance RSUs (“market-based PRSUs”). An option is a right to purchase Common Stock at a set price. An RSU award is an agreement to issue a set number of shares of Common Stock at the time of vesting. The Company’s market-based PRSUs contain both a market condition and a service condition. The Company’s option, RSU, and market-based PRSU awards typically vest over a period of three years. The Company also has an employee stock purchase plan that allows employees to purchase its Common Stock at a discount through payroll deductions.

The Company recognized the following equity-based compensation expense (including expense related to the employee stock purchase plan) and related income tax benefit in the Condensed Consolidated Statements of Operations:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(in thousands)
Equity-based compensation expense	$	73,911	$	68,543	$	218,105	$	189,476
Income tax benefit recognized related to equity-based compensation expense	$	12,045	$	23,933	$	32,249	$	41,155

XML

OTHER INCOME (EXPENSE), NET

9 Months Ended

Mar. 26, 2023

Other Income and Expenses [Abstract]

OTHER INCOME (EXPENSE), NET

OTHER INCOME (EXPENSE), NET

The significant components of other income (expense), net, are as follows:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(in thousands)
Interest income	$	41,974	$	1,938	$	83,155	$	8,988
Interest expense	(47,217)		(46,710)		(139,930)		(138,531)
Gains (losses) on deferred compensation plan-related assets, net	5,443		(13,118)		3,588		(5,737)
Foreign exchange (losses) gains, net	(5,519)		943		(8,812)		1,657
Other, net	1,988		(455)		(12,661)		65,363
	$	(3,331)	$	(57,402)	$	(74,660)	$	(68,260)

Other, net includes an unrealized gain totaling $63.6 million associated with an equity investee that became publicly traded during the nine months ended March 27, 2022. Refer to Note 8 - Financial Instruments for additional information regarding the Company’s investments.

XML

INCOME TAX EXPENSE

9 Months Ended

Mar. 26, 2023

Income Tax Disclosure [Abstract]

INCOME TAX EXPENSE

INCOME TAX EXPENSE

The Company’s provision for income taxes and effective tax rate are as follows:

	Three Months Ended						Nine Months Ended
	March 26, 2023			March 27, 2022			March 26, 2023			March 27, 2022
	(in thousands, except percentages)
Income tax expense	$	124,914		$	112,917		$	537,201		$	437,857
Effective tax rate	13.3		%	10.0		%	12.7		%	11.4		%

The difference between the U.S. federal statutory tax rate of 21% and the Company’s effective tax rate for the three and nine months ended March 26, 2023 and March 27, 2022 was primarily due to income in lower tax jurisdictions.

The Internal Revenue Service (“IRS”) has examined the Company’s U.S. federal income tax return for the fiscal year ended June 24, 2018. As of September 25, 2022, the IRS has proposed adjustments resulting in a tax liability increase of approximately $50.0 million, which was previously reserved. The Company has agreed to pay the amount and has made a partial cash settlement in the September quarter with the remaining settlement expected to be paid based on the IRS requirements.

The IRS is examining the Company’s U.S. federal income tax returns for the fiscal years ended June 30, 2019, and June 28, 2020. As of March 26, 2023, no adjustments have been proposed by the IRS. The Company is unable to make a reasonable estimate as to when cash settlements, if any, with the IRS will occur.

The Company is in various stages of examinations in connection with all of its tax audits worldwide, and it is difficult to determine when these examinations will be settled. It is reasonably possible that over the next 12-month period the Company may experience an increase or decrease in its uncertain tax positions as a result of tax examinations or lapses of statutes of limitation. The change in uncertain tax positions as a result of lapses of statutes of limitation may range up to $18.3 million.

XML

NET INCOME PER SHARE

9 Months Ended

Mar. 26, 2023

Earnings Per Share [Abstract]

NET INCOME PER SHARE

NET INCOME PER SHARE

Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the treasury stock method, for dilutive stock options, restricted stock units, and convertible notes. The following table reconciles the inputs to the basic and diluted computations for net income per share. 

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(in thousands, except per share data)
Numerator:
Net income	$	814,008	$	1,021,778	$	3,708,394	$	3,396,352
Denominator:
Basic average shares outstanding	134,924		139,229		135,945		140,534
Effect of potential dilutive securities:
Employee stock plans	471		828		369		866
Diluted average shares outstanding	135,395		140,057		136,314		141,400
Net income per share - basic	$	6.03	$	7.34	$	27.28	$	24.17
Net income per share - diluted	$	6.01	$	7.30	$	27.20	$	24.02

For purposes of computing diluted net income per share, weighted-average common shares do not include potentially dilutive securities that are anti-dilutive under the treasury stock method. The impact from potentially dilutive securities, including options and RSUs, was not material for the three and nine months ended March 26, 2023 and March 27, 2022.

XML

FINANCIAL INSTRUMENTS

9 Months Ended

Mar. 26, 2023

Fair Value Disclosures [Abstract]

FINANCIAL INSTRUMENTS

FINANCIAL INSTRUMENTS

The Company maintains an investment portfolio of various holdings, types, and maturities. The Company’s mutual funds, which are related to the Company’s obligations under the deferred compensation plan, are classified as trading securities. Investments classified as trading securities are recorded at fair value based upon quoted market prices. Differences between the cost and fair value of trading securities are recognized as other income (expense), net in the Condensed Consolidated Statements of Operations. All of the Company’s debt securities are classified as available-for-sale and consequently are recorded in the Condensed Consolidated Balance Sheets at fair value with unrealized gains or losses associated with market valuation changes, unrelated to credit losses, reported as a separate component of accumulated other comprehensive income (loss), net of tax; and credit losses, if any, recognized as other income (expense), net in the Condensed Consolidated Statements of Operations.

The Company periodically invests in equity securities. For equity investments that do not have a readily determinable fair value, the Company records them using either 1) the measurement alternative which measures the equity investments at cost minus impairment, if any, plus or minus changes resulting from qualifying observable price changes; or 2) the equity method whereby the Company recognizes its proportional share of the income or loss from the equity method investment on a one-quarter lag. The equity method is utilized when the Company does not have the ability to control the investee but is deemed to have the ability to exercise significant influence over the investee’s operating or financial policies. For equity investments that have a readily determinable fair value, the Company records them at fair market value on a recurring basis based upon quoted market prices. Realized and unrealized gains and losses resulting from application of the measurement alternative, the impact of the application of the equity method to the Company’s equity investments, and recognition of changes in fair market value, as applicable, are recognized as other income (expense), net in the Condensed Consolidated Statements of Operations.

Fair Value

The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining the fair value measurements for assets and liabilities required or permitted to be recorded at fair value, the Company considers the principal or most advantageous market in which it would transact, and it considers assumptions that market participants would use when pricing the asset or liability.

A fair value hierarchy has been established that prioritizes the inputs to valuation techniques used to measure fair value. The level of an asset or liability in the hierarchy is based on the lowest level of input that is significant to the fair value measurement. Assets and liabilities carried at fair value are classified and disclosed in one of the following three categories:

Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities with sufficient volume and frequency of transactions.

Level 2: Valuations based on observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active for identical assets or liabilities, or model-derived valuations techniques for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3: Valuations based on unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities and based on non-binding, broker-provided price quotes and may not have been corroborated by observable market data.

The Company engages with pricing vendors to provide fair values for a majority of its Level 1 and Level 2 investments. The vendors provide either a quoted market price or use observable inputs without applying significant adjustments in their pricing. Significant observable inputs include interest rates and yield curves observable at commonly quoted intervals, volatility and credit risks. The fair value of derivative contracts is determined using observable market inputs such as the foreign currency rates, forward rate curves, currency volatility and interest rates and considers nonperformance risk of the Company and its counterparties.

The Company’s primary financial instruments include its cash, cash equivalents, investments, restricted cash and investments, long-term investments, accounts receivable, accounts payable, long-term debt and leases, and foreign currency related derivative instruments. The estimated fair value of cash, time deposits, accounts receivable, and accounts payable approximates their carrying value due to the short period of time to their maturities. The estimated fair values of lease obligations approximate their carrying value as the majority of these obligations have interest rates that adjust to market rates on a periodic basis. The fair value of the Company’s senior notes is based on the quoted price (level 2); the fair value of the Company's senior notes have not changed materially to that disclosed in Note 14, “Long Term Debt and Other Borrowings,” to the Company’s Consolidated Financial Statements in Part II, Item 8 of our 2022 Form 10-K.

Equity Investments measured at fair value on a non-recurring basis

As of March 26, 2023, and June 26, 2022, equity investments of $128.9 million and $125.2 million, respectively, were reported in other assets in the Condensed Consolidated Balance Sheets.

With the exception of one equity investee that became publicly traded during the nine months ended March 27, 2022, net gains resulting from the application of the measurement alternative to the Company’s equity investments were immaterial for the three and nine months ended March 26, 2023, and March 27, 2022. Refer to Note 5 - Other Income (Expense), net for additional information regarding the gain associated with an equity investee that became publicly traded in the nine months ended March 27, 2022.

Debt and Equity Investments measured at fair value on a recurring basis

The following tables set forth the Company’s cash, cash equivalents, investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of March 26, 2023, and June 26, 2022:

	March 26, 2023
									(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)		Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Level 1:
Money market funds	$	2,534,717	$	—	$	—	$	2,534,717	$	2,534,717	$	—	$	—	$	—
Mutual funds	87,004		9,710		(2,234)		94,480		—		—		—		94,480
Level 1 Total	2,621,721		9,710		(2,234)		2,629,197		2,534,717		—		—		94,480
Level 2:
Corporate notes and bonds	64,593		—		(744)		63,849		—		63,849		—		—
Level 2 Total	64,593		—		(744)		63,849		—		63,849		—		—
Total subject to fair value hierarchy	$	2,686,314	$	9,710	$	(2,978)	$	2,693,046
Cash							$	1,414,563	$	1,411,064	$	—	$	661	$	2,838
Time deposits							1,609,894		1,359,867		—		250,027		—
Total							$	5,717,503	$	5,305,648	$	63,849	$	250,688	$	97,318

	June 26, 2022
									(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)		Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Level 1:
Money market funds	$	712,076	$	—	$	—	$	712,076	$	712,076	$	—	$	—	$	—
Mutual funds	84,851		12,027		(1,659)		95,219		—		—		—		95,219
Level 1 Total	796,927		12,027		(1,659)		807,295		712,076		—		—		95,219
Level 2:
Corporate notes and bonds	137,859		—		(2,128)		135,731		—		135,731		—		—
Level 2 Total	137,859		—		(2,128)		135,731		—		135,731		—		—
Total subject to fair value hierarchy	$	934,786	$	12,027	$	(3,787)	$	943,026
Cash							$	1,017,253	$	1,015,747	$	—	$	1,506	$	—
Time deposits							2,044,206		1,794,178		—		250,028		—
Total							$	4,004,485	$	3,522,001	$	135,731	$	251,534	$	95,219

The Company accounts for its investment portfolio at fair value. Realized gains (losses) for investment sales are specifically identified. Management assesses the fair value of investments in debt securities that are not actively traded through consideration of interest rates and their impact on the present value of the cash flows to be received from the investments.

The Company evaluates its investments with fair value less than amortized cost by first considering whether the Company has the intent to sell the security or whether it is more likely than not that the Company will be required to sell the security before recovery of its amortized cost basis. In either such situation, the difference between fair value and amortized cost is recognized as a loss in the income statement. Where such sales are not likely to occur, the Company considers whether a portion of the loss is the result of a credit loss. To the extent such losses are the result of credit losses, those amounts are recognized in the income statement. All other differences between fair value and amortized cost are recognized in other comprehensive income. No such losses were recognized through the income statement during the three and nine months ended March 26, 2023 and March 27, 2022.

Gross realized gains/(losses) from sales of investments were insignificant in the three and nine months ended March 26, 2023 and March 27, 2022.

The following is an analysis of the Company’s investments in unrealized loss positions:

	March 26, 2023
	Unrealized Losses Less than 12 Months				Unrealized Losses 12 Months or Greater				Total
	Fair Value		Gross Unrealized Loss		Fair Value		Gross Unrealized Loss		Fair Value		Gross Unrealized Loss
	(in thousands)
Mutual funds	$	11,634	$	(922)	$	15,332	$	(1,312)	$	26,966	$	(2,234)
Corporate notes and bonds	16,838		(88)		46,560		(656)		63,398		(744)
	$	28,472	$	(1,010)	$	61,892	$	(1,968)	$	90,364	$	(2,978)

The amortized cost and fair value of cash equivalents, investments, and restricted investments with contractual maturities are as follows as of March 26, 2023:

	Cost		Fair Value
	(in thousands)
Due in one year or less	$	4,200,733	$	4,200,066
Due after one year through five years	8,471		8,394
	$	4,209,204	$	4,208,460

The Company has the ability, if necessary, to liquidate its investments in order to meet the Company’s liquidity needs in the next 12 months. Accordingly, those investments with contractual maturities greater than 12 months from the date of purchase nonetheless are classified as short-term on the accompanying Condensed Consolidated Balance Sheets.

Derivative Instruments and Hedging

The Company’s hedging strategies and policies are unchanged from those disclosed in Note 9, “Financial Instruments,” to our Consolidated Financial Statements in Part II, Item 8 of our 2022 Form 10-K. The financial statement impacts from derivative instruments and hedging activities were not material as of and for the three and nine months ended March 26, 2023 and March 27, 2022.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, investments, restricted cash and investments, trade accounts receivable, and derivative financial instruments used in hedging activities. Cash is placed on deposit at large, global financial institutions. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company’s cash are creditworthy and, accordingly, minimal credit risk exists with respect to these balances.

The Company’s overall portfolio of available-for-sale securities must maintain an average minimum rating of “AA-” or “Aa3” as rated by Standard and Poor’s, Fitch Ratings, or Moody’s Investor Services. To ensure diversification and minimize concentration, the Company’s policy limits the amount of credit exposure with any one financial institution or commercial issuer.

The Company is exposed to credit losses in the event of nonperformance by counterparties on foreign currency and interest rate hedge contracts that are used to mitigate the effect of exchange rate and interest rate fluctuations, and on contracts related to structured share repurchase arrangements. These counterparties are large global financial institutions, and, to date, no such counterparty has failed to meet its financial obligations to the Company.

Credit risk evaluations, including trade references, bank references, and Dun & Bradstreet ratings, are performed on all new customers and the Company monitors its customers’ financial condition and payment performance. In general, the Company does not require collateral on sales.

XML

INVENTORIES

9 Months Ended

Mar. 26, 2023

Inventory Disclosure [Abstract]

INVENTORIES

INVENTORIES

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. System shipments to customers in Japan, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers. Inventories consist of the following:

	March 26, 2023		June 26, 2022
	(in thousands)
Raw materials	$	3,219,721	$	2,401,490
Work-in-process	396,415		471,348
Finished goods	1,265,799		1,093,456
	$	4,881,935	$	3,966,294

XML

GOODWILL AND INTANGIBLE ASSETS

9 Months Ended

Mar. 26, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS

Goodwill

The balance of goodwill is approximately $1.6 billion and $1.5 billion as of March 26, 2023 and June 26, 2022, respectively. As of March 26, 2023 and June 26, 2022, $62.0 million of the goodwill balance is tax deductible and the remaining balance is not tax deductible due to purchase accounting and applicable foreign law. Refer to Note 17 - Business Combinations for additional information regarding the Company’s goodwill balance.

Intangible Assets

The following table provides the Company’s intangible assets, other than goodwill:

	March 26, 2023						June 26, 2022
	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
	(in thousands)
Customer relationships	$	644,083	$	(630,262)	$	13,821	$	633,252	$	(627,376)	$	5,876
Existing technology	717,210		(671,335)		45,875		676,924		(664,278)		12,646
Patents and other intangible assets	197,612		(107,742)		89,870		167,821		(84,493)		83,328
Intangible assets subject to amortization	1,558,905		(1,409,339)		149,566		1,477,997		(1,376,147)		101,850
In process research and development	30,081		—		30,081		—		—		—
Total intangible assets	$	1,588,986	$	(1,409,339)	$	179,647	$	1,477,997	$	(1,376,147)	$	101,850

The Company recognized $13.8 million and $20.4 million in intangible asset amortization expense during the three months ended March 26, 2023 and March 27, 2022, respectively. The Company recognized $37.4 million and $58.9 million in intangible asset amortization expense during the nine months ended March 26, 2023 and March 27, 2022, respectively.

The estimated future amortization expense of intangible assets as of March 26, 2023, is reflected in the table below. The table excludes $20.7 million of capitalized costs for internal-use software, included in Patents and other intangible assets in the table above, that have not been placed into service.

Fiscal Year	Amount
	(in thousands)
2023 (remaining 3 months)	$	13,014
2024	40,799
2025	26,696
2026	16,575
2027	12,262
Thereafter	19,570
	$	128,916

Refer to Note 17 - Business Combinations for additional information regarding the Company’s intangible assets.

XML

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

9 Months Ended

Mar. 26, 2023

Payables and Accruals [Abstract]

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES

Accrued expenses and other current liabilities consist of the following:

	March 26, 2023		June 26, 2022
	(in thousands)
Accrued compensation	$	433,643	$	481,070
Warranty reserves	277,183		232,248
Income and other taxes payable	383,610		465,601
Dividend payable	233,043		205,615
Restructuring	75,257		—
Other	587,411		589,738
	$	1,990,147	$	1,974,272

XML

LONG-TERM DEBT AND OTHER BORROWINGS

9 Months Ended

Mar. 26, 2023

Debt Disclosure [Abstract]

LONG-TERM DEBT AND OTHER BORROWINGS

LONG-TERM DEBT AND OTHER BORROWINGS

Revolving Credit Facility

On March 12, 2014, the Company established an unsecured Credit Agreement. This agreement was amended on November 10, 2015 (the “Amended and Restated Credit Agreement”), October 13, 2017 (the “2nd Amendment”), February 25, 2019 (the “3rd Amendment”), June 17, 2021 (the “Second Amended and Restated Credit Agreement”), and December 7, 2022 (“Amendment No.1 to Second Amended and Restated Credit Agreement”). The Amendment No.1 To Second Amended and Restated Credit Agreement replaces the benchmark reference rate, LIBOR, with term SOFR equal to the term rate determined by the CME term SOFR administrator plus 0.10% (“adjusted term SOFR”), with no change to the amount or timing of contractual cash flows.

Interest on amounts borrowed under the credit facility is, at the Company’s option, based on (1) a base rate, defined as the greatest of (a) prime rate, (b) Federal Funds rate plus 0.5%, or (c) adjusted term SOFR plus 1.0%, plus a spread of 0.00% to 0.30%, or (2) adjusted term SOFR, plus a spread of 0.805% to 1.30%, in each case plus a facility fee, with such spread and facility fee determined based on the rating of the Company’s non-credit enhanced, senior unsecured long-term debt. Such spreads and such facility fees are further subject to sustainability adjustments as described in the Amendment No.1 To Second Amended and Restated Credit Agreement, in each case based on the Company’s performance of certain energy savings and health and safety standards metrics. As of March 26, 2023, the Company had no borrowings outstanding under the credit facility and was in compliance with all financial covenants.

XML

LEASES

9 Months Ended

Mar. 26, 2023

Leases [Abstract]

LEASES

LEASES

The Company leases certain office spaces, manufacturing and warehouse spaces, equipment, and vehicles. While the majority of the Company’s lease arrangements are operating leases, the Company has certain leases that qualify as finance leases.

Selected Leases and Related Guarantees

The Company leases the majority of its administrative, research and development and manufacturing facilities, regional sales/service offices, and certain equipment under non-cancelable leases. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters, Tualatin, Oregon campus, and certain other facility leases provide the Company with options to extend the leases for additional periods or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based on the general rate of inflation.

The Company has finance leases for certain improved properties in Fremont and Livermore, California (the “California Facility Leases”). The Company is required to maintain cash collateral in an aggregate of approximately $250.0 million in separate interest-bearing accounts as security for the Company’s obligations. These amounts are recorded with other restricted cash and investments in the Company’s Condensed Consolidated Balance Sheet as of March 26, 2023.

During the seven-year term of the California Facility Leases and when the terms of the California Facility Leases expire, the property subject to the California Facility Leases may be re-marketed. The Company has guaranteed to the lessor that each property will have a certain minimum residual value. The aggregate maximum guarantee made by the Company under the California Facility Leases is $298.4 million.

LEASES

LEASES

The Company leases certain office spaces, manufacturing and warehouse spaces, equipment, and vehicles. While the majority of the Company’s lease arrangements are operating leases, the Company has certain leases that qualify as finance leases.

Selected Leases and Related Guarantees

The Company leases the majority of its administrative, research and development and manufacturing facilities, regional sales/service offices, and certain equipment under non-cancelable leases. Certain of the Company’s facility leases for buildings located at its Fremont, California headquarters, Tualatin, Oregon campus, and certain other facility leases provide the Company with options to extend the leases for additional periods or to purchase the facilities. Certain of the Company’s facility leases provide for periodic rent increases based on the general rate of inflation.

The Company has finance leases for certain improved properties in Fremont and Livermore, California (the “California Facility Leases”). The Company is required to maintain cash collateral in an aggregate of approximately $250.0 million in separate interest-bearing accounts as security for the Company’s obligations. These amounts are recorded with other restricted cash and investments in the Company’s Condensed Consolidated Balance Sheet as of March 26, 2023.

During the seven-year term of the California Facility Leases and when the terms of the California Facility Leases expire, the property subject to the California Facility Leases may be re-marketed. The Company has guaranteed to the lessor that each property will have a certain minimum residual value. The aggregate maximum guarantee made by the Company under the California Facility Leases is $298.4 million.

XML

COMMITMENTS AND CONTINGENCIES

9 Months Ended

Mar. 26, 2023

Commitments and Contingencies Disclosure [Abstract]

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIESRefer to Note 13 - Leases for details regarding guarantees surrounding selected leases.

Other Guarantees

The Company has issued certain indemnifications to its lessors for taxes and general liability under some of its agreements. The Company has entered into insurance contracts that are intended to limit its exposure to such indemnifications. As of March 26, 2023, the Company had not recorded any liability on its Condensed Consolidated Financial Statements in connection with these indemnifications, as it does not believe that it is probable that any material amounts will be paid under these guarantees.

Generally, the Company indemnifies, under pre-determined conditions and limitations, its customers for infringement of third-party intellectual property rights by the Company’s products or services. The Company seeks to limit its liability for such indemnity to an amount not to exceed the sales price of the products or services subject to its indemnification obligations. The Company does not believe that it is probable that any material amounts will be paid under these guarantees.

The Company provides guarantees and standby letters of credit to certain parties as required for certain transactions initiated during the ordinary course of business. As of March 26, 2023, the maximum potential amount of future payments that the Company could be required to make under these arrangements and letters of credit was $99.6 million. The Company does not believe, based on historical experience and information currently available, that it is probable that any material amounts will be required to be paid.

In addition, the Company has entered into indemnification agreements with its directors, officers, and certain other employees, consistent with its Bylaws and Certificate of Incorporation; and under local law, the Company may be required to provide indemnification to its employees for actions within the scope of their employment. Although the Company maintains insurance contracts that cover some of the potential liability associated with these indemnification agreements, there is no guarantee that all such liabilities will be covered. The Company does not believe, based on historical experience and information currently available, that it is probable that any material amounts will be required to be paid under such indemnification agreements or statutory obligations.

Warranties

The Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements. As of March 26, 2023, warranty reserves totaling $35.6 million were recognized in other long-term liabilities, the remainder were included in accrued expenses and other current liabilities in the Company’s Condensed Consolidated Balance Sheets.

Changes in the Company’s product warranty reserves were as follows:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(in thousands)
Balance at beginning of period	$	318,969	$	228,388	$	256,258	$	191,758
Warranties issued during the period	54,158		71,707		225,735		213,816
Settlements made during the period	(60,440)		(71,957)		(187,174)		(200,375)
Changes in liability for warranties issued during the period	(942)		—		999		—
Changes in liability for pre-existing warranties	1,087		12,190		17,014		35,129
Balance at end of period	$	312,832	$	240,328	$	312,832	$	240,328

Legal Proceedings

While the Company is not currently a party to any legal proceedings that it believes material, the Company is either a defendant or plaintiff in various actions that have arisen from time to time in the normal course of business, including intellectual property claims. The Company accrues for a liability when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. Based on current information, the Company does not believe that a material loss from known matters is probable and therefore has not recorded an accrual of any material amount for litigation or other contingencies related to existing legal proceedings.

XML

STOCK REPURCHASE PROGRAM

9 Months Ended

Mar. 26, 2023

Equity [Abstract]

STOCK REPURCHASE PROGRAM

STOCK REPURCHASE PROGRAM

In May 2022, the Board of Directors authorized the Company to repurchase up to an additional $5.0 billion of Common Stock; this authorization supplements the remaining balances from any prior authorizations. These repurchases can be conducted on the open market or as private purchases and may include the use of derivative contracts with large financial institutions, in all cases subject to compliance with applicable law. This repurchase program has no termination date and may be suspended or discontinued at any time.

Repurchases under the repurchase program were as follows during the periods indicated:

Period	Total Number of Shares Repurchased		Total Cost of Repurchase			Average Price Paid Per  Share (1)			Amount Available Under Repurchase Program (3)
	(in thousands, except per share data)
Available balance as of June 26, 2022									$	5,514,636
Quarter ended September 25, 2022	675	(2)	$	104,982		$	432.74		$	5,409,654
Quarter ended December 25, 2022	1,125		$	483,226		$	429.42		$	4,926,428
Quarter ended March 26, 2023	1,017		$	483,418	(3)	$	475.18	(3)	$	4,443,010

(1)    Average price paid per share excludes the effect of accelerated share repurchase activities. See additional disclosure below regarding the Company’s accelerated share repurchase activity during the nine months ended March 26, 2023.

(2)    Includes shares received at final settlement of accelerated share repurchase agreements; see additional disclosures below regarding the Company’s accelerated share repurchase activity during the nine months ended March 26, 2023.

(3)    As of January 1, 2023, the Company’s net share repurchases are subject to a 1% excise tax under the Inflation Reduction Act. Excise tax incurred reduces the amount available under the repurchase program, as applicable, and is included in the cost of share repurchased in the Condensed Consolidated Statement of Stockholders’ Equity.

In addition to the shares repurchased under the Board-authorized repurchase program shown above, during the three and nine months ended March 26, 2023, the Company acquired 148 thousand shares at a total cost of $72.5 million and 167 thousand shares at a total cost of $80.4 million, respectively, which the Company withheld through net settlements to cover minimum tax withholding obligations upon the vesting of restricted stock unit awards granted under the Company’s equity compensation plans. The shares retained by the Company through these net share settlements are not a part of the Board-authorized repurchase program but instead are authorized under the Company’s equity compensation plan.

Accelerated Share Repurchase Agreements

On June 2, 2022, the Company entered into an accelerated share repurchase agreement (the "June 2022 ASR") with two financial institutions to repurchase a total of $500 million of Common Stock. The Company took an initial delivery of approximately 717 thousand shares, which represented 75% of the prepayment amount divided by our closing stock price on June 2, 2022. The total number of shares received under the June 2022 ASR was based upon the average daily volume weighted average price of the Company’s Common Stock during the repurchase period, less an agreed upon discount. Final settlement of the June 2022 ASR occurred in September 2022, resulting in the receipt of approximately 433 thousand additional shares, which yielded a weighted-average share price of $435.20 for the transaction period.

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS

9 Months Ended

Mar. 26, 2023

Equity [Abstract]

ACCUMULATED OTHER COMPREHENSIVE LOSS

ACCUMULATED OTHER COMPREHENSIVE LOSS

The components of accumulated other comprehensive loss, net of tax at March 26, 2023, as well as the activity for the nine months ending March 26, 2023, were as follows:

	Accumulated Foreign Currency Translation Adjustment		Accumulated Unrealized  Gain or Loss on Cash flow hedges		Accumulated Unrealized  Holding Gain or Loss on Available-For-Sale Investments		Accumulated Unrealized  Components of Defined  Benefit Plans		Total
	(in thousands)
Balance at June 26, 2022	$	(81,755)	$	(12,330)	$	(1,637)	$	(14,260)	$	(109,982)
Other comprehensive income (loss) before reclassifications	11,588		(3,135)		1,222		848		10,523
Gains reclassified from accumulated other comprehensive loss to net income (1)	—		(5,478)		(158)		—		(5,636)
Net current-period other comprehensive income (loss)	11,588		(8,613)		1,064		848		4,887
Balance at March 26, 2023	$	(70,167)	$	(20,943)	$	(573)	$	(13,412)	$	(105,095)

(1)    Amount of after-tax gains reclassified from AOCI into net income is not material in the aggregate, or to any individual location in our Condensed Consolidated Statements of Operations.

XML

BUSINESS COMBINATIONS

9 Months Ended

Mar. 26, 2023

Business Combination and Asset Acquisition [Abstract]

BUSINESS COMBINATIONS

BUSINESS COMBINATIONS

In November 2022, the Company completed two business combination transactions acquiring the outstanding shares of two separate private companies in cash transactions valued at $153.8 million as of the respective purchase dates. The Company’s preliminary assessment of acquisition date fair value of the assets acquired and liabilities assumed resulted in the recognition of $102.2 million of goodwill and $81.2 million of intangible assets; all other assets acquired and all liabilities assumed were immaterial. The preliminary fair value of net tangible liabilities assumed and intangible assets acquired was based on preliminary valuations, estimates, and assumptions which are subject to change within the measurement period (up to one year from the acquisition date). The Company expensed all associated costs, as incurred, in selling, general, and administrative expense in the Condensed Consolidated Statement of Operations for the three and nine months ended March 26, 2023.

The following table is a summary of the preliminary fair value estimates of the identifiable intangible assets and their useful lives:

	Weighted-Average Useful Life	Estimated Purchase Date Fair Value
		(in thousands)
Existing technology	7 years	$	40,294
Customer relationships	8 years	10,835
In process research and development	Indefinite	30,081
		$	81,210

XML

RESTRUCTURING CHARGES, NET

9 Months Ended

Mar. 26, 2023

Restructuring and Related Activities [Abstract]

RESTRUCTURING CHARGES, NET

RESTRUCTURING CHARGES, NETThe Company records employee severance and separation costs that meet the requirements for recognition in accordance with the relevant guidance of ASC 420, Exit or Disposal Cost Obligations, or ASC 712, Compensation - Non-retirement Post-employment Benefits, as applicable. For involuntary termination benefits that are not provided under the terms of an ongoing benefit arrangement, the liability for the current fair value of expected future costs associated with a management-approved restructuring plan is recognized in the period in which the plan is communicated to the employees and the plan is not expected to change significantly. For ongoing benefit arrangements, inclusive of statutory requirements, employee termination costs are accrued when the existing situation or set of circumstances indicates that an obligation has been incurred, it is probable the benefits will be paid, and the amount can be reasonably estimated. Termination benefits associated with employees that elected to voluntarily terminate as part of the restructuring plan are recorded when the employee irrevocably accepts the offer and the amount can be reasonably estimated. If applicable, the Company records such costs into operating expense over the terminated employees’ future service period beyond any minimum or legally required retention period. The majority of restructuring charges that have been incurred but not yet paid are recorded in Accrued expenses and other current liabilities in the Condensed Consolidated Balance Sheets.

In the three and nine months ended March 26, 2023, the Company initiated a restructuring plan designed to better align the Company’s cost structure with its outlook for the economic environment and business opportunities. Under the plan the Company terminated approximately 1,400 employees, incurring expenses related to employee severance and separation costs. Employee severance and separation costs primarily relate to severance, non-cash severance, including equity award compensation expense, pension and other termination benefits. Additionally, the Company made a strategic decision to relocate certain manufacturing activities to pre-existing facilities.

During the three and nine months ended March 26, 2023, net restructuring costs of $66.7 million and $40.4 million were recorded in restructuring charges, net - cost of goods sold, and restructuring charges, net - operating expenses, respectively in the Condensed Consolidated Statements of Operations.

The Company anticipates the restructuring plan to be substantially complete by December 24, 2023, and estimates that incremental restructuring charges totaling approximately $40 million will be incurred through the fiscal quarter ending December 24, 2023.

The following table is a summary of the activity related to the restructuring plan:

	Severance and Benefits		Other		Total
	(in thousands)
Restructuring expense	$	98,508	$	8,620	$	107,128
Cash payments	(20,658)		(2,967)		(23,625)
Non-cash activities	(2,269)		(794)		(3,063)
Restructuring liability as of March 26, 2023	$	75,581	$	4,859	$	80,440

XML

BASIS OF PRESENTATION (Policies)

9 Months Ended

Mar. 26, 2023

Accounting Policies [Abstract]

Consolidation

The condensed consolidated financial statements include the accounts of Lam Research and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.

Fiscal Period

The Company’s reporting period is a 52/53-week fiscal year. The Company’s current fiscal year will end June 25, 2023 and includes 52 weeks.

Recently Adopted or Effective and Updates Not Yet Effective

Recently Adopted or Effective

In March 2020, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting.” The ASU provides temporary optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued. In January 2021, the FASB issued ASU 2021-01, “Reference Rate Reform (Topic 848),” which permits entities to apply optional expedients in Topic 848 to derivative instruments modified because of discounting transition resulting from reference rate reform. In December 2022, the FASB issued ASU 2022-06, “Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848,” extending the relief offered in this series of ASUs through December 31, 2024.

In December 2022, the Company executed Amendment No. 1 To Second Amended and Restated Credit Agreement, the primary purpose of which was to change the reference rate for borrowings under the Credit Agreement by replacing LIBOR with the Secured Overnight Financing Rate (“SOFR”). The Company applied practical expedients provided in Topic 848 allowing for the changes in contractual terms to be accounted for prospectively. These modifications had no significant impact on our financial statements. Refer to Note 12 - Long-term debt and other borrowings for further information regarding the terms of the Credit Agreement.

In October 2021, the FASB issued ASU No. 2021-08, “Business Combinations (Topic 805), Accounting for Contract Assets and Contract Liabilities from Contracts with Customers,” which requires contract assets and contract liabilities (e.g., deferred revenue) acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, “Revenue from Contracts with Customers” as if the acquirer had originated the contracts. The guidance is applied prospectively to acquisitions occurring on or after the effective date. The Company early adopted ASU No. 2021-08 during the quarter ended December 25, 2022. The adoption of the new standard did not have a material impact on the Company’s Condensed Consolidated financial statements.

Updates Not Yet Effective

There are no new accounting pronouncements not yet adopted or effective that are expected to have a material impact on the Company’s Condensed Consolidated Financial Statements.

Inventories

Inventories are stated at the lower of cost (first-in, first-out method) or net realizable value. System shipments to customers in Japan, for which title does not transfer until customer acceptance, are classified as finished goods inventory and carried at cost until title transfers.

Warranties

The Company provides standard warranties on its systems. The liability amount is based on actual historical warranty spending activity by type of system, customer, and geographic region, modified for any known differences such as the impact of system reliability improvements.

XML

REVENUE (Tables)

9 Months Ended

Mar. 26, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Contract Transaction Price Not Yet Recognized as Revenue

The following table summarizes the transaction price for contracts that have not yet been recognized as revenue as of March 26, 2023 and when the Company expects to recognize the amounts as revenue:

	Less than 1 Year		1-3 Years			More than 3 Years			Total
	(In thousands)
Deferred revenue	$	1,731,567	$	243,733	(1)	$	27,444	(1)	$	2,002,744

(1)This amount is reported in Deferred profit on the Company's Condensed Consolidated Balance Sheets as the customers can demand the liability to be performed at any time.

Schedule of Disaggregation of Revenue

The following table presents the Company’s revenues disaggregated between system and its customer support-related revenue:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(In thousands)
System revenue	$	2,256,033	$	2,650,842	$	8,985,538	$	8,315,898
Customer support-related revenue and other	1,613,536		1,409,574		5,235,721		4,275,587
	$	3,869,569	$	4,060,416	$	14,221,259	$	12,591,485

The following table presents the Company’s revenues disaggregated by geographic region:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(In thousands)
Korea	$	847,728	$	961,300	$	2,780,158	$	2,947,657
China	839,710		1,277,502		3,633,692		3,966,185
Taiwan	713,708		663,494		2,825,827		2,074,681
United States	594,426		309,161		1,402,641		782,170
Japan	406,219		342,329		1,440,857		1,324,996
Europe	311,843		128,149		912,249		387,685
Southeast Asia	155,935		378,481		1,225,835		1,108,111
	$	3,869,569	$	4,060,416	$	14,221,259	$	12,591,485

Schedule of System Revenues of Primary Markets

The following table presents the percentages of leading- and non-leading-edge equipment and upgrade revenue to each of the primary markets the Company serves:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
Memory	32	%	66	%	46	%	62	%
Foundry	46	%	21	%	18	%	26	%
Logic/integrated device manufacturing	22	%	13	%	36	%	12	%

XML

EQUITY-BASED COMPENSATION PLANS (Tables)

9 Months Ended

Mar. 26, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Recognized Equity Based Compensation Expenses and Benefits

The Company recognized the following equity-based compensation expense (including expense related to the employee stock purchase plan) and related income tax benefit in the Condensed Consolidated Statements of Operations:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(in thousands)
Equity-based compensation expense	$	73,911	$	68,543	$	218,105	$	189,476
Income tax benefit recognized related to equity-based compensation expense	$	12,045	$	23,933	$	32,249	$	41,155

XML

OTHER INCOME (EXPENSE), NET (Tables)

9 Months Ended

Mar. 26, 2023

Other Income and Expenses [Abstract]

Schedule of Components of Other Income (Expense), Net

The significant components of other income (expense), net, are as follows:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(in thousands)
Interest income	$	41,974	$	1,938	$	83,155	$	8,988
Interest expense	(47,217)		(46,710)		(139,930)		(138,531)
Gains (losses) on deferred compensation plan-related assets, net	5,443		(13,118)		3,588		(5,737)
Foreign exchange (losses) gains, net	(5,519)		943		(8,812)		1,657
Other, net	1,988		(455)		(12,661)		65,363
	$	(3,331)	$	(57,402)	$	(74,660)	$	(68,260)

XML

INCOME TAX EXPENSE (Tables)

9 Months Ended

Mar. 26, 2023

Income Tax Disclosure [Abstract]

Schedule of Effective Income Tax Rate Reconciliation

The Company’s provision for income taxes and effective tax rate are as follows:

	Three Months Ended						Nine Months Ended
	March 26, 2023			March 27, 2022			March 26, 2023			March 27, 2022
	(in thousands, except percentages)
Income tax expense	$	124,914		$	112,917		$	537,201		$	437,857
Effective tax rate	13.3		%	10.0		%	12.7		%	11.4		%

XML

NET INCOME PER SHARE (Tables)

9 Months Ended

Mar. 26, 2023

Earnings Per Share [Abstract]

Schedule of Numerators and Denominators of Basic and Diluted Computations for Net Income Per Share

The following table reconciles the inputs to the basic and diluted computations for net income per share. 

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(in thousands, except per share data)
Numerator:
Net income	$	814,008	$	1,021,778	$	3,708,394	$	3,396,352
Denominator:
Basic average shares outstanding	134,924		139,229		135,945		140,534
Effect of potential dilutive securities:
Employee stock plans	471		828		369		866
Diluted average shares outstanding	135,395		140,057		136,314		141,400
Net income per share - basic	$	6.03	$	7.34	$	27.28	$	24.17
Net income per share - diluted	$	6.01	$	7.30	$	27.20	$	24.02

XML

FINANCIAL INSTRUMENTS (Tables)

9 Months Ended

Mar. 26, 2023

Fair Value Disclosures [Abstract]

Schedule of Cash, Cash Equivalents, Investments, Restricted Cash and Investments and Other Assets Measured at Fair Value on Recurring Basis

The following tables set forth the Company’s cash, cash equivalents, investments, restricted cash and investments, and other assets measured at fair value on a recurring basis as of March 26, 2023, and June 26, 2022:

	March 26, 2023
									(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)		Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Level 1:
Money market funds	$	2,534,717	$	—	$	—	$	2,534,717	$	2,534,717	$	—	$	—	$	—
Mutual funds	87,004		9,710		(2,234)		94,480		—		—		—		94,480
Level 1 Total	2,621,721		9,710		(2,234)		2,629,197		2,534,717		—		—		94,480
Level 2:
Corporate notes and bonds	64,593		—		(744)		63,849		—		63,849		—		—
Level 2 Total	64,593		—		(744)		63,849		—		63,849		—		—
Total subject to fair value hierarchy	$	2,686,314	$	9,710	$	(2,978)	$	2,693,046
Cash							$	1,414,563	$	1,411,064	$	—	$	661	$	2,838
Time deposits							1,609,894		1,359,867		—		250,027		—
Total							$	5,717,503	$	5,305,648	$	63,849	$	250,688	$	97,318

	June 26, 2022
									(Reported Within)
	Cost		Unrealized Gain		Unrealized (Loss)		Fair Value		Cash and Cash Equivalents		Investments		Restricted Cash & Investments		Other Assets
	(in thousands)
Level 1:
Money market funds	$	712,076	$	—	$	—	$	712,076	$	712,076	$	—	$	—	$	—
Mutual funds	84,851		12,027		(1,659)		95,219		—		—		—		95,219
Level 1 Total	796,927		12,027		(1,659)		807,295		712,076		—		—		95,219
Level 2:
Corporate notes and bonds	137,859		—		(2,128)		135,731		—		135,731		—		—
Level 2 Total	137,859		—		(2,128)		135,731		—		135,731		—		—
Total subject to fair value hierarchy	$	934,786	$	12,027	$	(3,787)	$	943,026
Cash							$	1,017,253	$	1,015,747	$	—	$	1,506	$	—
Time deposits							2,044,206		1,794,178		—		250,028		—
Total							$	4,004,485	$	3,522,001	$	135,731	$	251,534	$	95,219

Schedule of Investments in Unrealized Loss Positions

The following is an analysis of the Company’s investments in unrealized loss positions:

	March 26, 2023
	Unrealized Losses Less than 12 Months				Unrealized Losses 12 Months or Greater				Total
	Fair Value		Gross Unrealized Loss		Fair Value		Gross Unrealized Loss		Fair Value		Gross Unrealized Loss
	(in thousands)
Mutual funds	$	11,634	$	(922)	$	15,332	$	(1,312)	$	26,966	$	(2,234)
Corporate notes and bonds	16,838		(88)		46,560		(656)		63,398		(744)
	$	28,472	$	(1,010)	$	61,892	$	(1,968)	$	90,364	$	(2,978)

Schedule of Amortized Cost and Fair Value of Cash Equivalents, Investments, Restricted Cash and Investments with Contractual Maturities

The amortized cost and fair value of cash equivalents, investments, and restricted investments with contractual maturities are as follows as of March 26, 2023:

	Cost		Fair Value
	(in thousands)
Due in one year or less	$	4,200,733	$	4,200,066
Due after one year through five years	8,471		8,394
	$	4,209,204	$	4,208,460

XML

INVENTORIES (Tables)

9 Months Ended

Mar. 26, 2023

Inventory Disclosure [Abstract]

Schedule of Inventories

Inventories consist of the following:

	March 26, 2023		June 26, 2022
	(in thousands)
Raw materials	$	3,219,721	$	2,401,490
Work-in-process	396,415		471,348
Finished goods	1,265,799		1,093,456
	$	4,881,935	$	3,966,294

XML

GOODWILL AND INTANGIBLE ASSETS (Tables)

9 Months Ended

Mar. 26, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets, Other Than Goodwill

The following table provides the Company’s intangible assets, other than goodwill:

	March 26, 2023						June 26, 2022
	Gross		Accumulated Amortization		Net		Gross		Accumulated Amortization		Net
	(in thousands)
Customer relationships	$	644,083	$	(630,262)	$	13,821	$	633,252	$	(627,376)	$	5,876
Existing technology	717,210		(671,335)		45,875		676,924		(664,278)		12,646
Patents and other intangible assets	197,612		(107,742)		89,870		167,821		(84,493)		83,328
Intangible assets subject to amortization	1,558,905		(1,409,339)		149,566		1,477,997		(1,376,147)		101,850
In process research and development	30,081		—		30,081		—		—		—
Total intangible assets	$	1,588,986	$	(1,409,339)	$	179,647	$	1,477,997	$	(1,376,147)	$	101,850

Schedule of Estimated Future Amortization Expense of Intangible Assets

The estimated future amortization expense of intangible assets as of March 26, 2023, is reflected in the table below. The table excludes $20.7 million of capitalized costs for internal-use software, included in Patents and other intangible assets in the table above, that have not been placed into service.

Fiscal Year	Amount
	(in thousands)
2023 (remaining 3 months)	$	13,014
2024	40,799
2025	26,696
2026	16,575
2027	12,262
Thereafter	19,570
	$	128,916

XML

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables)

9 Months Ended

Mar. 26, 2023

Payables and Accruals [Abstract]

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consist of the following:

	March 26, 2023		June 26, 2022
	(in thousands)
Accrued compensation	$	433,643	$	481,070
Warranty reserves	277,183		232,248
Income and other taxes payable	383,610		465,601
Dividend payable	233,043		205,615
Restructuring	75,257		—
Other	587,411		589,738
	$	1,990,147	$	1,974,272

XML

COMMITMENTS AND CONTINGENCIES (Tables)

9 Months Ended

Mar. 26, 2023

Commitments and Contingencies Disclosure [Abstract]

Schedule of Changes in Product Warranty Reserves

Changes in the Company’s product warranty reserves were as follows:

	Three Months Ended				Nine Months Ended
	March 26, 2023		March 27, 2022		March 26, 2023		March 27, 2022
	(in thousands)
Balance at beginning of period	$	318,969	$	228,388	$	256,258	$	191,758
Warranties issued during the period	54,158		71,707		225,735		213,816
Settlements made during the period	(60,440)		(71,957)		(187,174)		(200,375)
Changes in liability for warranties issued during the period	(942)		—		999		—
Changes in liability for pre-existing warranties	1,087		12,190		17,014		35,129
Balance at end of period	$	312,832	$	240,328	$	312,832	$	240,328

XML

STOCK REPURCHASE PROGRAM (Tables)

9 Months Ended

Mar. 26, 2023

Equity [Abstract]

Schedule of Repurchases Under the Repurchase Program

Repurchases under the repurchase program were as follows during the periods indicated:

Period	Total Number of Shares Repurchased		Total Cost of Repurchase			Average Price Paid Per  Share (1)			Amount Available Under Repurchase Program (3)
	(in thousands, except per share data)
Available balance as of June 26, 2022									$	5,514,636
Quarter ended September 25, 2022	675	(2)	$	104,982		$	432.74		$	5,409,654
Quarter ended December 25, 2022	1,125		$	483,226		$	429.42		$	4,926,428
Quarter ended March 26, 2023	1,017		$	483,418	(3)	$	475.18	(3)	$	4,443,010

(1)    Average price paid per share excludes the effect of accelerated share repurchase activities. See additional disclosure below regarding the Company’s accelerated share repurchase activity during the nine months ended March 26, 2023.

(2)    Includes shares received at final settlement of accelerated share repurchase agreements; see additional disclosures below regarding the Company’s accelerated share repurchase activity during the nine months ended March 26, 2023.

(3)    As of January 1, 2023, the Company’s net share repurchases are subject to a 1% excise tax under the Inflation Reduction Act. Excise tax incurred reduces the amount available under the repurchase program, as applicable, and is included in the cost of share repurchased in the Condensed Consolidated Statement of Stockholders’ Equity.

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS (Tables)

9 Months Ended

Mar. 26, 2023

Equity [Abstract]

Components of Accumulated Other Comprehensive Loss

The components of accumulated other comprehensive loss, net of tax at March 26, 2023, as well as the activity for the nine months ending March 26, 2023, were as follows:

	Accumulated Foreign Currency Translation Adjustment		Accumulated Unrealized  Gain or Loss on Cash flow hedges		Accumulated Unrealized  Holding Gain or Loss on Available-For-Sale Investments		Accumulated Unrealized  Components of Defined  Benefit Plans		Total
	(in thousands)
Balance at June 26, 2022	$	(81,755)	$	(12,330)	$	(1,637)	$	(14,260)	$	(109,982)
Other comprehensive income (loss) before reclassifications	11,588		(3,135)		1,222		848		10,523
Gains reclassified from accumulated other comprehensive loss to net income (1)	—		(5,478)		(158)		—		(5,636)
Net current-period other comprehensive income (loss)	11,588		(8,613)		1,064		848		4,887
Balance at March 26, 2023	$	(70,167)	$	(20,943)	$	(573)	$	(13,412)	$	(105,095)

(1)    Amount of after-tax gains reclassified from AOCI into net income is not material in the aggregate, or to any individual location in our Condensed Consolidated Statements of Operations.

XML

BUSINESS COMBINATIONS (Tables)

9 Months Ended

Mar. 26, 2023

Business Combination and Asset Acquisition [Abstract]

Schedule of Preliminary Fair Value Estimates of Identifiable Intangible Assets

The following table is a summary of the preliminary fair value estimates of the identifiable intangible assets and their useful lives:

	Weighted-Average Useful Life	Estimated Purchase Date Fair Value
		(in thousands)
Existing technology	7 years	$	40,294
Customer relationships	8 years	10,835
In process research and development	Indefinite	30,081
		$	81,210

XML

RESTRUCTURING CHARGES, NET (Tables)

9 Months Ended

Mar. 26, 2023

Restructuring and Related Activities [Abstract]

Summary of the Activity Related to the Restructuring Plan

The following table is a summary of the activity related to the restructuring plan:

	Severance and Benefits		Other		Total
	(in thousands)
Restructuring expense	$	98,508	$	8,620	$	107,128
Cash payments	(20,658)		(2,967)		(23,625)
Non-cash activities	(2,269)		(794)		(3,063)
Restructuring liability as of March 26, 2023	$	75,581	$	4,859	$	80,440

XML

REVENUE - Additional Information (Details) $ in Millions	3 Months Ended	9 Months Ended
	Mar. 26, 2023 USD ($)	Mar. 26, 2023 USD ($) primary_market region segment
Revenue from Contract with Customer [Abstract]
Revenue recognized | $	$ 149.1	$ 1,881.8
Number of reportable business segment | segment		1
Number of operating geographic regions | region		7
Number of primary markets | primary_market		3

XML

REVENUE - Summary of Contract Transaction Price Not Yet Recognized as Revenue (Details) $ in Thousands	Mar. 26, 2023 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue	$ 2,002,744
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-03-27
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue	$ 1,731,567
Deferred revenue, expected recognition period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue	$ 243,733
Deferred revenue, expected recognition period	2 years
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-03-30
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Deferred revenue	$ 27,444
Deferred revenue, expected recognition period

XML

REVENUE - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 26, 2023	Mar. 27, 2022	Mar. 26, 2023	Mar. 27, 2022
Disaggregation of Revenue [Line Items]
Revenue	$ 3,869,569	$ 4,060,416	$ 14,221,259	$ 12,591,485
Korea
Disaggregation of Revenue [Line Items]
Revenue	847,728	961,300	2,780,158	2,947,657
China
Disaggregation of Revenue [Line Items]
Revenue	839,710	1,277,502	3,633,692	3,966,185
Taiwan
Disaggregation of Revenue [Line Items]
Revenue	713,708	663,494	2,825,827	2,074,681
United States
Disaggregation of Revenue [Line Items]
Revenue	594,426	309,161	1,402,641	782,170
Japan
Disaggregation of Revenue [Line Items]
Revenue	406,219	342,329	1,440,857	1,324,996
Europe
Disaggregation of Revenue [Line Items]
Revenue	311,843	128,149	912,249	387,685
Southeast Asia
Disaggregation of Revenue [Line Items]
Revenue	155,935	378,481	1,225,835	1,108,111
System revenue
Disaggregation of Revenue [Line Items]
Revenue	2,256,033	2,650,842	8,985,538	8,315,898
Customer support-related revenue and other
Disaggregation of Revenue [Line Items]
Revenue	$ 1,613,536	$ 1,409,574	$ 5,235,721	$ 4,275,587

XML

REVENUE - Schedule of System Revenues of Primary Markets (Details) - Equipment and upgrade revenue - Revenue	3 Months Ended		9 Months Ended
	Mar. 26, 2023	Mar. 27, 2022	Mar. 26, 2023	Mar. 27, 2022
Memory
Concentration Risk [Line Items]
Concentration by percent	32.00%	66.00%	46.00%	62.00%
Foundry
Concentration Risk [Line Items]
Concentration by percent	46.00%	21.00%	18.00%	26.00%
Logic/integrated device manufacturing
Concentration Risk [Line Items]
Concentration by percent	22.00%	13.00%	36.00%	12.00%

XML

EQUITY-BASED COMPENSATION PLANS - Additional Information (Details)	9 Months Ended
	Mar. 26, 2023
Share-Based Payment Arrangement [Abstract]
Vesting period (in years)	3 years

XML

EQUITY-BASED COMPENSATION PLANS - Recognized Equity-Based Compensation Expenses and Related Income Tax Benefit (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 26, 2023	Mar. 27, 2022	Mar. 26, 2023	Mar. 27, 2022
Share-Based Payment Arrangement [Abstract]
Equity-based compensation expense	$ 73,911	$ 68,543	$ 218,105	$ 189,476
Income tax benefit recognized related to equity-based compensation expense	$ 12,045	$ 23,933	$ 32,249	$ 41,155

XML

OTHER INCOME (EXPENSE), NET - Components of Other Expense, Net (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 26, 2023	Mar. 27, 2022	Mar. 26, 2023	Mar. 27, 2022
Other Income and Expenses [Abstract]
Interest income	$ 41,974	$ 1,938	$ 83,155	$ 8,988
Interest expense	(47,217)	(46,710)	(139,930)	(138,531)
Gains (losses) on deferred compensation plan-related assets, net	5,443	(13,118)	3,588	(5,737)
Foreign exchange (losses) gains, net	(5,519)	943	(8,812)	1,657
Other, net	1,988	(455)	(12,661)	65,363
Other income (expense), net	$ (3,331)	$ (57,402)	$ (74,660)	$ (68,260)

XML

OTHER INCOME (EXPENSE), NET - Additional Information (Details) $ in Millions	9 Months Ended
	Mar. 27, 2022 USD ($)
Corporate equities | Publicly traded
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unrealized gain	$ 63.6

XML

INCOME TAX EXPENSE (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
	Sep. 25, 2022	Mar. 26, 2023	Mar. 27, 2022	Mar. 26, 2023	Mar. 27, 2022
Income Tax Disclosure [Abstract]
Income tax expense		$ 124,914	$ 112,917	$ 537,201	$ 437,857
Effective tax rate		13.30%	10.00%	12.70%	11.40%
Tax examinations or lapses of statute of limitation
Income Tax Contingency [Line Items]
Estimated unrecognized tax benefits reduction (up to)		$ 18,300		$ 18,300
Tax Year 2018
Income Tax Contingency [Line Items]
Settlement	$ 50,000

XML

NET INCOME PER SHARE - Schedule of Numerators and Denominators of Basic and Diluted Computations for Net Income Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 26, 2023	Mar. 27, 2022	Mar. 26, 2023	Mar. 27, 2022
Numerator:
Net income	$ 814,008	$ 1,021,778	$ 3,708,394	$ 3,396,352
Denominator:
Basic average shares outstanding (in shares)	134,924	139,229	135,945	140,534
Effect of potential dilutive securities:
Employee stock plans (in shares)	471	828	369	866
Diluted average shares outstanding (in shares)	135,395	140,057	136,314	141,400
Net income per share - basic (in dollars per share)	$ 6.03	$ 7.34	$ 27.28	$ 24.17
Net income per share - diluted (in dollars per share)	$ 6.01	$ 7.30	$ 27.20	$ 24.02

XML

FINANCIAL INSTRUMENTS - Additional Information (Details) - USD ($) $ in Millions	Mar. 26, 2023	Jun. 26, 2022
Corporate equities | Nonrecurring
Derivative Instruments, Gain (Loss) [Line Items]
Equity investments	$ 128.9	$ 125.2

XML

FINANCIAL INSTRUMENTS - Schedule of Cash, Cash Equivalents, Investments, Restricted Cash and Investments and Other Assets Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Mar. 26, 2023	Jun. 26, 2022		Mar. 27, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, Cost	$ 4,209,204
Debt securities, Fair Value	4,208,460
Cash and Cash Equivalents	5,305,648	$ 3,522,001	[1]	$ 4,194,719
Investments	63,849	135,731	[1]
Restricted Cash & Investments	250,688	251,534	[1]
Other Assets	97,318	95,219
Cash
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	1,411,064	1,015,747
Investments	0	0
Restricted Cash & Investments	661	1,506
Other Assets	2,838	0
Time deposits
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	1,359,867	1,794,178
Investments	0	0
Restricted Cash & Investments	250,027	250,028
Other Assets	0	0
Recurring
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	2,686,314	934,786
Unrealized Gain	9,710	12,027
Unrealized (Loss)	(2,978)	(3,787)
Fair Value	2,693,046	943,026
Fair Value	5,717,503	4,004,485
Recurring | Cash
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	1,414,563	1,017,253
Recurring | Time deposits
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value	1,609,894	2,044,206
Level 1:
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	2,534,717	712,076
Investments	0	0
Restricted Cash & Investments	0	0
Other Assets	94,480	95,219
Level 1: | Money market funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	2,534,717	712,076
Investments	0	0
Restricted Cash & Investments	0	0
Other Assets	0	0
Level 1: | Mutual funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Investments	0	0
Restricted Cash & Investments	0	0
Other Assets	94,480	95,219
Level 1: | Recurring
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cost	2,621,721	796,927
Unrealized Gain	9,710	12,027
Unrealized (Loss)	(2,234)	(1,659)
Fair Value	2,629,197	807,295
Level 1: | Recurring | Money market funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, Cost	2,534,717	712,076
Debt securities, Unrealized Gain	0	0
Debt securities, Unrealized (Loss)	0	0
Debt securities, Fair Value	2,534,717	712,076
Level 1: | Recurring | Mutual funds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Trading securities, Cost	87,004	84,851
Trading securities, Unrealized Gain	9,710	12,027
Trading securities, Unrealized (Loss)	(2,234)	(1,659)
Trading securities, Fair Value	94,480	95,219
Level 2:
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Investments	63,849	135,731
Restricted Cash & Investments	0	0
Other Assets	0	0
Level 2: | Corporate notes and bonds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Cash and Cash Equivalents	0	0
Investments	63,849	135,731
Restricted Cash & Investments	0	0
Other Assets	0	0
Level 2: | Recurring
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, Cost	64,593	137,859
Debt securities, Unrealized Gain	0	0
Debt securities, Unrealized (Loss)	(744)	(2,128)
Debt securities, Fair Value	63,849	135,731
Level 2: | Recurring | Corporate notes and bonds
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Debt securities, Cost	64,593	137,859
Debt securities, Unrealized Gain	0	0
Debt securities, Unrealized (Loss)	(744)	(2,128)
Debt securities, Fair Value	$ 63,849	$ 135,731

[1] Derived from audited financial statements

XML

FINANCIAL INSTRUMENTS - Schedule of Investments in Unrealized Loss Positions (Details) $ in Thousands	Mar. 26, 2023 USD ($)
Fair Value
Unrealized Losses Less than 12 Months	$ 28,472
Unrealized Losses 12 Months or Greater	61,892
Fair Value	90,364
Gross Unrealized Loss
Unrealized Losses Less than 12 Months	(1,010)
Gross Unrealized Loss	(1,968)
Gross Unrealized Loss	(2,978)
Mutual funds
Fair Value
Unrealized Losses Less than 12 Months, trading	11,634
Unrealized Losses 12 Months or Greater, trading	15,332
Trading , Fair Value	26,966
Gross Unrealized Loss
Unrealized Losses Less than 12 Months, trading	(922)
Unrealized Losses 12 Months or Greater, trading	(1,312)
Gross Unrealized Loss, trading	(2,234)
Corporate notes and bonds
Fair Value
Unrealized Losses Less than 12 Months, available for sale	16,838
Unrealized Losses 12 Months or Greater, available for sale	46,560
Available for sale, Fair Value	63,398
Gross Unrealized Loss
Unrealized Losses Less than 12 Months, available for sale	(88)
Unrealized Losses 12 Months or Greater, available for sale	(656)
Gross Unrealized Loss, available for sale	$ (744)

XML

FINANCIAL INSTRUMENTS - Schedule of Amortized Cost and Fair Value of Cash Equivalents, Investments, and Restricted Cash and Investments with Contractual Maturities (Details) $ in Thousands	Mar. 26, 2023 USD ($)
Cost
Due in one year or less	$ 4,200,733
Due after one year through five years	8,471
Debt securities, Cost	4,209,204
Fair Value
Due in one year or less	4,200,066
Due after one year through five years	8,394
Fair Value	$ 4,208,460

XML

INVENTORIES (Details) - USD ($) $ in Thousands	Mar. 26, 2023	Jun. 26, 2022
Inventory Disclosure [Abstract]
Raw materials	$ 3,219,721	$ 2,401,490
Work-in-process	396,415	471,348
Finished goods	1,265,799	1,093,456
Total inventories	$ 4,881,935	$ 3,966,294	[1]

[1] Derived from audited financial statements

XML

GOODWILL AND INTANGIBLE ASSETS - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 26, 2023	Mar. 27, 2022	Mar. 26, 2023	Mar. 27, 2022	Jun. 26, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	$ 1,622,172		$ 1,622,172		$ 1,515,113	[1]
Tax deductible goodwill	62,000		62,000		$ 62,000
Intangible asset amortization expense	13,800	$ 20,400	37,400	$ 58,900
Capitalized costs for internal-use software	$ 20,700		$ 20,700

[1] Derived from audited financial statements

XML

GOODWILL AND INTANGIBLE ASSETS - Schedule of Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 26, 2023	Jun. 26, 2022
Finite-Lived Intangible Assets [Line Items]
Gross	$ 1,558,905	$ 1,477,997
Accumulated Amortization	(1,409,339)	(1,376,147)
Net	149,566	101,850
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Gross	1,588,986	1,477,997
Accumulated Amortization	(1,409,339)	(1,376,147)
Net	179,647	101,850	[1]
In process research and development
Indefinite-Lived Intangible Assets [Line Items]
Indefinite-lived intangible assets	30,081	0
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross	644,083	633,252
Accumulated Amortization	(630,262)	(627,376)
Net	13,821	5,876
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	(630,262)	(627,376)
Existing technology
Finite-Lived Intangible Assets [Line Items]
Gross	717,210	676,924
Accumulated Amortization	(671,335)	(664,278)
Net	45,875	12,646
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	(671,335)	(664,278)
Patents and other intangible assets
Finite-Lived Intangible Assets [Line Items]
Gross	197,612	167,821
Accumulated Amortization	(107,742)	(84,493)
Net	89,870	83,328
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Accumulated Amortization	$ (107,742)	$ (84,493)

[1] Derived from audited financial statements

XML

GOODWILL AND INTANGIBLE ASSETS - Estimated Future Amortization Expense of Intangible Assets (Details) $ in Thousands	Mar. 26, 2023 USD ($)
Fiscal Year
2023 (remaining 3 months)	$ 13,014
2024	40,799
2025	26,696
2026	16,575
2027	12,262
Thereafter	19,570
Net	$ 128,916

XML

ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) - USD ($) $ in Thousands	Mar. 26, 2023	Jun. 26, 2022
Payables and Accruals [Abstract]
Accrued compensation	$ 433,643	$ 481,070
Warranty reserves	277,183	232,248
Income and other taxes payable	383,610	465,601
Dividend payable	233,043	205,615
Restructuring	75,257	0
Other	587,411	589,738
Accrued expenses and other current liabilities	$ 1,990,147	$ 1,974,272	[1]

[1] Derived from audited financial statements

XML

LONG-TERM DEBT AND OTHER BORROWINGS - Additional Information (Details) - Revolving credit facility - USD ($)	Dec. 07, 2022	Mar. 26, 2023
Line of Credit Facility [Line Items]
Borrowings outstanding		$ 0
Adjusted term SOFR
Line of Credit Facility [Line Items]
Variable interest spread	0.10%
Federal Funds rate
Line of Credit Facility [Line Items]
Variable interest spread	0.50%
SOFR
Line of Credit Facility [Line Items]
Variable interest spread	1.00%
SOFR | Minimum | Variable Rate Component One
Line of Credit Facility [Line Items]
Variable interest spread	0.00%
SOFR | Minimum | Variable Rate Component Two
Line of Credit Facility [Line Items]
Variable interest spread	0.805%
SOFR | Maximum | Variable Rate Component One
Line of Credit Facility [Line Items]
Variable interest spread	0.30%
SOFR | Maximum | Variable Rate Component Two
Line of Credit Facility [Line Items]
Variable interest spread	1.30%

XML

LEASES (Details) - USD ($) $ in Thousands	Mar. 26, 2023	Jun. 26, 2022	[1]
Guarantor Obligations [Line Items]
Restricted cash and investments	$ 250,688	$ 251,534
California Facility Leases
Guarantor Obligations [Line Items]
Additional term	7 years
Cash collateral
Guarantor Obligations [Line Items]
Restricted cash and investments	$ 250,000
California Facility Leases
Guarantor Obligations [Line Items]
Residual value of operating lease, maximum	$ 298,400

[1] Derived from audited financial statements

XML

COMMITMENTS AND CONTINGENCIES - Additional Information (Details) - USD ($) $ in Thousands	Mar. 26, 2023	Dec. 25, 2022	Jun. 26, 2022	Mar. 27, 2022	Dec. 26, 2021	Jun. 27, 2021
Loss Contingencies [Line Items]
Warranty reserves	$ 312,832	$ 318,969	$ 256,258	$ 240,328	$ 228,388	$ 191,758
Other long-term liabilities
Loss Contingencies [Line Items]
Warranty reserves	35,600
Letters of Credit
Loss Contingencies [Line Items]
Maximum potential amount of future payments	$ 99,600

XML

COMMITMENTS AND CONTINGENCIES - Schedule of Changes in Product Warranty Reserves (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 26, 2023	Mar. 27, 2022	Mar. 26, 2023	Mar. 27, 2022
Changes in Product Warranty Reserve
Balance at beginning of period	$ 318,969	$ 228,388	$ 256,258	$ 191,758
Warranties issued during the period	54,158	71,707	225,735	213,816
Settlements made during the period	(60,440)	(71,957)	(187,174)	(200,375)
Changes in liability for warranties issued during the period	(942)	0	999	0
Changes in liability for pre-existing warranties	1,087	12,190	17,014	35,129
Balance at end of period	$ 312,832	$ 240,328	$ 312,832	$ 240,328

XML

STOCK REPURCHASE PROGRAM - Additional Information (Details) $ / shares in Units, shares in Thousands		1 Months Ended			3 Months Ended			9 Months Ended
	Jun. 02, 2022 USD ($) financial_institution shares	Sep. 30, 2022 shares	Sep. 25, 2022 $ / shares	May 31, 2022 USD ($)	Mar. 26, 2023 USD ($) $ / shares shares	Dec. 25, 2022 $ / shares shares	Sep. 25, 2022 $ / shares shares	Mar. 26, 2023 USD ($) shares
Equity, Class of Treasury Stock [Line Items]
Net shares of settlements to cover tax withholding obligations (in shares) | shares					148			167
Amount paid for shares under net share settlements | $					$ 72,500,000			$ 80,400,000
Stock repurchase program
Equity, Class of Treasury Stock [Line Items]
Increase in authorized amount | $				$ 5,000,000,000
Purchase of treasury stock (in shares) | shares					1,017	1,125	675
Weighted-average share price (in dollars per share) | $ / shares					$ 475.18	$ 429.42	$ 432.74
June 2022 ARS
Equity, Class of Treasury Stock [Line Items]
Number of financial institutions | financial_institution	2
Repurchase amount | $	$ 500,000,000
Purchase of treasury stock (in shares) | shares	717	433
Percent of prepayment amount	75.00%
Weighted-average share price (in dollars per share) | $ / shares			$ 435.20

XML

STOCK REPURCHASE PROGRAM - Repurchases Under the Repurchase Program (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended				9 Months Ended
	Mar. 26, 2023	Dec. 25, 2022	Sep. 25, 2022	Mar. 27, 2022	Mar. 26, 2023	Mar. 27, 2022	Jun. 26, 2022
Equity, Class of Treasury Stock [Line Items]
Total Cost of Repurchase	$ 555,899			$ 1,322,527	$ 1,152,033	$ 2,974,193
Stock repurchase program
Equity, Class of Treasury Stock [Line Items]
Total Number of Shares Repurchased (in shares)	1,017	1,125	675
Total Cost of Repurchase	$ 483,418	$ 483,226	$ 104,982
Average Price Paid Per Share (in dollars per share)	$ 475.18	$ 429.42	$ 432.74
Amount Available Under Repurchase Program	$ 4,443,010	$ 4,926,428	$ 5,409,654		$ 4,443,010		$ 5,514,636

XML

ACCUMULATED OTHER COMPREHENSIVE LOSS - Components of Accumulated Other Comprehensive Loss (Details) $ in Thousands	9 Months Ended
	Mar. 26, 2023 USD ($)
Change in Accumulated Other Comprehensive Loss
Beginning balance	$ 6,278,366	[1]
Other comprehensive income (loss) before reclassifications	10,523
Gains reclassified from accumulated other comprehensive loss to net income	(5,636)
Net current-period other comprehensive income (loss)	4,887
Ending balance	8,407,388
Total
Change in Accumulated Other Comprehensive Loss
Beginning balance	(109,982)
Ending balance	(105,095)
Accumulated Foreign Currency Translation Adjustment
Change in Accumulated Other Comprehensive Loss
Beginning balance	(81,755)
Other comprehensive income (loss) before reclassifications	11,588
Gains reclassified from accumulated other comprehensive loss to net income	0
Net current-period other comprehensive income (loss)	11,588
Ending balance	(70,167)
Accumulated Unrealized  Gain or Loss on Cash flow hedges
Change in Accumulated Other Comprehensive Loss
Beginning balance	(12,330)
Other comprehensive income (loss) before reclassifications	(3,135)
Gains reclassified from accumulated other comprehensive loss to net income	(5,478)
Net current-period other comprehensive income (loss)	(8,613)
Ending balance	(20,943)
Accumulated Unrealized  Holding Gain or Loss on Available-For-Sale Investments
Change in Accumulated Other Comprehensive Loss
Beginning balance	(1,637)
Other comprehensive income (loss) before reclassifications	1,222
Gains reclassified from accumulated other comprehensive loss to net income	(158)
Net current-period other comprehensive income (loss)	1,064
Ending balance	(573)
Accumulated Unrealized  Components of Defined  Benefit Plans
Change in Accumulated Other Comprehensive Loss
Beginning balance	(14,260)
Other comprehensive income (loss) before reclassifications	848
Gains reclassified from accumulated other comprehensive loss to net income	0
Net current-period other comprehensive income (loss)	848
Ending balance	$ (13,412)

[1] Derived from audited financial statements

XML

BUSINESS COMBINATIONS - Additional Information (Details) $ in Thousands	1 Months Ended
	Nov. 30, 2022 USD ($) business	Mar. 26, 2023 USD ($)	Jun. 26, 2022 USD ($)	[1]
Business Acquisition [Line Items]
Goodwill		$ 1,622,172	$ 1,515,113
Two separate private companies
Business Acquisition [Line Items]
Number of businesses transactions | business	2
Consideration transferred of cash	$ 153,800
Goodwill	102,200
Intangible assets	81,210
Other assets acquired	0
Liabilities assumed	$ 0

[1] Derived from audited financial statements

XML

BUSINESS COMBINATIONS - Schedule of Identified Intangible Assets Assumed in the Acquisition (Details) - Two separate private companies $ in Thousands	1 Months Ended
	Nov. 30, 2022 USD ($)
Acquired Finite-Lived Intangible Assets [Line Items]
Estimated Purchase Date Fair Value	$ 81,210
In process research and development
Acquired Finite-Lived Intangible Assets [Line Items]
In process research and development	$ 30,081
Existing technology
Acquired Finite-Lived Intangible Assets [Line Items]
Weighted-Average Useful Life	7 years
Finite-lived intangible assets acquired	$ 40,294
Customer relationships
Acquired Finite-Lived Intangible Assets [Line Items]
Weighted-Average Useful Life	8 years
Finite-lived intangible assets acquired	$ 10,835

XML

RESTRUCTURING CHARGES, NET - Additional Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 26, 2023 USD ($) employee	Mar. 27, 2022 USD ($)	Mar. 26, 2023 USD ($) employee	Mar. 27, 2022 USD ($)
Restructuring and Related Activities [Abstract]
Headcount reduction | employee	1,400		1,400
Restructuring charges, net - cost of goods sold	$ 66,720	$ 0	$ 66,720	$ 0
Restructuring charges, net - operating expenses	40,408	$ 0	40,408	$ 0
Anticipated incremental restructuring charges	$ 40,000		$ 40,000

XML

RESTRUCTURING CHARGES, NET - Summary of the Activity Related to the Restructuring Plan (Details) $ in Thousands	9 Months Ended
	Mar. 26, 2023 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	$ 107,128
Cash payments	23,625
Non-cash activities	3,063
Restructuring liability as of March 26, 2023	80,440
Severance and Benefits
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	98,508
Cash payments	20,658
Non-cash activities	2,269
Restructuring liability as of March 26, 2023	75,581
Other
Restructuring Cost and Reserve [Line Items]
Restructuring Charges	8,620
Cash payments	2,967
Non-cash activities	794
Restructuring liability as of March 26, 2023	$ 4,859